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Studies on chemistry of N-heterocyclic carbene-borane complexes (NHC-boranes), a new class 
of organic reagents, are reported. The radical chain mechanism of xanthate reduction with 
NHC-boranes has been established by the evaluation of rate constants of hydrogen abstraction, 
the isolation of boron-derived by-products, and EPR spectroscopic studies.  
NHC-BH3 complexes have been found to react with many electrophilic compounds. They 
reduce alkyl halides and sulfonates by an ionic mechanism. The boron products of their reactions 
with halogenation agents, Brønsted and Lewis acids were isolated and characterized.  
NHC-boryl iodide and triflate complexes undergo nucleophilic substitutions at the boron 
atom. In this way, a variety of substituted boranes with unusual and unprecedented structural 
motifs were prepared, including boryl azides, nitrosooxyborane, and nitroborane. The reaction 
with phenoxides in tetrahydrofuran (THF) afforded unexpected products of THF ring opening. A 
compound with a novel dihydroxyborenium cation was obtained from certain disubstituted 
NHC-boranes under acidic conditions. 
Reduction of NHC-boryl iodide complex with lithium di-tert-butylbiphenylide (LDDB) 
gave a reactive NHC-boryl anion. This was trapped with several electrophiles to obtain boron-
substituted complexes, including acyl boranes. Deprotonation of imidazol-2-ylidene-boranes 
with BuLi and subsequent reactions with electrophiles allowed us to prepare ring-functionalized 
NHC-borane complexes. The resulting complexes of substituted NHC and BH3 can be converted 
to corresponding substituted imidazolium salts by a simple deboronation protocol. 
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 1 
1.0  INTRODUCTION 
In this dissertation, I report my research on the chemistry of the complexes between 
N-heterocyclic carbenes (NHC) and boranes. Section 1 introduces the importance of Lewis 
adducts of boranes in organic chemistry and provides an overview of the literature on carbene-
boranes. Section 2 describes mechanistic studies of the radical reduction of alkyl xanthates with 
NHC-BH3 complexes. In Section 3, the reactions of NHC-BH3 with various electrophilic 
reagents are presented. These include the ionic reductions of alkyl halides and sulfonates, 
reactions with halogenation agents, and reactions with strong Brønsted and Lewis acids. Section 
4 deals with the nucleophilic substitution at the boron atom in NHC-boranes. During this 
research, we discovered an unusual THF ring-opening reaction and synthesized an 
unprecedented dihydroxyborenium cation. Finally, the reactions of NHC-borane anions with 
electrophiles are reported in Section 5. Depending on the structure of the anion, either boron or 
NHC part of NHC-boranes can be functionalized. 
 After general conclusions made in Section 6, the experimental details and 
characterization of new compounds are reported in Section 7. Appendix A includes stereoviews 
of X-ray crystal structures. Appendix B describes the content of the supporting DVD. 
 2 
1.1 COMPLEXES OF BORANES WITH LEWIS BASES 
Boron-based reagents (boranes, borohydrides, boronic acids and esters) play an important role in 
modern organic synthesis.
1
 The parent tricoordinate borane 1 exerts Lewis acidic properties due 
to its vacant p-orbital (Scheme 1). The complexation with neutral or negatively charged Lewis 
bases results in neutral (2) or anionic (3) Lewis acid–base complexes that contain a four-
coordinate boron atom. Such adducts are also called ligated boranes. 
 
Scheme 1. Borane 1 forms neutral (with THF) and anionic (with H
–
) Lewis complexes. 
Almost all boron reactions in organic synthesis either start with four-coordinate boron reagents 
or proceed via four-coordinate boron intermediates. For example, popular borohydride reducing 
agents are formally complexes between borane and Lewis basic hydride (R3B–H
–
). The first step 
of alkene hydroboration is the formation of a weak four-coordinate π-complex between borane 
and alkene. Stereoselective allylation of aldehyde 4 with chiral allylborane 5 requires the 
coordination of a lone electron pair of the C=O group to the boron atom (Scheme 2, top).
2
 The 
reaction proceeds via an intermediate complex 6 and a chair-like transition state to give alcohol 
7.
3
 Another important reaction with organoboron reagents is the Pd-catalyzed Suzuki coupling.
4
 
Aryl boronic acid 8 initially associates with a base to an “ate” complex 9.5 Transmetallation with 
an aryl palladium species 10, derived from starting bromide 11, gave the biaryl product 12 
(Scheme 2, bottom).
6
 
 3 
 
Scheme 2. Four-coordinate boron intermediates 6 and 9 in the Brown allylation and Suzuki coupling 
reactions. 
In complexes with ethers and sulfides, boranes are weakly bound. This makes BH3-THF and 
BH3-SMe2 convenient commercial sources of boranes in the laboratory. In solution, they 
equilibrate with free borane
7
 and can be used instead of toxic gaseous diborane B2H6.
8
 
Boranes form much stronger bonds with amines and especially phosphines.
9,10
 These 
complexes can be split either at high temperature or by the substitution with an even stronger 
Lewis base. Thus, amine-boranes can be employed when a slow addition of borane is desirable. 
For example, tricyclic dodecahydro-1H-3a
1
-boraphenalene 13 was synthesized by hydroboration 
of cyclododeca-1,5,9-triene 14 with Et3N-BH3 at 140 °C (Scheme 3, top).
9
 Recently, Vedejs and 
coworkers developed the protocol for the low-temperature hydroboration with amine-boranes 
activated with I2 or TfOH.
11
 Pyridine-boryl iodide 15, prepared in situ from unreactive pyridine-
borane 16 and iodine, hydroborates β-methylstyrene 17. The oxidative workup gave a 
15:1 mixture of regioisomeric alcohols 18 (Scheme 3, bottom). 
 4 
 
 
Scheme 3. Hydroboration of alkenes with amine-boranes. 
Phosphine-boranes are even more stable complexes that do not exhibit typical free borane 
chemistry. The complexation with a BH3 group protects a phosphine from the oxidation to a 
phosphine oxide. For example, the hydrazone group of complex 19 was removed by ozonolysis 
without affecting the phosphine-borane part. The resulting aldehyde 20 was then reduced to 
alcohol 21, which was finally deprotected to free phosphine 22 by treatment with an excess of 
DABCO (Scheme 4).
12
 
 
Scheme 4. Sequential ozonolysis, reduction, and deprotection of phosphine-borane 19. 
Other important applications of amine-boranes in organic synthesis are reductions of C=N and 
C=O bonds. Successful reductive amination of cyclohexanone 23 to aniline 24 was achieved 
with the stable liquid 5-ethyl-2-methylpyridine-borane 25.
13
 Amine-boranes react slowly with a 
starting ketone and rapidly with an intermediate iminium cation (Scheme 5, top). The Corey–
 5 
Bakshi–Shibata protocol for the catalytic asymmetric reduction of ketones employs BH3-THF as 
a terminal reducing agent but the active reductant is the chiral oxazaborolidine-BH3 complex 26. 
The reduction of acetophenone 27 to chiral alcohol 28 was accomplished in high yield and with 
excellent stereoselectivity (Scheme 5, bottom).
14
 
 
Scheme 5. Reductions of C=N and C=O bonds with amine-boranes. 
Besides the synthetic methodology, the interest in the chemistry of boranes and ways of their 
functionalization is maintained by the discovery of boron-containing natural compounds and 
pharmaceuticals. The macrocyclic antiobiotic boromycin was isolated from soil bacteria
15
 and 
the dipeptidyl boronic acid bortezomib is a proteosome inhibitor and an anticancer drug 
(Velcade®)16 (Figure 1). Boron analogs of aminoacids (for example, Me3N-BH2-COOH) have 
been found to exhibit anticancer, anti-inflammatory, analgesic, and hypolipidemic activities.
17
 
Ammonia-borane complex H3N-BH3 has become one of leading candidates for the chemical 
hydrogen storage.
18
 Many groups continue the search for its effective catalytic dehydrogenation 
and recovery.
19
 
 6 
 
Figure 1. The structures of boromycin and bortezomib.
 
1.2 NHC-BORANES 
N-Heterocyclic carbenes (NHCs) are a relatively new class of neutral Lewis bases. In 1991, the 
Arduengo group reported the isolation and the crystal structure of the stable free NHC, 
1,3-bis(adamantyl)imidazol-2-ylidene 29 (Figure 2, left).
20
 The carbene center is stabilized by 
two neighboring nitrogen atoms and bears a lone electron pair that is responsible for the 
nucleophilic and Lewis basic character of NHCs. From the electronic point of view, NHCs are 
strong σ-donors and weak π-acceptors. They have seen widespread applications in organic, 
transition metal, and main group chemistry.
21
 
 
Figure 2. The structures of diAd-Imd 29 and the 2nd generation Grubbs catalyst 30. 
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NHCs have been used as nucleophilic organocatalysts.
22
 They became an alternative to 
traditional Lewis basic ligands such as amines, phosphines, CO, etc. Many complexes of NHCs 
with transition metals have found the application as catalysts for organic transformations.
23
 For 
example, the 2nd generation Grubbs catalyst 30 bearing the 
1,3-bis(2,4,6-trimethylphenyl)imidazolin-2-ylidene ligand is commonly used in alkene 
metathesis (Figure 2, right).
24
 Complexation with bulky NHC groups was widely employed to 
stabilize the unusual oxidation states and allotropic modifications of main group elements.
25
 
Most of these applications have been achieved with easily accessible 
imidazol(in)-2-ylidenes. However, many other classes of free carbenes with various electron 
donating and accepting abilities have been synthesized over last two decades.
26
 In this 
dissertation, the names of imidazol-2-ylidene ligands are abbreviated by writing first substituents 
at nitrogen atoms followed by “-Imd”. For example, 29 will be denoted as diAd-Imd. 
The availability of sterically and electronically diverse NHCs, including chiral ones, can 
explain their growing popularity.
27
 Because of the importance of ligated boranes in modern 
organic synthesis, it would be interesting to study the chemistry of NHC-borane complexes. 
The first NHC-borane complex was prepared in 1968, long before free NHCs were 
isolated. Deprotonation of the isonitrile-triphenylborane complex 31 followed by 1,3-dipolar 
cycloaddition to acetone and reprotonation gave oxazolin-2-ylidene-triphenylborane 32 
(Scheme 6).
28
 
 
Scheme 6. The synthesis of the first NHC-borane complex. 
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Over the next 40 years, several other carbene-boranes were prepared (Figure 3) but no systematic 
research on the chemistry and application of such complexes has been conducted.
29
 Publications 
on carbene-boranes during this period can be divided into two major categories: 
1) Trapping of new carbenes by common boron Lewis acids. For example, Enders 
prepared the first 1,2,4-triazol-5-ylidene-borane 33 (1996)
30
 and Bertrand used BF3 to stabilize 
transient acyclic amino-aryl-carbenes as complex 34 (2004).
31
 
2) Stabilization of unusual and reactive boron species. Representative examples of this 
type are the 3,5-dimethylborabenzene adduct 35 (Herberich, 2000)
32
 and ligated with two NHCs 
diborene(4) HB=BH 36 (Robinson, 2007).
33
  
 
Figure 3. Representative examples of NHC-borane complexes synthesized before 2008. 
The number of publications on NHC-boranes has increased dramatically since this dissertation 
work was begun in 2008. NHC-boranes were applied as radical,
34
 ionic, and organometallic 
reducing agents,
35
 as coupling partners in the Suzuki–Miyaura reaction,36 and as co-initiators in 
flash laser photopolymerization.
37
 NHC-borane intermediates were observed in the NHC-
catalyzed borylation of α,β-unsaturated compounds38 and in the Ni(NHC)2-catalyzed 
dehydrogenation of H3N-BH3.
39
 
NHC-boranes are commonly prepared from a free carbene and a borane complex with a 
weak Lewis base. Complexes of boranes with ethers and sulfides are usually used as 
 9 
demonstrated by the Kuhn’s synthesis of 4,5-Me2-diMe-Imd-BH3 37, the first carbene-BH3 
complex ever prepared (Scheme 7, top).
40
 Even amine-boranes can be employed in this synthesis 
showing that as Lewis bases towards boranes, NHCs are stronger than amines.
41
 Free carbenes 
are easily prepared by in situ deprotonation of azolium salts. For example, the treatment of 
1,3-bis(2,6-diisopropylphenyl)imidazolium chloride 38 with t-BuOK and then refluxing of the 
resulting carbene 39 with Me3N-BH3 gave dipp-Imd-BH3 complex 40  (Scheme 7, bottom).
41
  
 
Scheme 7. The syntheses of NHC-BH3 complexes 37 and 40. 
Among other methods of NHC-borane synthesis, the short route to diMe-Imd-BH3 41 by 
Braunschweig is noteworthy. Only two steps are needed to convert cheap starting materials into 
41 via imidazolium-2-carboxylate 42 (Scheme 8, top).
42
 The reaction of imidazolium chloride 43 
with LiBEt3H allowed Yamaguchi and coworkers to prepare diiPr-Imd-BEt3 44.
43
 Due to the 
bulkiness of the triethylborane group, complex 44 was labile and was used as a carbene analog in 
synthesis of diiPr-Imd-BH3 45 and various NHC-metal complexes (Scheme 8, bottom).
44
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Scheme 8. Syntheses of diMe-Imd-BH3 41 and diiPr-Imd-BEt3 44. 
Many NHC-BH3 complexes such as 40, 41, and 45 are easy available solids, stable to air, 
moisture, chromatography purification, and storage. These features make them attractive as the 
reagents for organic synthesis and as the starting points for the preparation of substituted 
NHC-boranes. 
 
 11 
2.0   MECHANISTIC STUDIES OF RADICAL REDUCTION WITH NHC-BORANES 
2.1 BARTON–MCCOMBIE DEOXYGENATION 
The Barton–McCombie reaction is the radical deoxygenation of thiocarbonyl esters derived from 
secondary alcohols with hydrogen atom donors.
45
 O-Esters of S-methyl dithiocarbonic acid 
ROC(=S)SMe, called xanthates, are especially popular substrates. Radical initiation is done 
either by thermal decomposition of azo compounds (R-N=N-R) such as azobisisobutyronitrile 
(AIBN) or by low temperature reaction of triethylborane with oxygen from air.
46
 The Barton–
McCombie deoxygenation has found a wide application in the total synthesis of natural 
compounds to remove the auxiliary alcohol group introduced in the earlier synthetic steps. 
A recent example from the total synthesis of lepadiformine C 46 is shown in Scheme 9.
47
 
Alcohol 47 was converted to xanthate 48 by a standard protocol. Deoxygenation reaction was 
conducted with AIBN as a radical initiator and Bu3SnH as a hydrogen donor to give 
compound 49. 
 
Scheme 9. The Barton–McCombie deoxygenation in the synthesis of lepadiformine C. 
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Although Bu3SnH remains the most popular hydrogen donor in the Barton–McCombie and other 
radical reactions because of its availability and high reactivity, it has several drawbacks.
48
 It is a 
toxic and expensive reagent. Tin by-products of the reaction are difficult to separate from the 
desired products. The atom economy of the transformation is low. The use of catalytic amounts 
of Bu3SnCl with NaBH3CN as a terminal reducing agent
49
 reduces but does not eliminate these 
problems completely. A number of compounds with weak element–hydrogen bonds have been 
used as alternative hydrogen donors. These include Ph3GeH, (TMS)3SiH, cyclohexa-1,4-diene,
48
 
H3PO2 and its salts,
50
  and trialkylborane-water complexes (the hydrogen atom is abstracted from 
the H2O ligand).
51
 These reagents are often more expensive and less reactive than Bu3SnH, so 
the search for reactive, non-toxic, selective, and cheap hydrogen donors continues. 
Free boranes are poor hydrogen donors because of a high bond dissociation energy 
(BDE) (105 kcal/mol) of a B–H bond in BH3. However, the complexation of BH3 with Lewis 
bases weakens the B–H bond. Ab initio molecular orbital calculations performed by Roberts 
evaluated the BDEs of B–H bonds in H3N-BH3 and H3P-BH3 to be 103 kcal/mol and 
93 kcal/mol, respectively.
52
 Barton and Jacob showed that phosphine-borane Bu3P-BH3 50 can 
act as a hydrogen donor.
53
 Refluxing of a solution of secondary xanthate 51, an excess of 50, and 
0.2 equiv of AIBN in 1,4-dioxane gave the reduction product 52 in 89% yield (Scheme 10).  
 
Scheme 10. Radical reduction of xanthate 51 with Bu3P-BH3. 
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Calculations performed by Rablen at a higher computational level for a large number of Lewis 
base-BH3 complexes showed that BDE(B–H) is considerably smaller (50–80 kcal/mol) in case of 
the Lewis bases with π-orbitals that allow the delocalization of a resulting radical.54 
Unfortunately, many of the calculated complexes such as O=C–BH3, HCN–BH3, or H2C=O–BH3 
are transient intermediates that cannot be used as reagents. Pyridine-BH3 16 (BDE(B–H) = 
68.8 kcal/mol) is a well-known reagent but it quickly decomposes at temperatures higher 50 °C 
or during the storage at rt.
13
 
In 2008, Ueng and coworkers predicted based on the DFT calculations that NHC-boranes 
would be good hydrogen donors in radical reductions.
34
 They reported that dipp-Imd-BH3 40 and 
bicyclic 1,2,4-triazol-3-ylidene-BH3 53 reduce secondary xanthates in 57–84% yields under the 
Barton–McCombie conditions. This was the first application of NHC-boranes as reagents in 
organic synthesis. 
Two typical examples of AIBN- and BEt3-initiated xanthate reductions are shown in 
Scheme 11. In the AIBN example, a solution of secondary xanthate 54, dipp-Imd-BH3 40, and 
AIBN in deaerated benzene was heated at reflux for 10 h to give the product 55 in 65% yield. 
In the BEt3 example, a solution of xanthate 51, complex 53, and BEt3 in benzene was stirred for 
2 h at rt. Air was admitted by piercing of the septum with a needle. The product 52 was isolated 
in 60% yield. Dipp-Imd-BH3 40 was generally less effective than 53. Higher loadings of 
initiators, longer reaction times, and 2 equiv of 40 were required to give the yields similar to 
those with 1 equiv of the complex 53. 
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Scheme 11. Reduction of secondary xanthates with NHC-boranes. 
The proposed mechanism of the reduction of a secondary xanthate 56 with NHC-BH3 57 is 
shown in Scheme 12. It is radical chain process analogous to the established mechanism of the 
Barton–McCombie deoxygenation with Bu3SnH.
55 
 
Scheme 12. The proposed mechanism for the reduction of secondary xanthates with NHC-boranes 
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After initiation (step a), the generated NHC-boryl radical 58 adds (perhaps reversibly) to the 
C=S bond of xanthate 56 (step b). The addition is followed by the fragmentation of the C–O 
bond in the intermediate 59 that leads to a complex 60 and a secondary alkyl radical 61 (step c). 
This radical 61 abstracts a hydrogen atom from NHC-BH3 57 giving the reduction product 62 
and the starting radical 58 and thereby propagating the chain (step d).  
Two lines of evidence were presented to support this mechanism.
34
  First, rearrangements 
typical for alkyl radicals occurred during the reaction. For example, the reduction of xanthate 63 
with 53 gave a mixture of linear products 64 that resulted from the ring-opening of an 
intermediate 1-cyclopropylalkyl radical 65 (Scheme 13). Second, deuterium labeling of the 
product 52 with NHC-BD3 (the deuterium analog of 53) was observed in one case, although the 
yield was low (27%) and the deuterium incorporation was moderate (70%). 
 
Scheme 13. Reduction of xanthate 63 accompanied by a radical rearrangement. 
We felt that more mechanistic evidence was needed to confirm that NHC-BH3 57 is a terminal 
reductant and NHC-BH2• 58 is a chain transfer agent. Many reagents including Et3B,
56
 
Et3B-H2O,
51
 and even some solvents are known to be radical hydrogen donors. The proposed 
NHC-boryls 58 are an unknown class of radicals, so their existence needs strong experimental 
support. 
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Based on the mechanistic framework in Scheme 12, we set out to: 
1) determine the rate constant kH for hydrogen abstraction from NHC-BH3 39 with an alkyl 
radical (Scheme 12, step d); 
2) detect or isolate the boron-derived by-product NHC-BH2SC(=O)SMe (60); 
3) observe NHC-BH2• 58 radicals by EPR spectroscopy; 
4) and perform the reduction of substrates other than xanthates, for example, alkyl halides. 
Aims 1 and 2 were successfully achieved as described below in Sections 2.2 and 2.3. The 
EPR studies of NHC-boryl radicals (aim 3) carried out by Prof. John Walton reported in Section 
2.4. In the pursuit of the aim 4, we discovered that alkyl halides can be reduced with NHC-
boranes by an ionic mechanism (Section 3.1). The boron-derived by-products of these ionic 
reactions were isolated. The development of their chemistry is reported in Sections 3–5. 
2.2 KINETIC STUDIES OF HYDROGEN ABSTRACTION FROM NHC-BORANES 
Knowledge of relative rate constants is important during planning of radical reactions. For 
example, a careful choice of a hydrogen donor and its concentration allows one to perform either 
the direct reduction of a radical precursor or the reduction after a competing radical 
rearrangement. By using less reactive hydrogen donors and lower concentrations, slower 
rearrangements can be conducted. However, the rate of hydrogen abstraction must be faster than 
the termination of the radical chain process. A range of hydrogen donors with various rate 
constants of hydrogen abstraction kH is available. A scale with several of the most popular 
reagents and their rate constant of hydrogen abstraction with a primary alkyl radical RCH2• is 
shown in Figure 4.
57 
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Figure 4. The scale of rates constants of common hydrogen atom donors with primary alkyl radicals. 
There were no known rate constants kH for NHC-boranes, and our goal was to place 
NHC-boranes on this scale. The most common and convenient way to determine rate constants 
of radical reactions is the “radical clock” method.58 This is based on the competition between the 
reaction of the interest and a reaction with a known rate constant for the same intermediate 
radical. The determination of the ratio of two products allows one to calculate the unknown rate 
constant. 
Initial screening of several “radical clock” reactions with different clock reaction rates 
was performed with dipp-Imd-BH3 40. The photochemical decomposition of 
1-hydroxypyridine-2(1H)-thione esters (also called the Barton’s PTOC esters – pyridine 
thiooxycarbonyl)
59
 was identified as the most suitable method for the rapid estimation of rate 
constants kH for NHC-boranes. The mechanistic framework of the PTOC method is shown in 
Scheme 14. 
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Scheme 14. The mechanistic framework of the PTOC method. 
The photochemical cleavage of the N–O bond in PTOC ester 65 (step a) is followed by 
the fast fragmentation of the acyloxy radical 66 (step b). The resulting alkyl radical 67 can either 
abstract a hydrogen atom from NHC-BH3 57 with the rate constant kH (step c) to give nonane 68 
or add to the starting PTOC ester 65 with the rate constant kT leading to 2-(nonylthio)pyridine 69 
and the acyloxy radical 66 (step d). This “self-trapping” is the radical clock reaction. The 
NHC-boryl radical 58 formed in the step c attacks the C=S bond of the starting PTOC ester 65 
giving the boron by-product 70 and the radical 66 propagating the chain (step e). The last 
reaction is not involved in the calculation of kH, so its rate constant is not important. With the 
 19 
known rate constant for self-trapping kT (25 °C) = 1.4 × 10
6
 M
–1
 s
–1
,
60
 we can calculate kH after 
measuring the ratio 68/69. 
 
Scheme 15. The determination of kH for dipp-Imd-BH3 40 by the PTOC method.  
In a typical experiment shown in Scheme 15, a solution of the PTOC ester 65, dipp-Imd-BH3 40, 
and dodecane (an internal GC standard) in benzene was irradiated with a sunlamp for 5 min. The 
PTOC ester was consumed according to the TLC analysis. The yields of the products 68 and 69 
were determined by the GC analysis of the crude reaction mixture. In control experiments, 
photoconversion of the pure PTOC ester 65 without any added hydrogen donor gave about 4 % 
of nonane 68 and 69% of 69. This “background reduction” could be explained by the hydrogen 
abstraction from the solvent or the PTOC ester 65. 
The advantages of the PTOC method are short reaction times, the absence of a chemical 
radical initiator (many of which can be hydrogen donors themselves), and the convenient GC 
determination of the ratio of reaction products. The disadvantages are the relatively low 
concentration of nonane in the final mixtures and the “background reduction”. To verify that this 
method was applicable for the rate constant determination, measurements for several hydrogen 
donors with the known kH were performed under the same conditions as for 40. The GC yields of 
68 and 69 and calculated and literature kH values are summarized in Table 1. (See the Section 7.2 
for the detailed description of the equations used and the assumptions made.) 
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Table 1. Results of PTOC experiments for hydrogen donors with known kH. 
Entry 
Hydrogen 
donor 
Yield of 
68, % 
Yield of 
69, % 
kH (25 °C) 
(calculated), 
M
–1 
s
–1
 
kH (25 °C) 
(literature), 
M
–1 
s
–1
 
Ref. 
1 Bu3SnH
a 
50.3 7.1 2.3 × 106 2.5 × 106 57 
2 (TMS)3SiH
a 
32.2 21.9 4.5 × 105 3.9 × 105 57 
3 Et3SiH
a 
3.4 35.4 < 1 × 104 3.2 × 102 57 
4 Me3N-BH3
b 
3.1 38.0 < 1× 104 < 1 × 103 61 
5 Bu3P-BH3 50
b 
4.9 55.3 < 1 × 104 3 × 103 c 61 
a
 2 equiv; 
b
 4 equiv; 
c
 at 80 °C. 
The rate constants for Bu3SnH and (TMS)3SiH were found to be 2.3 × 10
6 
and 4.5 × 105 M–1 s–1, respectively (entries 1, 2). These results are in a good agreement with 
literature values.
57
 The GC yields of nonane 68 with Et3SiH, Me3N-BH3, and Bu3P-BH3 50 were 
below the “background reduction” levels (entries 3–5). In these cases, the values kH have to be 
less than 10
4 
M
–1 
s
–1
. This is consistent with literature estimations for these hydrogen donors.
57,61
 
We concluded that as long as the rate constant being measured is >10
4 
M
–1 
s
–1
, the developed 
PTOC ester method should provide a reasonably accurate estimate. The error becomes higher for 
the slower hydrogen donors due to the greater interference of the “background reduction”. 
The next step was to figure out what factors influence the kH of NHC-boranes and which 
complex is the best hydrogen donor. First, we obtained 15 NHC-BH3 complexes 40, 41, 45, 53, 
71–81 with different steric and electronic environments by using the procedure shown in the 
Scheme 7, Section 1.2. Complexes 71 and 72 were synthesized by Dr. Julien Monot; complexes 
41, 74, 76, 79–81 were prepared by Dr. Shau-Hua Ueng. All complexes were white or light 
yellow solids, stable to moisture and soluble in benzene. Their rate constants kH measured by the 
PTOC method for complexes are shown in Figure 5.
62
  
 21 
 
Figure 5. Rate constants kH (M
–1
 s
–1
) measured for 15 NHC-BH3 complexes by the PTOC method. 
The rate constant kH for dipp-Imd-BH3 40 was found to be about 2 × 10
4
 M
–1 
s
–1
. This value is 
close to the lower limit of measurement. Except the tricyclic compound 71 and diAd-Imd-BH3 
72, most of NHC-BH3 complexes were more reactive than 40. The poor hydrogen donor abilities 
of 40, 71, and 72 can be explained by the shielding of the boron atom by bulky substituents at 
nitrogen atoms. This was consistent with the subsequent measurements of kH for the boron-
substituted complexes dipp-Imd-BH2X (X = SC(=O)SMe, X = Cl; see Sections 2.3 and 3.2 for 
their synthesis). The estimated rate constants for both compounds were less than 10
4
 M
–1
 s
–1
. 
 Complexes 41, 45, 53, 73–81 with less hindered BH3 groups have kH ranging from 
5 × 104 to 8 × 104 M–1 s–1. The highest kH = 8 × 10
4 
M
–1
 s
–1
 was found for diMe-Imd-BH3 41. 
Other imidazol-2-ylidene complexes bearing two alkyl (isopropyl in 45 and cyclohexyl in 75), 
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aryl and alkyl (mesityl and allyl in 77 or homoallyl in 78), or two aryl (4-chlorophenyl in 76) 
groups showed slightly smaller kH values (5–7 × 10
4 
M
–1
 s
–1
). The introduction of electron-
withdrawing groups CN (79) and Cl (80) to C-4,5 position of the NHC ring reduced the 
hydrogen donor ability insignificantly (kH = 6 × 10
4 
M
–1
 s
–1
). The benzimidazol-2-ylidene (74) 
and 1,2,4-triazol-3-ylidene (81) analogs of 41 had almost identical kH = 7 × 10
4 
M
–1
 s
–1
. The rate 
constants of AllylMe-BImd-BH3 73 and triazolylidene complex 53 were unexceptional 
(kH = 5 × 10
4 and 6 × 104 M–1 s–1). These values are surprisingly similar for so structurally diverse 
compounds. 
Because the rate constants in Figure 5 were measured under identical conditions, the 
relative kH values should be accurate. But because these rate constants were measured at single 
concentrations, there may be an absolute error. It was important to have at least one precisely 
determined absolute kH for NHC-boranes. Experiments performed by Prof. Martin Newcomb and 
Dr. Xinting Yuan (University of Illinois at Chicago) complemented our kinetic studies.
63
 
Multiple measurements of kH for dipp-Imd-BH3 40 by the modified PTOC method at different 
concentrations and temperatures gave the Arrhenius function for this hydrogen abstraction: 
log kH = (9.6±0.5) − (6.9±0.7)/2.3RT. The value of the pre-exponential factor (log A = 9.6) is 
similar to those for second-order radical hydrogen abstraction from other hydrogen donors.
58 
The 
rate constant for dipp-Imd-BH3 40 was found to be kH (28 °C) = 3.8 × 10
4
 M
–1
 s
–1
. Differing by a 
factor about 2, our result (kH (25 °C) = 2 × 10
4
 M
–1
 s
–1) and Newcomb’s result are in acceptable 
agreement. Moreover, Newcomb and Yuan did not perform any adjustments for the “background 
reduction”. Our result without the “background reduction” correction would be kH = 4 × 10
4
 M
–1
 
s
–1, perfectly matching Newcomb’s result. 
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The Newcomb’s method is more precise but requires several experiments. Our method 
allows a fast “one-point” evaluation of the rate constant for a newly synthesized complex with an 
error small enough to place NHC-boranes on the scale of hydrogen donors (Figure 6). They 
occupy an interesting region. Being slower hydrogen donors than popular (TMS)3SiH and 
Bu3SnH, NHC-boranes are significantly better donors than trialkylsilanes that do not propagate 
chain efficiently. 
 
Figure 6. The place of NHC-boranes among other hydrogen donors. 
Among tested compounds (Figure 5), cheap and easily available diMe-Imd-BH3 41 and 
diMe-Tri-BH3 81 were identified as the most promising reagents for the Barton–McCombie 
deoxygenation reactions. Besides the relatively high reactivity (kH = 8 × 10
4
 M
–1
 s
–1
), they are 
attractive due to a high atom economy of the transformation. Their molecular weights 
(111 g mol
–1
 for 41 and 110 g mol
–1
 for 81) are 4 times lower than MW of dipp-Imd-BH3 40 
(402 g mol
–1
) and 3 times lower than MW of Bu3SnH (291 g mol
–1
). The superior reactivity of 
41 and 81 over the first generation reagents 40 and 53 was confirmed by preparative experiments 
performed by Dr. Shau-Hua Ueng.
64
 The solubility of diMe-Tri-BH3 81 in water simplified the 
product purification and broadened the scope of the reaction. 
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2.3 ISOLATION OF BORON-DERIVED BY-PRODUCT 
Every Barton–McCombie deoxygenation has a reduction product and an oxidized product, 
derived from the reagent. When Bu3SnH is used as a hydrogen donor, the observed by-product is 
Bu3SnSMe due to the instability of the initially formed Bu3SnSC(=O)SMe.
55
 In the reduction 
with Bu3P-BH3 50 (Scheme 10), Bu3P-BH2SC(=O)SMe was isolated in 85% yield and 
spectroscopically characterized.
53
 
If the mechanism in Scheme 12 is correct, then it should be possible to identify the 
boron-derived product 60 of reduction with NHC-borane 57.  During the preliminary kinetic 
studies (Section 2.2), we conducted a reaction between 
1-(cyclobutyl)dodec-1-yl xanthate 82, dipp-Imd-BH3 40, and BEt3 in benzene at rt. Besides 
hydrocarbon products of the xanthate reduction 83, flash column chromatography afforded the 
boron by-product dipp-Imd-BH2SC(=O)SMe 84 in 79% isolated yield (Table 2, entry 1).  
Table 2. The isolated yields of dipp-Imd-BH2SC(=O)SMe 84. 
 
Entry Xanthate R R' Yield of 84, % 
1 82 C11H23 cyclobutyl 79
 
2 85 Me C6H13 70 
3 86 i-Pr BnO(CH2)5 66 
 
Comparable yields of the same product 84 was obtained in the reactions of 40 with 2-octyl 
xanthate 85 (70%, entry 2) and secondary xanthate 86 (66%, entry 3). The isolated yields of 84 
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reported are comparable to the yields of the reduction products in these experiments. This 
supports the proposal that dipp-Imd-BH3 40 is the primary hydrogen donor in the Barton–
McCombie deoxygenation reactions (Section 2.1). The product dipp-Imd-BH2SC(=O)Me 84 is a 
very stable solid. All attempts to substitute a second hydrogen atom at boron or reduce 84 back 
to dipp-Imd-BH3 40 failed. 
The structure of 84 was deduced from the appearance of the strong band at 1631 cm
–1
 in 
the IR spectrum (C=O), a new singlet (3H) at 2.07 ppm in the 
1
H NMR spectrum (CH3S), two 
new peaks at 13.6 and 191.9 ppm in the 
13
C NMR spectrum (CH3S and C=O), and the shift of 
the signal in the 
11
B NMR spectrum from –36.5 ppm (q, JB–H = 89 Hz) in 40 to –25.6 (br s) in 
product 84 (NHC-BH2-SR). When a solution of 84 in toluene-d8 was heated to 80 °C (353 K), 
the 
11
B NMR signal sharpened to a triplet with JB–H = 105 Hz. The broadening of the signal at 
low temperatures was attributed to a quadrupole moment of the neighboring boron atom.
65
 The 
larger JB-H value compared to dipp-Imd-BH3 40 is due to the increased s-character of B–H bonds 
and p-character of the B–S bond in 84.66 
Finally, the structure of 84 was established by X-ray crystallographic analysis (Figure 7). 
All X-ray crystal structures reported in this dissertation were resolved by Dr. Steven J. Geib. 
Stereoviews of crystal structures are shown in Appendix A. The distance C(14)–B (1.563 Å) is 
shorter than the length of the C–B bond in dipp-Imd-BH3 40 (1.585 Å).
33
 The angle N–C(14)–N 
= 104.3° is the same as in 40 (104.1°). The B–S1 bond is almost orthogonal to the plane of the 
imidazolylidene ring (the dihedral angle S(1)–B–C(14)–N is 89°). The methyl dithiocarbonate 
side chain assumes the conformation with the anti arrangement of  B–S(1) and C(15)–S(2) bonds 
relative to the S(1)–C(15) axis. 
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Figure 7. The X-Ray crystal structure of dipp-Imd-BH2SC(=O)SMe 84.  
Selected bond lengths (Å), angles (deg), and torsion angles: B–S(1) 1.924(6), S(1)–C(15) 1.714(5), C(15)–
O 1.194(5), C(15)–S(2) 1.760(4), S(2)–C(16) 1.764(6), B–C(14) 1.563(8), B–S(1)–C(15) 104.3(3), S(1)–B–C(14) 
104.3(3), S(1)–C(15)–S(2) 111.2(2), N–C(14)–N 104.3(3), B–S(1)–C(15)–S(2) 180.0(3), S(1)–B–C(14)–N 89.4(5). 
The [(methylthiocarbonyl)thio]borane products NHC-BH2SC(=O)SMe 60 (for example, 84 if 
NHC = dipp-Imd) form by the C–O fragmentation of the intermediate radical 59 (Scheme 16, 
left). In the reaction of a primary xanthate (R = BnO(CH2)6–) with dipp-Imd-BH3 40 initiated 
with BEt3/O2, Dr. Shau-Hua Ueng isolated both products 84 (18% yield) and 87 (NHC = dipp-
Imd, 38% yield).
63
 The alternative C–S fragmentation pathway leading to 
[(alkoxycarbonothioyl)thio]boranes NHC-BH2SC(=S)OR 87 can be proposed (Scheme 16, 
right). The direction of fragmentation is guided by the relative stability of R• and methyl 
radicals: 2° >> 1° > Me•. Thus secondary xanthates (R = 2°) react exclusively via the C–O 
fragmentation pathway giving products 60 such as 84 (Table 2).  
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Scheme 16. Two fragmentation pathways provide different boron by-products. 
2.4 EPR STUDIES 
The rate constant measurements and the isolation of the boron-derived by-product 84 strongly 
supported the intermediacy of dipp-Imd-BH2• radical 88. This indirect evidence was 
complemented by its direct detection in EPR studies performed by Prof. John Walton in the 
University of St. Andrews, U.K.
63
 Photolysis of a solution of dipp-Imd-BH3 40 and (t-BuO)2 in t-
BuPh at 300 K provided the experimental EPR spectrum. Its first derivative (Figure 8, top) 
matched well with the computer simulation of the spectrum for dipp-Imd-BH2• 88 (Figure 8, 
bottom) with the g-factor 2.0028 and the hyperfine splittings a(
11
B) = 7.3 G, a(2Hα) = 11.4 G, 
a(2N) = 4.03 G, a(2H4,5) = 1.0 G.
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Figure 8. The EPR spectrum of the radical 88. 
The hfs values confirm that in dipp-Imd-BH2• 88, the spin density delocalized on the boron atom 
and over the imidazolium ring. The boron atom has a planar geometry. The unpaired electron 
occupies a π-type SOMO orbital (Figure 9).67 NHC-boryls 58 are structurally very different from 
amine- and phosphine-boryl radicals studied by Roberts.
68
 The pyramidal at boron σ-type radical 
Me3N-BH2• 89 has the much larger a(
11
B) = 51.3 G and the much smaller a(2N) = 1.4 G 
showing the localization of the spin-density on the boron atom. The additional stabilization of 58 
by the conjugation with the NHC ring explains the lower BDE(B–H) of NHC-boranes comparing 
to amine- and phosphine-boranes.
69
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Figure 9. The sketches of SOMO orbitals of NHC- and amine-boryl radicals. 
The further collaboration of our group with Prof. Walton resulted in recording of the EPR spectra 
for more than a dozen of NHC-BH2• and NHC-BHX• radicals, highlighting the rich chemistry of 
this new class of radicals.
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By the determination of the rate constants of hydrogen abstraction kH for a number of 
NHC-boranes, the isolation of the boron-derived by-product dipp-Imd-BH2SC(=O)SMe 84, and 
the EPR observation NHC-boryl radicals 58, the mechanism proposed in Scheme 12 is firmly 
established. 
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3.0  REACTIONS OF NHC-BH3 COMPLEXES WITH ELECTROPHILES 
Besides the radical reactions, NHC-boranes can participate in various ionic reactions due to the 
hydridic (nucleophilic) character of hydrogen atoms attached to boron. This section describes the 
reactions of NHC-BH3 complexes with electrophiles including alkyl halides and sulfonates, 
Brønsted and Lewis acids, and halogenating agents. A convenient procedure for the ionic 
reduction of alkyl halides and sulfonates is established. The boron-derived by-products of these 
reactions are isolated. Among them are an NHC-boryl triflate and an NHC-boryl iodide that are 
starting materials for the further development of NHC-borane chemistry (see Sections 4 and 5.1). 
3.1 IONIC REDUCTION OF ALKYL HALIDES AND SULFONATES 
Based on successful reduction of secondary xanthates with NHC-BH3 complexes (Section 2.1), 
we decided to study the reaction of NHC-boranes with alkyl halides, another class of organic 
compounds suitable for radical reduction. Preliminary experiments were performed by Dr. Qianli 
Chu.
35
 When a solution of 1-iodododecane 90, dipp-Imd-BH3 40, and BEt3 in toluene was 
refluxed for 2 days, the reduction product, dodecane 91, was isolated in 89% yield. Unlike the 
reaction with xanthates, high temperature and long reaction time were required for the 
completion of the reduction of 90. In the control experiment without a radical initiator, a benzene 
solution was heated in a sealed tube at 125 °C for 36 h and the GC yield of 91 was 99% (Table 3, 
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entry 1). Similarly high yields of dodecane 91 were obtained in such solvents as CH3CN and 
2-butanone, eliminating the possible intermediacy of free borane because it would hydroborate 
these solvents. 
1-Bromododecane 92 was efficiently reduced to 91 (94% GC yield) with 40 after heating 
in BTF (“benzotrifluoride”, PhCF3, a toluene analog without benzylic C–H bonds that can be a 
hydrogen source) at 140 °C for 16 h (entry 2). However, primary alkyl chloride 93 reacted 
slowly even under such harsh conditions giving 49% GC yield of 91 after 24 h of heating at 140 
°C (entry 3). It was much easier to reduce tetrachloromethane CCl4. After heating of a solution of 
40 in CCl4 for 36 h at 80 °C, the complete disappearance of starting NHC-borane 40 and the 
formation of chloroform were observed by the NMR spectroscopy (entry 4). 
Table 3. Ionic reduction of halides with dipp-Imd-BH3 40. 
 
Entry
a 
R–X Conditions R–H Yield of R–H, %b 
1 C12H25–I, 90 PhH, 125 °C, 36 h 91 99
 
2 C12H25–Br, 92 BTF, 140 °C, 16 h 91 94 
3 C12H25–Cl, 93 BTF, 140 °C, 24 h 91 49 
4 Cl3C–Cl
c 
CCl4, 80 °C, 36 h CHCl3 not determined 
a 
Experiments are performed by Dr. Qianli Chu;
 b 
The GC yield against an internal standard 
(pentadecane, C15H32); 
c
 72 equiv. 
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From these results, it was unclear whether dipp-Imd-BH3 40 reduces alkyl halides by a radical 
mechanism, analogous to that with secondary xanthates (Scheme 12, Section 2.1), or by an 
alternative ionic mechanism. On the one hand, substitution of iodide can proceed by a radical 
single-electron transfer (SET) chain pathway.
71
 This chain could initiate if the C–I bond 
undergoes a homolytic cleavage at high temperatures or under irradiation. A radical chain 
pathway was suggested for the reaction between amine-boranes and CCl4 or CCl3Br.
72
 On the 
other hand, reduction of alkyl halides and alkyl sulfonates by borohydrides such as NaBH4, 
NaBH3CN, or NaBH(OMe)3 proceeds through the SN2 mechanism at high temperatures in polar 
solvents.
73 
To distinguish between the two possible mechanisms, we studied reduction of 
(Z)-1-iodoheptadec-5-ene 94 under the conditions optimized by Dr. Qianli Chu (Scheme 17). If 
the radical 95 is a reaction intermediate, then it can either undergo a radical 5-exo cyclization (kR 
at 25 °C = 2 × 105 s–1)74 or abstract a hydrogen atom from 40 (kH at 25 °C = 2 × 10
4
 M
–1
 s
–1
; 
Section 2.2). With this values, even at high temperature and the average concentration of 40 = 
0.2 mol L
–1
, the rate of the cyclization reaction significantly exceeds the rate of the direct 
reduction. Thus if a radical mechanism is operative, then we expect the cyclized product 96 to be 
a major one. Instead, heating of a solution of 94 and 40 in BTF at 125 °C for 18 h gave 
exclusively the linear product 97 in 58% isolated yield. Its structure was confirmed by 
1
H NMR 
spectroscopy and the GC coinjection with a standard sample. No cyclic product 96 was observed 
by the GC analysis in the crude mixture. This experiment clearly showed that the radical 95 is 
not a reaction intermediate. 
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Scheme 17. Reduction of iodide 94 with dipp-Imd-BH3 40 without radical initiators. 
The reduction mechanism was next probed by changing the substrates to primary alkyl 
sulfonates ROSO2X. Like alkyl halides, they are reduced by borohydrides by an ionic 
mechanism,
73b
 but they are unreactive in radical reductions because the strong C–O bond is not 
prone to the homolytic cleavage.  When a solution of dodecyl tosylate 98 and dipp-Imd-BH3 40 
in toluene was heated at 140 °C for 48 h, dodecane 91 was isolated in 57% yield (Table 4, 
entry 1). Encouraged by this result, we performed the reduction of primary tosylate 99, mesylates 
100 and 101, and triflates 102 and 103 with 40 under similar thermal conditions (Table 4). 
Table 4. Ionic reduction of alkyl sulfonates with dipp-Imd-BH3 40. 
 
Entry R–X Conditions R–H Yield of R–H, % a 
1 C12H25–OTs, 98 toluene, 140 °C, 48 h 91 57 
2 BnO(CH2)6–OTs, 99 toluene, 140 °C, 48 h 104 67 
3 C12H25–OMs, 100 toluene, 140 °C, 48 h 91 60 
4 BnO(CH2)6–OMs, 101 toluene, 140 °C, 48 h 104 61 
5 C12H25–OTf, 102 1,4-dioxane, 25 °C, 24 h 91 76
b 
6 BnO(CH2)6–OTf, 103 toluene, 25 °C, 24 h 104 64 
7 BnO(CH2)6–OTf, 103 
(t-BuO)2 / toluene (2:1) 
25 °C, 24 h 
104 77 
a 
Isolated yields;
   b
 The GC yield against an internal standard (pentadecane, C15H32). 
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Reduction of both tosylates and mesylates in toluene required high temperature and long time 
(140 °C, 48 h) for the completion of the reaction (entries 1–4). The isolated yields of dodecane 
91 and BnOC6H13 104 were 57–67%. More active alkyl triflates gave comparably high yields of 
products when the reduction was performed at rt. This reaction were successfully performed in 
toluene (entry 5), more polar 1,4-dioxane (entry 6), and even in the di-t-butyl peroxide–toluene 
mixture (2:1 v/v) (entry 7). In last case, the yield of 104 (77%) was even higher than in pure 
toluene (64%, entry 6), probably due to the greater polarity of (t-BuO)2. Peroxides are not safe 
solvents, but this experiment was performed to demonstrate the unique chemoselectivity of the 
reduction with NHC-boranes suggesting that primary triflates containing a peroxide functionality 
can be selectively reduced. 
A ketone group is sensitive to the borohydride reduction. However, the chemoselective 
deoxygenation of hydroxyketone 105 with 40 was achieved with by the two-step sequence 
shown in Scheme 18. First, alcohol 105 was converted to triflate 106 by a standard protocol. This 
triflate 106 was stable enough to survive column chromatography, but it decomposed during the 
concentration of fractions. So the reduction step was performed in hexane:EtOAc 2:1 (the eluent 
for chromatography) without the fraction concentration. Dipp-Imd-BH3 40 was added to the 
solution of 106, and the reaction mixture was stirred for 15 h at rt and then for 3 h at 50 °C.  The 
product 107 was isolated in 31% yield after two steps. The 
1
H NMR spectrum of 107 confirmed 
that the carbonyl group remained untouched.  
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Scheme 18. The two-step deoxygenation of hydroxyketone 105. 
Another triflate AllylNTsCH2CH2OTf 108 was synthesized by a standard procedure from 
alcohol 109 (Scheme 19). Heating of a solution of 108 and dipp-Imd-BH3 40 in toluene at 50 °C 
for 20 h afforded the reduction product 110 in 59% isolated yield (Scheme 19). In fully 
accordance with the ionic mechanism of the reduction, no cyclization to pyrrolidine 111 was 
observed. 
 
Scheme 19. The two-step deoxygenation of alcohol 109. 
Ionic reductions of primary alkyl halides and sulfonates showed that NHC-BH3 complexes are 
not only hydrogen atom donors in radical reactions but also a source of hydride ions. Lindsay 
and McArthur reduced acetophenone 27 with a chiral NHC-borane (a complex of 9-BBN) 112 
when the ketone was activated with Lewis acidic BF3-OEt2 (Scheme 20).
75
  The reaction was 
stereoselective and the alcohol ent-28 was isolated in 80% yield (84% ee).  
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Scheme 20. Ketones activated with Lewis acids are reduced by NHC-boranes. 
Besides radical and ionic reductions, NHC-BH3 complexes participate in organometallic 
reactions. Our collaborators from the University of Pierre and Marie Curie (Paris, France) 
discovered the Pd-catalyzed reduction of aryl triflates and aryl iodides with NHC-boranes.
35
 For 
example, refluxing of a THF solution of 4-iodoacetophenone 113, NHC-BH3 53, Pd(OAc)2 (10 
mol%), and 1,1'-bis(diphenylphosphino)ferrocene (dppf; 10 mol%) resulted in the quantitative 
conversion of 113 into acetophenone 27 (Scheme 21).  The key reaction step is likely to be a 
hydride transfer from NHC-BH3 to an arylpalladium intermediate. 
 
Scheme 21. Pd-catalyzed reduction of aryl iodide 113 with NHC-borane. 
Despite these advances, the reduction of alkyl halides with NHC-BH3 complexes under mild 
conditions remains a challenging problem. DiMe-Imd-BH3 41 is a more active reagent than dipp-
Imd-BH3 40 (Section 2.2). However, the radical reduction with 41 was effective only for alkyl 
halides bearing nearby electron-withdrawing groups.
76
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3.2 ISOLATION OF BORON-DERIVED BY-PRODUCTS OF IONIC REDUCTIONS 
The elucidation of the fate of the boron reagent is an important step towards understanding the 
reduction reactions. As in case of the xanthate reduction (Section 2.3), every ionic reduction with 
NHC-BH3 (Tables 3, 4) should produce an oxidized boron-derived product along with the 
reduced substrate. The reactions of dipp-Imd-BH3 40 with alkyl halides and sulfonates were 
repeated focusing on the isolation and characterization of boron products (Table 5). Now R–X 
become halogenating agents and can be used in excess. 
Table 5. The formation of dipp-Imd-BH2X by the reduction of alkyl halides and sulfonates. 
 
Entry R–X equiv solvent 
temp. 
(°C) 
prod,  
X = 
yield, %
 
11
B NMR 
(CDCl3), δ 
1 C12H25Cl, 93 1 BTF 140 114, Cl N.D.
a
  –18.7 
2
b 
CCl4 64 CCl4/ CDCl3
 
80 114, Cl 84
c –18.7 
3 C12H25Br, 92 1.5 toluene 140 115, Br 70
d –23.0 
4 C12H25Br, 92 1.5 toluene 140 115, Br 19
c
 –23.0 
5
b
 CBr4 1 C6D6
 
80 115, Br 56
d –23.0 
6
e 
C12H25I, 90 1 C6D6 180 116, I 90
d –33.0f 
7 C12H25OTs, 98 1.5 toluene 140 117, OTs 70
d –11.4 
8 C12H25OMs, 100 1.5 toluene 140 118, OMs 60
c
 –11.0 
9 C12H25OTf, 102 1.5 1,4-dioxane 25 119, OTf N.D.
a
 –8.7 
a
 The product observed by NMR but was not isolated in a pure form; 
b
 72 h; 
c 
Isolated yield 
after chromatography; 
d
 Isolated yield after filtration; 
e
 Performed by Dr. Qianli Chu; 
f
 in C6D6. 
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In a typical reaction, dipp-Imd-BH3 40 (1 equiv) and dodecyl chloride 93 (1 equiv) were heated 
in BTF at 140 °C for 72 h (entry 1).  The reaction mixture was analyzed by the 11B NMR 
spectroscopy. By this time, about 50% of borane 40 was converted into chloroborane dipp-Imd-
BH2Cl 114. This result was consistent with the previously reported conversion of 93 (Table 3, 
entry 3). The product 114 in entry 1 was not isolated because there are easier routes to this 
compound. For example, heating of 40 in refluxing carbon tetrachloride for 72 h led to a 
complete conversion into 114, which was isolated in 84% yield after chromatography (entry 2).  
The bromoborane dipp-Imd-BH2Br 115 was cleanly formed by reduction of dodecyl 
bromide 92 (1.5 equiv) with 40 in toluene at 140 °C.  Simple cooling of the reaction mixture to rt 
and filtration provided product 115 in 70% yield (entry 3).  However, the sample isolated in this 
way contained about 10% of the corresponding imidazolium bromide ([dipp-Imd-H]Br). This 
impurity was removed by flash column chromatography. A sample of pure 115 was isolated. 
However, this complex was sensitive to silica gel and the yield dropped to 19% (entry 4).  The 
reaction of 40 with CBr4 (1 equiv) in C6D6 at 80 °C for 72 h provided a better route to pure 115, 
which was isolated in 56% yield after the filtration (entry 5). The related iodoborane dipp-Imd-
BH2I 116 had been already isolated by Dr. Qianli Chu by the filtration of the reaction mixture 
after heating 40 and 90 in C6D6 at 180 °C (90% yield; entry 6).
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 Iodoborane 116 is sensitive to 
moisture and completely decomposed during the attempted chromatographic purification.  
Then we prepared NHC-boryl sulfonate esters dipp-Imd-BH2OSO2R 117–119 by the 
reduction of corresponding dodecyl sulfonates (1.5 equiv). The reaction of 40 and tosylate 98 
gave tosylate dipp-Imd-BH2OTs 117. The pure compound was isolated in 70% yield by cooling 
and filtration of the reaction mixture (entry 7).  The mesylate dipp-Imd-BH2OMs 118 was 
purified from contaminating imidazolium mesylate [dipp-Imd-H]OMs by flash chromatography. 
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The yield of 118 was 60% (entry 8).  The reduction of dodecyl triflate 102 was performed at rt 
(entry 9). Like iodoborane 116, the NHC-boryl triflate dipp-Imd-BH2OTf 119 quickly 
decomposed into the imidazolium triflate salt during column chromatography. Its formation was 
confirmed by the 
11
B NMR analysis of the crude reaction mixture. The synthesis of a pure 
sample of 119 will be described in Section 3.3.   
The structure of a representative sulfonate, dipp-Imd-BH2OTs 117, was solved by the 
X-ray analysis (Figure 10). In crystal, 117 exists as two similar but crystallographically 
independent molecules. In contrast to 84 (Section 2.3), the tosyloxy substituent at the boron atom 
in 117 is not orthogonal to the plane of the imidazolylidene ring.  Instead, it is closer to coplanar; 
the N(1)–C(1)–B(1)–O(3) angle is 9° in the left molecule shown in Figure 10 and N(4)–C(35)–
B(2)–O(6) is –35.2° in another molecule. 
 
Figure 10. Two independent crystallographic molecules of dipp-Imd-BH2OTs 117.   
Selected bond lengths (Å), angles (deg), and torsion angles (deg) are listed. Left molecule: S(1)–O(3) 
1.500(3), B(1)–O(3) 1.522(7), B(1)–C(1) 1.606(7), S(1)–O(3)–B(1) 123.9(3), O(3)–B(1)–C(1) 108.8(5), N(1)–C(1)–
B(1)–O(3) 9.4(8), N(2)–C(1)–B(1)–O(3) –169.1(4). Right molecule: S(2)-O(6) 1.518(3), B(2)–O(6) 1.557(8), B(2)–
 40 
C(35) 1.597(7), S(2)–O(6)–B(2) 122.8(3), O(6)–B(2)–C(35) 105.9(4), N(3)–C(35)–B(2)–O(6) 147.4(4), N(4)–
C(35)–B(2)–O(6) –35.2(7). 
All NHC-boryl halides and sulfonates 114–119 are white solids that vary greatly in their stability 
towards moisture and column chromatography. The most stable are dipp-Imd-BH2Cl 114 and 
dipp-Imd-BH2OMs 118, which survive column chromatography and can be exposed to water or 
dissolved in MeOH without decomposition. Dipp-Imd-BH2Br 115 and dipp-Imd-BH2OTs 117 
are more sensitive and their chromatographic purification results in significant losses of the 
product because of decomposition. Finally, the iodide 116 and triflate 119 cannot be purified on 
silica gel at all and undergo fast hydrolysis or methanolysis. The addition of water or methanol to 
a solution of dipp-Imd-BH2I 116 in benzene was accompanied by the vigorous evolution of a gas 
(presumably H2) (Scheme 22). The 
1
H NMR analysis of the reaction mixture showed the 
formation of imidazolium iodide [dipp-Imd-H]I 120. A broad signal at +18.7 ppm attributed to 
B(OR)3 (R = H or Me)
78
 appeared in the 
11
B NMR spectrum.   
 
Scheme 22. The deboronation of dipp-Imd-BH2I 116 with methanol. 
Clearly there is a qualitative correlation between the leaving group ability of the group X and the 
hydrolytic sensitivity of the corresponding borane complex dipp-Imd-BH2X. The following 
mechanism of the transformation is proposed (Scheme 23).  The first step of hydrolysis or 
methanolysis might be a nucleophilic substitution with ROH (R = H or Me) by a uni- or 
bimolecular mechanism (step a). Strong intermediate acids 121 react further until there are 
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available basic hydrides (step b). The evolution of hydrogen gas and reactions of reactive 
cationic boranes 122 with other molecules of ROH make the decomposition irreversible. When 
all hydrides have reacted, a strong acid HX cleaves the C–B bond in NHC-B(OR)3 forming a 
protonated carbene (an imidazolium salt) and B(OR)3 (step c). An alternative mechanism 
suggests that the C–B cleavage in 123 occurs first (step d) followed by methanolysis/hydrolysis 
of [BH2OR]. 
 
Scheme 23. The proposed mechanism of NHC-BH2X hydrolysis or methanolysis. 
This hydrolysis of certain NHC-BH2X complexes is one of only a few deboronation processes 
discovered so far in which the boron atom disassociates from its NHC ligand.  Such 
transformations are useful for the preparation of substituted imidazolium salts from ring-
substituted NHC-boranes as will be shown in Section 5.2. 
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The NHC-BH2X complexes with a carbene part less bulky than dipp are even more 
susceptible to the hydrolytic deboronation. The formation of diMe-Imd-BH2Br 124 in situ was 
observed by the 
11
B NMR spectroscopy (triplet at –22.5 ppm)76 but this and related complexes 
have not been completely characterized. The ionic reduction of the diMe-Imd-BH2Br 124, a 
by-product of the alkyl halide reduction, to diMe-Imd-BH3 41 with NaBH4 was performed by 
Dr. Shau-Hua Ueng.
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 The reagent 41 was recovered in 77% yield.  
We demonstrated that radical reduction of dipp-Imd-BH2Br 115 to dipp-Imd-BH3 40 is 
also possible. Bu3SnH alone does not reduce 115 even when their solution in benzene-d6 is 
heated at 80 °C. The addition of a radical initiator AIBN, however, resulted in a complete 
conversion into dipp-Imd-BH3 40 after 5 h at 80 °C (the isolated yield was 81%) (Scheme 24). In 
this case, tin has a greater affinity for bromine than boron. 
 
Scheme 24. The radical reduction of boryl bromide 115. 
Before further studies of the chemistry of dipp-Imd-BH2X complexes, we decided to develop 
convenient methods of their syntheses that avoid long reaction times and harsh conditions 
reported in Table 5. Dipp-Imd-BH2Cl 114 and dipp-Imd-BH2Br 115 can be prepared by the 
reaction of free carbene dipp-Imd 39 with commercially available solutions of Me2S-BH2Cl and 
Me2S-BH2Br.
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 However, other Me2S-BH2X complexes are not easily available. Reactions of 
NHC-BH3 with strong acids and halogenation agents more powerful than alkyl halides were 
targeted for investigation. 
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3.3 REACTIONS WITH HALOGENATING AGENTS AND ACIDS 
Elemental halogens and reagents such as N-halosuccinimides were used for the preparation of 
halogenated amine- and phosphine-boranes.
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 The addition of 0.5 equiv of I2 or 1 equiv of 
N-iodosuccinimide (NIS) to a solution of dipp-Imd-BH3 40 in benzene at rt quickly and cleanly 
provided boron iodide 116 as the only boron-containing product according to the 
11
B NMR 
analysis (Scheme 25, top). The reaction of NHC-BH3 with I2 forms 116 and a strong acid HI that 
can further react with remaining 40 producing boryl iodide 116 and H2 gas. This explains why 
0.5 equiv of I2 is enough for the complete conversion of 40. 
 
Scheme 25. Electrophilic halogenation of dipp-Imd-BH3 40. 
NIS is less convenient than I2 because it generates the succinimide by-product that is hard to 
separate from silica gel sensitive boryl iodide 116. Indeed, among the several ways now 
available to generate 116, the reaction of 40 with I2 is the most convenient. 
Analogous bromination of dipp-Imd-BH3 40 with either Br2 (0.5 equiv) or 
N-bromosuccinimide (NBS) (1 equiv) was not selective even at –45 °C. The bromination 
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reactions were very fast and produced mixtures of monobromide 115, dibromide 125 and 
unreacted 40 according to the 
11
B NMR spectroscopy (Scheme 25, bottom). When 2 equiv of Br2 
was used, the known tribromoborane dipp-Imd-BBr3 126 was the only product. Its structure was 
confirmed by comparison of 
1
H and 
11
B NMR signal with the literature data.
33
 Crystals of 126 
was obtained by the concentration of the crude mixture but this compound was unstable towards 
silica gel. The preferred way to make 126 is by the direct complexation of dipp-Imd 39 with 
BBr3 since this takes only one step.
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The complete formation of tribromide 126 from 40 with only 2 equiv of Br2 means that 
the third hydride at boron was substituted by generated HBr. We decided to investigated how 
strong a Brønsted acid should be to react with dipp-Imd-BH3 40 and whether such acid/base 
reactions can be employed for the synthesis of interesting NHC-BH2X complexes. Preliminary 
studies showed that dipp-Imd-BH3 40 was stable towards weak acids such as alcohols, phenols, 
water, and even acetic acid. No reaction was observed after heating 40 with 2 equiv of AcOH 
(pKa = 4.75) at 60 °C in a CDCl3 solution. This suggests that NHC-BH3 complexes can be used 
as reducing reagents under mild acidic conditions. The reactions of 40 with stronger acids are 
summarized in Table 6 in order of decreasing acidity. 
In a typical experiment, 1 equiv of triflic acid was added to a solution of 40 in CDCl3 at 0 
°C (entry 1).  A vigorous reaction with the immediate evolution of hydrogen gas took place.  
After 5 min, 
11
B NMR spectroscopic analysis of the reaction mixture showed the complete 
conversion of 40 into the NHC-boryl triflate 119 that was already prepared by the reduction of 
alkyl triflates (Table 5, entry 9). Triflate 119 was too sensitive to be purified by chromatography 
(see Section 3.2) but it can be used in situ for onward reactions (Section 4.1). 
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Table 6. The reactions of dipp-Imd-BH3 with Brønsted acids. 
 
Entry H–X pKa
80
 
temp.  
(°C) 
prod,  
X = 
yield, %
 
11
B NMR 
(CDCl3), δ 
1 TfOH –14 0 °C 119, OTf NMRa –8.7 
2
 
HBr
b
 –9 0 °C 115, Br NMRa –23.0 
3 HCl
c,d
 –8 0 °C 114, Cl 81 –18.7 
4 TsOH
e
 –2.6 60 °C 117, OTs NMRa –11.4 
5 MsOH
d
 –0.6 0 °C 118, OMs 88 –11.0 
6
 
CF3COOH 0.52 25 °C 127, OCOCF3 85 –10.9 
7 Cl2CHCOOH 1.30 60 °C 128, OCOCHCl2 67 –11.1 
8 NCCH2COOH
e
 2.46 60 °C 129, OCOCH2CN 24 –11.9 
a
 The product observed by NMR but was not isolated in a pure form; 
b
 33% solution of HBr in 
AcOH; 
c 
4 M solution in 1,4-dioxane; 
d
 2 equiv of acid; 
e
 Solid acids that required heating to 
dissolve. 
The reactions of 40 with other strong acids such as HBr, HCl, MsOH, and CF3COOH were also 
quick at 0 °C. The complete conversion into dipp-Imd-BH2Br 115 after the treatment with a 
solution of HBr was confirmed by the 
11
B NMR spectroscopy (entry 2). Stable boryl chloride 
114 (entry 3), mesylate 118 (entry 5), and trifluoroacetate 127 (entry 6) were isolated by 
chromatography in 81–88% yields after the reactions with corresponding acids. Compound 127 
is new while the others are identical to samples prepared by ionic reduction (Section 3.2). 
 To dissolve solid TsOH in CDCl3, the reaction mixture was heated at 60 °C. The 
11
B NMR spectroscopy showed the clean conversion of 40 into boryl tosylate 117 (entry 4). The 
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reaction of 40 with Cl2CHCOOH (pKa = 1.30) was slow at rt (30% conversion after 3 h 
according to the 
11
B NMR spectroscopy).  The complete conversion into dichloroacetate 128 was 
achieved by heating, and the stable product was isolated in 67% yield (entry 7). The even weaker 
cyanoacetic acid NCCH2CO2H (pKa = 2.46) required heating to dissolve in CDCl3 and reacted 
slowly with 40. After 20 h at 60 °C, cyanoacetate 129 was formed in 24% isolated yield. We 
conclude that a Brønsted acid should have pKa of 1 or below to react quickly with 40 at rt and 
pKa of about 3 or below is necessary to react at 60 °C. 
After HX substitutes the first hydrogen atom in 40, the further acid/base reactions of 
dipp-Imd-BH2X complexes become very slow. For example, treatment of 40 with 5 equiv of 
CF3COOH, 2 equiv of HCl, or 2 equiv of MsOH resulted in monosubstituted products 127, 114, 
and 118, respectively. No further substitution was observed even after days at rt. The exception 
was TfOH, the strongest tested acid with pKa = –14. The reaction of 40 with TfOH (2.5 equiv) at 
rt produced ditriflate dipp-Imd-BH(OTf)2 130 as indicated by the appearance of a new broad 
signal at –2.5 ppm in the 11B NMR spectrum (Scheme 26). The reaction was complete in 15 min. 
Further addition of TfOH (2.5 equiv) to 130, however, did not lead to tritriflate 
dipp-Imd-B(OTf)3 131. 
 
Scheme 26. The reaction of dipp-Imd-BH3 40 with excess triflic acid. 
In contrast to sensitive dipp-Imd-BH2OTf 119, ditriflate 130 was isolated by column 
chromatography in 54% yield and can be handled and stored on the bench without the 
decomposition to imidazolium triflate. This stability can be explained at least in part by a greater 
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steric hindrance of the boron atom in 130 comparing to 119 that prevents nucleophilic attacks by 
water molecules (see Scheme 23, Section 3.2). The inductive effect of a second triflate group 
may also disfavor the formation of cationic species such as 122. A solution of 130 in CDCl3 was 
stable in the presence of H2O (20 equiv). Remarkably, the related Cy3P-BH(OTf)2 quickly 
decomposes to free Cy3P and other products in water.
81
 
 Triflic acid can be used for the modification of other dipp-Imd-BH2X complexes. 
Monochloride 114 completely reacted with 1.5 equiv of TfOH at rt (Scheme 27). The only signal 
in the 
11
B NMR of the crude mixture at –3.1 ppm corresponds to dipp-Imd-BH(OTf)Cl 132. 
However, the chromatographic purification gave only 20% of 132 along with 11% of dichloride 
133 (a broad doublet at –8.0 ppm in the 11B NMR spectrum). This result shows that the stability 
of 132 towards hydrolysis is intermediate between those of dipp-Imd-BH2OTf 119 and dipp-
Imd-BH(OTf)2 130. The partial decomposition of 132 generates imidazolium chloride 38 and 
triflate. The nucleophilic substitution of a triflate group in 132 by chloride ions accounts for the 
formation of 133 (these reactions are described in Section 4.1). Dichloride 133 was also prepared 
in 45% yield by the reaction of carbene 39 with the commercial dioxane-BHCl2 complex. 
 
Scheme 27. The reaction of dipp-Imd-BH2Cl 114 with triflic acid. 
The X-ray crystal structure of dipp-Imd-BH(OTf)Cl 132 is shown in Figure 11. This confirms 
that the boron atom bears both chloride and triflate substituents. Since bulky 2,6-diisopropyl 
groups prevent a close package of molecules in crystal, the rotation around the C(1)–B bond is 
not frozen. This results in the overlapping diffractions from two rotamers of 132. The position of 
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hydrogen atom at boron was not resolved but its presence was confirmed by the 
1
H NMR 
spectroscopy. 
 
Figure 11. The X-ray crystal structure of dipp-Imd-BH(OTf)Cl 132.   
Selected bond lengths (Å), angles (deg), and torsion angles: B–C(1) 1.604(9), B–Cl 1.814(8), B–O(1) 
1.365(8), O(1)–S 1.604(5), S–O(2) 1.368(6), N(1)–C(1)–N(1) 105.1(4), C(1)–B–Cl 110.2(4), C(1)–B–O(1) 
119.8(6), B–O(1)–S 122.3(5), N(1)–C(1)–B–Cl 84.6(6), N(1)–C(1)–B–O(1) 59.3(8) and 131.5(6). 
Limited information is available about the reactivity of NHC-BH3 complexes with Lewis acids. 
The Scheer group showed that 4,5-Me2-diMe-Imd-BH3 37 with PhPH2-B(C6F5)3 134 give the 
ionic product 135 (Scheme 28, top).
82
 The authors suggested that 134 is in equilibrium with 
strong Lewis acid B(C6F5)3 136 that abstracts a hydride from 37. The intermediate [NHC-BH2]
+
 
cation then complexes with PhPH2. 
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Scheme 28. The reaction of NHC-BH3 complexes with Lewis acids. 
In her Ph.D. thesis, our collaborator Dr. Malika Makhlouf Brahmi described the related hydride 
abstraction reaction of dipp-Imd-BH3 40 with trityl tetrafluoroborate Ph3C
+
BF4
–
 137 (1 equiv).
83
 
The product dipp-Imd-BF3 138 was isolated in 90% yield (Scheme 28, bottom). The reaction is 
likely to proceed via the intermediate 139 but the mechanism of 138 formation remains unclear. 
Preliminary studies on the reactions of dipp-Imd-BH3 40 with other strong Lewis acids 
are shown in Scheme 29. The reaction with 1 equiv of either TiCl4 or AlCl3 in CH2Cl2 led to the 
complete conversion to a new compound (a signal at –24 ppm in the 11B NMR spectrum) that 
was stable in solution at rt. We suggest the hydride-bridged [NHC-BH2---H---BH2-NHC]X 140 
(X = Cl, titanate, or aluminate counterion) structure analogous to [R3N-BH2---H---BH2-NR3]
+
 
cations prepared by the Vedejs group by the treatment of R3N-BH3 with [Ph3C][B(C6F5)4].
84
 The 
initially formed borenium cation [dipp-Imd-BH2]
+
 141 is stabilized by the complexation with 
another molecule of 40. While this work was in progress, Alcarazo and coworkers reported the 
synthesis of the cation 140 with the HB(C6F5)3
– 
counterion
 
from 40 and B(C6F5)3 136 
(0.5 equiv).
85
 The structure was confirmed by the X-ray crystallographic analysis. The NMR data 
of our and their complexes were identical. Thus, our initial structural assignment is confirmed. 
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Scheme 29. The reactions of NHC-boranes with TiCl4 and AlCl3. 
Bridged cation 140 decomposed upon the addition of D2O or AcOH producing mixtures of dipp-
Imd-BH3 40, dipp-Imd-BH2Cl 114, and dipp-Imd-BHCl2 133. The addition of the second 
equivalent of TiCl4 to 140 resulted in no change in the 
11
B NMR spectrum. However, the 
addition of 3 equiv of a stronger Lewis acid AlCl3 converted 140 into a new compound that 
resonates at +11.7 ppm in the 
11
B NMR spectrum. The same spectrum was observed in the 
reaction mixture of dipp-Imd-BH2Cl 114 and AlCl3 (1 equiv). The structure [dipp-Imd-
BH2][AlCl4] 141 is tentatively suggested for this new complex. The downfield shifts of the 
signals in 
11
B NMR spectra are characteristic for tricoordinate boron compounds comparing to 
tetracoordinate boranes.
78
 After 24 h at rt, the 
11
B NMR spectrum of the solution of 141 in 
CH2Cl2 showed the disappearance of the signal at +11.7 ppm and the formation of a singlet at 
+44 ppm. This value is very close to that reported for [Py-BCl2][Al2Cl7] complex prepared 
directly from Py-BCl3 and AlCl3.
86
 Thus, we propose that the signal at +44 ppm in our spectrum 
corresponds to [dipp-Imd-BCl2][AlCl4] 142 formed by the hydride/chloride exchange in 141. 
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Monitoring the transformation of 141 to 142 by 
11
B NMR spectroscopy showed the small 
transient peak at +28 ppm that might correspond to [dipp-Imd-BHCl]
+
. 
 All attempts to obtain crystal of 141 or 142 for the X-ray crystallographic analysis failed, 
so structures drawn in Scheme 29 remain tentative and additional studies in this direction are 
required. Recently, the interest in boron cations has increased because of their applications as 
Lewis acidic catalysts
87
 and the electrophilic borylation agents for electron-rich aromatic 
compounds.
88
. Arylboron products are valuable substrates for the Suzuki coupling. However, no 
stable products were isolated after the reactions of 141 or 142 with N-methylindole, 1,3,5-
trimethoxybenzene, or N,N-dimethylaniline. The reason of the failure may be the steric 
hindrance of the dipp-Imd carbene part. If so, then borenium cations obtained from diMe-Imd-
BH3 41 and AlCl3 may be more reactive electrophiles. 
In this section, we presented simple protocols for the in situ generation of dipp-Imd-BH2I 
116, dipp-Imd-BH2OTf 119, and dipp-Imd-BH(OTf)2 130 from dipp-Imd-BH3 40 and I2 
(0.5 equiv) or TfOH (1 or 2.5 equiv), respectively.
77
 Their availability opened doors to many 
other substituted NHC-boranes by nucleophilic substitution (Section 4) and reductive metallation 
(Section 5.1). 
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4.0  NUCLEOPHILIC SUBSTITUTION AT BORON ATOM 
In this Section, we present the reactions of NHC-BH2X and NHC-BHX2 complexes with various 
nucleophiles that resulted in the substitution at the boron atom. An interesting activation of THF 
and other small molecules that relates to the chemistry of frustrated Lewis pairs was observed in 
case of relatively bulky electrophiles (Section 4.2). A slow substitution reaction of 
dipp-Imd-BH(OTf)2 130 in the acidic medium produced the unprecedented dihydroxyborenium 
cation (Section 4.3). 
4.1 NUCLEOPHILIC SUBSTITUTION OF NHC-BORYL IODIDE AND TRIFLATE 
Nucleophilic substitutions are known for amine- and phosphine-boranes bearing leaving groups 
at the boron atom.
81,89
 In related hydroboration reactions with amine-boryl iodides and triflates 
(see Scheme 3, bottom; Section 1.1), the first step was proposed to be a displacement of iodide or 
triflate with an alkene.
11,90
 We already proposed nucleophilic substitutions of NHC-BH2X (if X 
is a good leaving group) with water and methanol (Scheme 23, Section 3.2) and the substitution 
of dipp-Imd-BH(OTf)Cl 132 with chloride (Scheme 27, Section 3.3). The results of expanded 
studies of such reactions between in situ prepared dipp-Imd-BH2I 116 and dipp-Imd-BH2OTf 
119 and various nucleophiles are presented in Table 7. All products were stable solids isolated by 
column chromatography. Solvent choices were usually based on the solubility of the nucleophile.  
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Table 7. Nucleophilic substitution of dipp-Imd-BH2X at boron. 
 
Entry X = Nucleophile solvent 
prod, 
Nu = 
yield, %
a 
11
B NMR 
(CDCl3), δ 
1 OTf Bu4NF CDCl3/THF 143, F 40 –6.1 
2 I BnEt3NCl CH2Cl2/THF 114, Cl 38 –18.7 
3 OTf PhMgBr THF 115, Br 31 –22.6 
4 OTf PhSLi
b
 CDCl3/THF 144, SPh 58 –24.9 
5 I PTSLi
b,c
 THF 145, SPT 42 –23.5 
6 OTf EtOC(=S)SK CDCl3/THF 146, SC(=S)OEt 35 –24.4 
7 OTf PhSC(=S)SLi
d
 CDCl3/THF 147, SC(=S)SPh 65 –22.9 
8 I NaSCN DMSO 148, NCS 24 –23.2 
9 OTf KOCN DMSO 149, NCO 35 –22.8 
10 OTf NaN3 DMSO 150, N3 42 –17.2 
11 I NaN3 DMSO 150, N3 74 –17.2 
12
e
 OMs NaN3 DMSO 150, N3 83 –17.2 
13 OTf NaNO2 DMSO 
151, ONO 
152, NO2 
12 
7 
–10.1 
–13.5 
14 I AgNO2 DMSO 
151, ONO 
152, NO2 
27 
10 
–10.1 
–13.5 
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15 OTf Bu4NCN CDCl3/THF 153, CN 81
f
 –36.7 
16 I NaCN DMSO 153, CN 21 –36.7 
17
e 
I AgCN DMSO 154, NC 55 –24.0 
18
 
OTf LiAlD4 THF 155, D 81 –36.6 
a
 The isolated yield is based on dipp-Imd-BH3 40; 
b
 Prepared in situ by the reaction between thiol 
and BuLi; 
c 
PT = 1-phenyltetrazol-5-yl; 
d
 Prepared in situ from PhSLi and CS2; 
e
 at 80 °C; f The 
purity was 90% by the NMR analysis. 
In a typical experiment, NHC-boryl triflate 119 was generated in situ by addition of TfOH to 
dipp-Imd-BH3 40 in CDCl3.  A solution of tetrabutylammonium fluoride (Bu4NF, 2 equiv) was 
then added and the mixture was stirred at rt for 20 h.  The solvent was removed and the residue 
was purified by flash chromatography to afford pure fluoroborane dipp-Imd-BH2F 143 as a white 
solid in 40% yield (entry 1).  The structure of 143 was established by its characteristic 
11
B and 
19
F NMR spectra (
1
JB–F = 72 Hz) and the HRMS analysis. Dipp-Imd-BH2F 143, dipp-Imd-BH2Cl 
114, dipp-Imd-BH2Br 115, and dipp-Imd-BH2I 116 constitute a complete set of 
monohalogenated NHC-boranes. 
Starting NHC-boryl iodide 116 was first prepared in situ by the reaction of 40 and I2 (0.5 
equiv) in benzene. The removal of the solvent gave a yellow residue that was mixed with a 
solution of a nucleophile. For example, the reaction of 116 with chloride BnMe3NCl provided 
the dipp-Imd-BH2Cl 114 in 38% yield (entry 2). The reaction of triflate 119 with PhMgBr gave 
dipp-Imd-BH2Br 115 (31% yield after column chromatography) and no phenyl substitution 
product dipp-Imd-BH2Ph
41
 (entry 3).  
Entries 4–8 summarize the reactions with sulfur-based nucleophiles. The reaction of 119 
with PhSLi (freshly prepared in situ from PhSH and BuLi) produced dipp-Imd-BH2SPh 144 in 
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58% yield as a stable white solid (entry 4).  Lithium 1-pheynl-1H-tetrazole-5-thiolate (PTSLi) 
reacted with 116 to give dipp-Imd-BH2SPT 145 in 42% yield (entry 5).  Oxidation of this 
compound with mCPBA (2 equiv) gave boryl sulfone dipp-Imd-BH2SO2PT 156 (Scheme 30). 
The stability of B–H bonds in NHC-boranes towards such a strong oxidant was remarkable. 
 
Scheme 30. Oxidation of sulfide 145 to sulfone 156. 
The structure of borane sulfone 156 was confirmed by the X-ray crystallographic analysis 
(Figure 12).  The B–S bond is almost orthogonal to the plane of the imidazolylidene ring (the 
torsion angle S–B–C(1)–N(1) is 89°).  The only other boron-substituted sulfone characterized by 
the X-ray analysis is compound 157 (Scheme 30, right).
91
  The geometric parameters of the 
sulfone part in 156 and 157 are similar (157: B–S 1.899(4), S–C 1.793(3), B–S–C 100.7(1)). 
 
Figure 12. The X-ray crystal structure of dipp-Imd-BH2SO2PT 156.   
Selected bond lengths (Å), angles (deg), and torsion angles: B–S 1.908(1), S–C(28) 1.821(1), B–C(1) 
1.586(2), B–S–C(28) 113.16(6), S–B–C(1) 112.59(9), B–S–C(28)–N(3) –46.9(1), B–S–C(28)–N(6) 146.6(1), S–B–
C(1)–N(1) 88.6(1), S–B–C(1)–N(2) –100.9(1). 
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Reactions of triflate 119 with commercially available potassium ethyl xanthogenate 
KSC(=S)OEt (Table 7, entry 6) and lithium carbonotrithiolate LiSC(=S)SPh (prepared in situ 
from PhSH, BuLi, and CS2, entry 7) gave corresponding products with a general formula 
dipp-Imd-BH2SC(=S)R 146 (R = OEt, 35% yield)  and 147 (R = SPh, 65% yield). The products 
144–147 containing a BH2–S bond show a characteristic signal at –22 to –25 ppm in the 
11
B NMR spectra. Dipp-Imd-BH2SC(=S)OEt 146 resembles the product 87 of the radical 
reduction of primary xanthates (Scheme 16, Section 2.3). 
 The reactions of 116 with NaSCN and 119 with KOCN in DMSO gave isothiocyanate 
148 (entry 8, yield 24%) and isocyanate 149 (entry 9, yield 35%), respectively. The X-ray 
crystallographic analysis showed that the boron atom is connected to the nitrogen atom in both 
148 and 149 (Figure 13). The bond lengths and angles of the B–N=C=Y moieties are similar to 
those in H3N-BH2–NCS (B–N 1.534(8), N–C 1.137(8), C–S 1.627(6), B–N–C 177.5(6), N–C–S 
179.2(5))
92
 and in a polyborane derivative [Et3NH]2[closo-2-B10H9–NCO] (B–N 1.498(7), N–C 
1.128(7), C–O 1.187(7), B–N–C 172.3(3), N–C–O 177.8(4)).93  The bond lengths suggest that 
the C–N bond may have some triple bond character as illustrated in the resonance form 149b 
(Figure 13, bottom).  This resonance may also explain the high value of the B–N(3)–C(28) angle 
of 167°, which is closer to that expected for sp-hybridization of the nitrogen atom (180° angle) 
than for sp
2
-hybridization (120° angle). 
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Figure 13. The X-ray crystal structures of dipp-Imd-BH2NCS 148 (top left) and dipp-Imd-BH2NCO 149 
(top right).   
Selected bond lengths (Å), angles (deg), and torsion angles 148: S–C(28) 1.648(3), C(28)–N(3) 1.089(4), 
B–N(3) 1.533(4), B–C(1) 1.608(4), N(3)–C(28)–S 178.2(3), B–N(3)–C(28) 169.2(3), N(3)–B–C(1) 109.8(2), N(3)–
B–C(1)–N(1) –79.1(3), N(3)–B–C(1)–N(2) 102.2(3), B–N(3)–C(28)–S –31(10). 
Selected bond lengths (Å), angles (deg), and torsion angles 149: O–C(28) 1.207(3), C(28)–N(3) 1.129(3), 
B–N(3) 1.543(3), B–C(1) 1.613(3), N(3)–C(28)–O 178.7(3), B–N(3)–C(28) 166.6(2), N(3)–B–C(1) 107.7(2), N(3)–
B–C(1)–N(1) 65.6(3), N(3)–B–C(1)–N(2) –112.5(2), B–N(3)–C(28)–O 150(11). 
The synthesis of NHC-boryl azide dipp-Imd-BH2N3 150 has been achieved from three different 
precursors: triflate 119, iodide 116, and mesylate 118 (entries 10–12) in 42%, 74%, and 83% 
yields, respectively. Mesylate 118 was generated in situ by the reaction of 40 with MsOH and 
was inert to the substitution with NaN3 at rt. Heating of the reaction mixture at 80 °C was 
required.  Azide 150 is a stable white solid with a distinct melting point (177–179 °C).  It is 
much more stable towards hydrolysis than Me3N-BH2N3, which has been prepared by pyrolysis 
of [H2B(NMe3)2]N3
94
 or from Me3N-BH2I by exchange on Amberlite IRA-400 resin in the azide 
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form.
95
  The incorporation of an azide group into 150 was evident from the strong band at 2096 
cm
–1 
in
 
the IR spectrum and the HRMS analysis. 
The X-Ray crystallographic analysis confirmed the structure of 150 (Figure 14, left).  The 
geometrical parameters are similar to those of another four coordinate boron azide Py-9-BBN-N3 
(B–Nα 1.588(3), Nα–Nβ 1.196(3), Nβ–Nγ 1.140(3), B–Nα–Nβ 119.5(2), Nα–Nβ–Nγ 176.3(3)).96  In 
contrast to dipp-Imd-BH2NCO 149, the B–N(3)–N(4) angle of 119° was consistent with 
sp
2
-hybridization of N
α
 and resonance forms 150a and 150b (Figure 14, right).  Like in azides 
bonded to carbon, the N
α–Nβ bond (1.212 Å) is longer than the Nβ–Nγ bond (1.137 Å). 
  
Figure 14. The X-ray crystal structure of dipp-Imd-BH2N3 150.   
Selected bond lengths (Å), angles (deg), and torsion angles: N(5)–N(4) 1.137(2), N(4)–N(3) 1.212(2), B–
N(3) 1.573(2), B–C(1) 1.614(2), N(5)–N(4)–N(3) 174.5(2), B–N(3)–N(4) 119.2(1), N(3)–B–C(1) 106.7(1), N(3)–B–
C(1)–N(1) 59.0(2), N(3)–B–C(1)–N(2) –119.9(2), B–N(3)–N(4)–N(5) –178(2). 
 
The reactions of triflate 119 with NaNO2 gave two isomeric products that were easily separated 
by column chromatography. These were the less polar boryl nitrite dipp-Imd-BH2ONO 151 
(12%) and more polar nitroborane dipp-Imd-BH2NO2 152 (7%) (entry 13). Reaction of iodide 
116 with AgNO2 gave the same products in slightly better isolated yields: 151 (27%) and 152 
(10%) (entry 14).  
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IR spectroscopy was used for the preliminary assignment of the structures (the 1682 cm
–1
 
O-N=O band in 151), and confirmation again came from the X-ray analyses of both samples 
(Figure 15).  For dipp-Imd-BH2–O–N=O 151, the N(3)–O(1) bond (1.388 Å) is longer than the 
N(3)–O(2) bond (1.150 Å) and these values are close to single N–O and double N=O bond 
lengths, respectively. The O(1)–N(3)–O(2) angle of 110° shows that the nitrite nitrogen atom has 
an accessible lone electron pair. To the best of our knowledge, 151 is the first boryl nitrite 
(nitrosooxyborane) to be isolated and characterized.  Previously only the IR observation of 
transient CatBONO in a mixture with other compounds was reported.
97
  
The B–N(3)–O(1), B–N(3)–O(2), and O(1)–N(3)–O(2) angles in dipp-Imd-BH2NO2 152 
are 121°, 119°, and 121° confirming a planar sp2-hybridized nitrogen atom of a nitro group.  The 
distances N(3)–O(1) and N(3)–O(2) are essentially equal (1.23 Å). Nitroborane compounds are 
extremely rare. The nitroborane salt Cs[(CF3)3BNO2]
98
  has similar structural parameters (B–N 
1.613(9), N–O 1.218(7) and 1.230(8), B–N–O 119.3(6) and 121.5(6), O–N–O  119.1(6)) but do 
not have B–H bonds. The substituents at boron atom in 149–152 are not orthogonal to the plane 
of the imidazolylidene ring (torsion angles N–C–B–X are between 50° and 70°) (Figures 13–15). 
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Figure 15. The X-ray crystallographic structures of dipp-Imd-BH2ONO 151 and dipp-Imd-BH2NO2 152. 
Selected bond lengths (Å), angles (deg), and torsion angles in 151: O(2)–N(3) 1.150(4), N(3)–O(1) 
1.388(4), B–O(1) 1.512(3), B–C(1) 1.616(3), O(2)–N(3)–O(1) 110.3(3), B–O(1)–N(3) 108.2(2), O(1)–B–C(1) 
110.5(2), O(1)–B–C(1)–N(1) –124.5(2), O(1)–B–C(1)–N(2) 57.1(3), B–O(1)–N(3)–O(2) 175.1(3).  
Selected bond lengths (Å), angles (deg), and torsion angles in 152: O(2)–N(3) 1.235(2), N(3)–O(1) 
1.230(2), B–N(3) 1.591(2), B–C(1) 1.604(2), C(1)–N(1) 1.354(2), O(1)–N(3)–O(2) 120.6(1), B–N(3)–O(1) 
120.9(1), B–N(3)–O(2) 118.5(1), N(3)–B–C(1) 107.4(1), N(3)–B–C(1)–N(1) –66.4(2), N(3)–B–C(1)–N(2) 114.6(1), 
C(1)–B–N(3)–O(1) 131.7(1), C(1)–B–N(3)–O(2) –50.4(2). 
The reaction between 119 and Bu4NCN (2 equiv) provided boryl nitrile dipp-Imd-BH2CN 153 in 
81% yield (entry 15). About 10 % of inseparable impurity was detected by the NMR analysis. To 
confirm that the structure of the product was the nitrile 153 rather than the isonitrile 
dipp-Imd-BH2NC 154, the isolated compound was converted into a boryl amide 158 by the 
protocol described for ligated cyanoboranes Me3N-BH2CN and Ph3P-BH2CN (Scheme 31).
99
  
First, 153 was methylated with Me3O
+
BF4
–
. The intermediate tetrafluoroborate 159 was not 
isolated or characterized. After the treatment with an aqueous solution of NaOH, standard 
workup and column chromatography provided N-methyl amide 158 in 61% yield as a white 
solid. This proves that 153 is a NHC-boryl nitrile. 
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Scheme 31. Methylation and basic hydrolysis of cyanoborane 153. 
The substitution of dipp-Imd-BH2I 116 with NaCN in DMSO gave a pure sample of nitrile dipp-
Imd-BH2CN 153 in 21% yield (entry 16). The analogous reaction of 116 with AgCN was slow 
and a product different from 153 was formed. The yield of the product increased from 6% to 
55% when the reaction was performed at 80 °C (entry 17). The NMR and IR spectroscopy 
showed that this product was not nitrile 153. The chemical shift of –24.0 ppm in the 11B NMR 
spectrum was close to that of dipp-Imd-BH2NCS 148 (–23.2 ppm) and dipp-Imd-BH2NCO 149 
(–22.8 ppm) suggesting a B–N bond. The IR band at 2192 cm–1 was very close to that in the IR 
spectrum of Me3N-BH2NC (2195 cm
–1
).
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 We conclude that it is the boryl isonitrile dipp-Imd-
BH2NC 154 and the HRMS analysis was also consistent with this formula. 
 The reduction of dipp-Imd-BH2OTf 119 with LiAlD4 (96% D) in THF gave dipp-Imd-
BH2D 155 in 81% yield (entry 18). The substitution of one hydride to deuteride comparing to 
dipp-Imd-BH3 40 was confirmed by the multiplicity of the 
11
B NMR signal of 155. While 40 
resonates as a 1:3:3:1 quartet due to the coupling with three hydrides, 155 has only two B–H 
bonds and resonates as a 1:2:1 triplet. Smaller B–D couplings caused line broadening in the 11B 
spectrum of 155. 
 The treatment of ditriflate dipp-Imd-BH(OTf)2 130 with 4 equiv of a nucleophile led to 
the double substitution of both triflates at the boron atom in several cases (Table 8). 
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 Table 8. Double nucleophilic substitution at the boron atom. 
 
Entry X =  Nucleophile 
prod,  
Nu =  
yield, %
 
11
B NMR 
(CDCl3), δ 
1 OTf Bu4NF 159, F 27
a 
+1.8 
2 OTf Bu4NCN 160, CN 54
a,b –35.7 
3 OTf Bu4NN3 161, N3 37
a –7.0 
3 OTf Bu4NN3 161, N3 61
c –7.0 
4 OTf BnEt3NCl 133, Cl N.R.
d – 
5
e 
Cl BnEt3NCl 133, Cl 15 –8.0 
a
 The isolated yield based on dipp-Imd-BH3 40; 
b 
The purity was 85% by the NMR analysis; 
c 
The isolated yield based on purified dipp-Imd-BH(OTf)2 130; 
d
 Unreacted 130 was recovered; 
e 
2 equiv of BnEt3NCl, 3 days. 
Though dipp-Imd-BH(OTf)2 130 is a stable compound that can be purified by chromatography 
(Section 3.3), the one-pot protocol starting from dipp-Imd-BH3 40 was faster and more 
convenient. In a typical experiment, TfOH (2.5 equiv) was added to a solution of 40 in CH2Cl2. 
After 30 min, 
11
B NMR spectroscopy showed the complete conversion into 130. Then a solution 
of tetrabutylammonium fluoride (Bu4NF, 4 equiv) was added and the reaction mixture was 
stirred at rt for 20 h. The difluoride dipp-Imd-BHF2 159 was isolated by column chromatography 
in 27% yield (entry 1). The substitution pattern at the boron atom was supported by multiplicities 
of signals in the 
11
B NMR and 
19
F NMR spectra (
1
JB–F = 58 Hz). Dipp-Imd-BH2F 143, dipp-Imd-
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BHF2 159, and dipp-Imd-BF3 138 constitute a complete set of NHC-fluoroboranes. An 
analogous series of trimethylamine-fluoroboranes was made by the reaction of Me3N-BH3 with 
HF.
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  However, reaction of Me3N–BH2I did not produce Me3N-BH2F, but instead gave a 
mixture of Me3N-BF3 and Me3N-BH3.
89a 
Dicyanide dipp-Imd-BH(CN)2 160 was prepared from ditriflate 130 and an excess of 
Bu4NCN in 54% yield (entry 2).  As in case of monocyanide 153 (Table 7, entry 15), this 
product contained about 15% of an inseparable and unidentified impurity that exhibited a broad 
multiplet at –26.5 ppm in the 11B NMR spectrum additionally to the sharp doublet belonging to 
160 at –35.7 ppm.  Just as monocyanide 153 can be considered as a NHC-borane analog of 
acetonitrile, dicyanide 160 is an analog of malononitrile.   
The one-pot procedure from dipp-Imd-BH3 40 (1. TfOH; 2. Bu4NN3) gave diazide dipp-
Imd-BH(N3)2 161 in 37% yield (entry 3). The same compound was prepared in 61% yield from 
purified dipp-Imd-BH(OTf)2 130 (entry 4). Since the isolated yield of 130 from 40 was 54% 
(Scheme 26, Section 3.3), the overall yield after two steps and two chromatographic separations 
was 33%. This value is very close to the 37% yield of the one-pot procedure. Diazide 161 is a 
white crystalline solid. The melting point of 161 was measured to be 220–222 °C. Heating above 
the melting point to 240 °C resulted in slow evolution of gas (presumably nitrogen). Despite the 
high nitrogen content, this compound was stable when heated in a toluene-d8 solution for 1 day 
at 140 °C (a sealed tube). The decomposition to the unidentified product was observed only after 
2 days at 165 °C. An empirical rule suggests that azides are safe to work with if the total number 
of carbon and boron atoms is at least 3 times larger than the total number of nitrogens.
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 For 
161, the ratio (C + B) / N = 3.5. 
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The X-ray crystal structure of diazide 161 is shown in Figure 16.  The azide nitrogens 
bonded to the boron appear in two positions (N2 and N2'), suggesting that there are two rotamers 
around the NHC–B bond in the crystal. Imprecise positions of azide groups prevent the 
comparisons of the geometric parameters with dipp-Imd-BH2N3 150 and few known boron 
diazides such as Py-BPh(N3)2.
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Figure 16. The X-ray crystal structure of dipp-Imd-BH(N3)2 161.  
Selected bond lengths and distances (Å) and angles (deg): B–C(1) 1.606(1), B–N(2) 1.465(5), B–N(2') 
1.54(1), N(2)–N(3) 1.271(6), N(2')–N(3) 1.216(9),  N(3)–N(4) 1.076(5), N(1)–C(1)–N(1) 104.7(3), C(1)–B–N(2) 
114.0(4), C(1)–B–N(2') 110.8(5), N(2)–B–N(2') 37.9(4), N(2)–N(3)–N(4) 162.7(4), N(2')–N(3)–N(4) 150.2(6). 
Unexpectedly, dipp-Imd-BH(OTf)2 130 did not react with BnEt3NCl and was recovered 
unchanged, highlighting the stability of 130 established earlier (Table 8, entry 4). The reaction of 
BnEt3NCl dipp-Imd-BH(OTf)Cl 132 displaced the triflate group with chloride (entry 5). This 
reaction was slow and required 3 days for the completion. The low isolated yield (15%) of 
dipp-Imd-BHCl2 133 can be explained by the competing decomposition of 132 to an 
imidazolium salt. A similar nucleophilic substitution of 132 with chlorides is responsible for the 
formation of 133 in the reaction reported in Scheme 27, Section 3.3. 
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The mechanism of nucleophilic substitutions at boron is less studied than the mechanisms 
of substitutions at the carbon atom. Reactions of chiral Cy3P-BH(CO2Me)Br with LiCN in 
DMF–THF and chiral Me3N-B(CH2Ph)(CN)H with pyridine proceeded with the inversion of the 
configuration at the boron atom suggesting a SN2-B mechanism.
104
 Both SN1-B and SN2-B 
mechanisms were proposed for the phosphine substitution of chiral Ph3P-BH(Ipc)CN with 
PMe2Ph depending on the solvent.
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A SN1-B mechanism for the substitution of dipp-Imd-BH2I 116 would require the 
intermediacy of borenium cation [dipp-Imd-BH2]
+
 or its solvent complex. To investigate the later 
possibility, we recorded the 
11
B NMR spectra of dipp-Imd-BH2I 116 in several solvents. The 
following chemical shifts () were observed (all broad singlets): C6D6 –33.0;  THF –32.8; 
CDCl3 –32.4;  acetone –31.6; CH3CN –23.0, DMSO-d8, –8.8 DMF, –5.2. The large changes in 
chemical shift observed upon dissolution in CH3CN, DMSO, and DMF suggest that the iodide is 
ionized in these coordinating solvents to give complex [dipp-Imd-BH2(N≡CMe)]
+
I
–
, 
[dipp-Imd-BH2(O=SMe2)]
+
I
–
, and [dipp-Imd-BH2(O=C(NMe2)H)]
+
I
–
. Triflate 119 is presumably 
ionized in these solvents as well. 
Many NHC-borane complexes prepared in this Section have rare or unique structural 
motifs previously unknown in the boron chemistry.
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 In future, several of these compounds (for 
example, azide 150) may find the applications as reagents for the organic synthesis. The 
spectroscopic information (first of all, 
11
B NMR data) collected during this research will 
facilitate the identification of intermediates and products in other NHC-borane reactions. 
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4.2 RING-OPENING OF TETRAHYDROFURAN AND RELATED REACTIONS 
Lithium phenoxide (PhOLi) was among the reagents tried for the nucleophilic substitution of 
dipp-Imd-BH2OTf 119 (Section 4.1). The reaction was expected to produce the 
dipp-Imd-BH2OPh complex 162, analogous to the formation of dipp-Imd-BH2SPh 144 with 
PhSLi (Table 7, entry 4). Surprisingly, after stirring of dipp-Imd-BH2OTf 119 and PhOLi in THF 
overnight and the flash chromatography purification, dipp-Imd-BH2O(CH2)4OPh 163 was 
obtained in 51% yield as the only product (Scheme 32). A molecule of the solvent was 
incorporated into the product structure. 
 
Scheme 32. The reaction of dipp-Imd-BH2OTf with PhOLi in THF. 
The similar yields of 163 were obtained with a commercial solution of PhOLi (1.0 M in THF) 
(45%) and with the reagent prepared from PhOH and bases such as BuLi or LiHMDS (39% and 
51%, respectively). The structure of 163 was unambiguously established by the NMR 
spectroscopy and HRMS analysis. In the 
1
H NMR spectrum, in addition to the signals of the 
NHC and OPh parts, there are two triplets (3.70 and 2.85 ppm) and two apparent quintets 
(1.29 and 1.07 ppm) assigned to the –O(CH2)4O– fragment. Corresponding signals at 68.8, 68.2, 
28.4, and 25.8 ppm were observed in the 
13
C NMR spectrum. Unfortunately, the relative 
instability of 163 in solution prevented us from getting crystals suitable for the X-ray 
crystallographic analysis. 
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We set out to investigate why 119 reacted with PhOLi so differently from other 
nucleophiles that gave products of direct B-substitution (see Table 7, Section 4.1). We changed 
variables including the amount of THF, the counterion and the substitution pattern of phenoxide, 
the reaction time and temperature, and the structure of boryl triflate.  
THF might take part in the reaction because of its high concentration as a solvent. To 
study the activation of smaller amounts of THF, we had to find a suitable inert solvent. Ideally, it 
should dissolve both dipp-Imd-BH2OTf 119 and phenoxide and not be subjected to the activation 
itself. Based on these needs, we chose CH2Cl2 and toluene as co-solvents (Table 9). The amounts 
of THF was varied from 250 equiv (85 vol%) to 5 equiv (2 vol%). 
Table 9. The influence of the amounts of THF on the yield of 163. 
 
Entry Solvent (mL) 
THF Reaction mixture 
appearance 
Isolated yield 
of 163, % equiv vol% 
1 THF (2) – Toluene (0.35) 250 85 homogeneous 46 
2 THF (1.5) – CH2Cl2 (1) 180 60 homogeneous 45 
3 
THF (0.25) – Toluene (0.5) 
– CH2Cl2 (2) 
30 9 homogeneous 44 
4 
THF (0.04) – Toluene (0.5) 
– CH2Cl2 (2) 
5 2 heterogeneous 16 
5 THF (0.04) – Toluene (2.5) 5 2 heterogeneous 12 
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At concentrations of THF above 10 vol%, the reaction mixture remained homogeneous and the 
isolated yield of dipp-Imd-BH2O(CH2)4OPh 163 was uniformly about 45% (entries 1–3). When 
only 5 equiv (2 vol%) of THF was added (entries 4–5), the reaction mixture was heterogeneous 
because PhONa did not dissolve completely. This led to decreased yields of 163. The reaction in 
a 4:1 CH2Cl2–toluene mixture (entry 4) gave a slightly higher yield (16%) than the reaction in 
pure toluene (12%) (entry 5). 
When 5 equiv of THF were used, the nature of the phenoxide counterion had a profound 
effect on the yield of the product 163 (Table 10). Phenoxides PhOM were prepared from phenol 
and toluene solutions of corresponding hexamethyldisilazides. With poorly soluble PhONa 
(entry 2; the result of entry 4, Table 9), the yield of 163 was 16%. PhOLi was more soluble in 
CH2Cl2–toluene than PhONa (entry 1); however, the isolated yield of 163 dropped to 5%. Most 
of PhOK was insoluble under the reaction conditions (entry 3), and the white reaction mixture 
became brown after mixing with a solution of dipp-Imd-BH2OTf 119. Nevertheless, PhOK gave 
the highest yield (33%) of product 163. 
Table 10. The influence of the phenoxide counterion on the yield of 163. 
 
Entry PhOM Reaction mixture appearance Isolated yield of 163, % 
1 PhOLi homogeneous 5 
2
a 
PhONa heterogeneous 16 
3 PhOK heterogeneous, brown 33 
a
 The result of entry 4, Table 9. 
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The ring-opening with PhOK was used for the optimization of the reaction time and temperature 
(Table 11). When the reaction was stopped after 3 h (entry 1), the yield of 163 (11%) was much 
lower than after 20 h (33%) (entry 2; the result of entry 3, Table 10). Increasing of the reaction 
time to 100 h (about 4 days) did not improve yield significantly (39%) (entry 3). Performing the 
reaction at 50 °C for 20 h gave 163 in 17% yield (entry 4). The lower yield obtained at higher 
temperature can be explained by the accelerated decomposition of 119 to an imidazolium salt. 
These results show that the THF ring-opening is a relatively slow reaction and initially chosen 
temperature (25 °C) and time (20 h) are optimal. 
Table 11. The optimization of time and temperature for the synthesis of 163. 
 
Entry Temperature, °C Time, h Yield of 3, % 
1 25 3 11 
2
a 
25 20 33 
3 25 100 39 
4 50 20 17 
a
 The result of entry 3, Table 10. 
The heterogeneity of the reaction mixture in case of PhOK complicated the experimental setup 
and could reduce the reproducibility. To address this issue, 18-crown-6 (1 equiv) was added. 
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This improved the solubility of PhOK but the yield of 163 dropped from 33% to 26% 
(Scheme 33). 
 
Scheme 33. The reaction of 119 with PhOK in presence of 18-crown-6. 
This time, two other products dipp-Imd-BH2Cl 114 and originally expected dipp-Imd-BH2OPh 
162 were isolated in 25% and 8% yields, respectively. The complexation of K
+
 with 18-crown-6 
apparently increased the nucleophilicity of PhO
–
,
 
so that it reacted with CH2Cl2 to produce a 
chloride ion. The substitution of triflate in 119 with chloride gave 114. The isolation of 
dipp-Imd-BH2OPh 162 as a stable solid was an important observation that opened the door to the 
following control experiment. Refluxing a solution of 162 in THF overnight gave no traces of 
dipp-Imd-BH2O(CH2)4OPh 163. It means that the exclusive formation of 163 reported in 
Scheme 32 cannot be explained by the conversion of initially formed 162 to 163 or by the 
decomposition of 162 during the workup or isolation. Performing the reaction between 119, 
PhOK, and 18-crown-6 in pure toluene (without added THF or CH2Cl2) gave dipp-Imd-BH2OPh 
162 in 64% yield (Scheme 34). The same product forms even in absence of 18-crown-6, though 
in a lower yield of 18%. (CH2Cl2 was added to increase the solubility of PhOK.) 
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Scheme 34. The synthesis of dipp-Imd-BH2OPh 162. 
The considerable influence of the phenoxide counterion on the reaction yield (Table 10) and the 
isolation of dipp-Imd-BH2OPh 162 prompted us to return to the initial studies when THF was 
used as a solvent. In addition to the experiments with PhOLi that gave 163 in 51% yield (Table 
12, entry 1; the result of Scheme 32) and with PhONa that afforded 163 in similar 46% yield 
(entry 2; the result of Table 9, entry 1), the transformation was conducted with potassium 
phenoxide. The reaction with PhOK was very different (entry 3) because dipp-Imd-BH2OPh 162 
was isolated in 30% yield along with 40% of 163. 
Table 12. The influence of the phenoxide counterion on the ratio of products 162 and 163. 
 
Entry PhOM Yield of 162, % Yield of 163, % 
1
a 
PhOLi 0 51 
2
b 
PhONa 0 46 
3 PhOK 30 40 
a
 The result of Scheme 32. 
b
 The result of Table 9, entry 1. 
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Next we decided to vary the structure of phenoxide. The reaction of dipp-Imd-BH2OTf 119 with 
sterically hindered potassium 2,6-dimethylphenoxide 164 (ArOK) gave almost exclusively THF 
ring-opening product dipp-Imd-BH2O(CH2)4OAr 165 in 60% yield (Scheme 4). Only traces of 
dipp-Imd-BH2OAr 166 were detected and that product was not completely characterized.  
 
Scheme 35. The reaction of 119 with 2,6-Me2C6H3OK 164. 
The introduction of an electron-withdrawing group into the para position of the phenoxide does 
not increase the steric demands of oxygen but decreases its basicity. The results of reactions of 
119 with sodium salts of 4-chloro-, 4-cyano-, and 4-nitrohenols 167a-c are summarized in 
Table 13.  
Like the already reported reaction with PhONa (entry 1; the result of entry 1, Table 9), 
4-ClC6H4ONa 167a gave the product of THF ring-opening 169a exclusively in 50% isolated 
yield (entry 2). Both products of the direct substitution at the boron atom 168b (20%) and THF 
ring-opening 169b (14%) were isolated in the reaction with 4-NCC6H4ONa 167b (entry 3). The 
structure of the product 169b was deduced from the NMR spectra and secured by the HRMS 
analysis, but the isolated sample contained about 25% of inseparable impurities. 
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Table 13. The reaction of 119 with 4-substituted sodium phenoxides 167a-c. 
 
Entry Nucleophile 
pKa of 
XC6H4OH
80a
 
NHC-BH2OC6H4X, 
yield (%) 
NHC-BH2O(CH2)4OC6H4X, 
yield (%) 
1
a 
PhONa 10.0 –b 163, 46 
2 4-ClC6H4ONa 9.4 –
b
 169a, 50 
3 4-NCC6H4ONa 8.0 168b, 20 169b, 14  
4 4-O2NC6H4ONa 7.2 168c, 43 –
b
 
a
 The result of entry 1, Table 9; 
b
 Not detected. 
Finally, only the product of the direct substitution 168c was isolated in 43% yield in case of 4-
O2NC6H4ONa 167c (entry 4). The reaction with the lithium analog 4-O2NC6H4OLi gave 168c in 
37% yield and again no traces of the THF ring-opening product was observed. The trends in the 
product ratio and its dependence on pKa will be discussed later in this Section. 
 Alkyl groups in the para position of the phenoxide anion PhO
–
 do not change the 
electronic or steric environment around the oxygen atom significantly, but they increase the 
solubility of the phenoxide in non-polar organic solvents. Thus, we tested potassium salts of p-
cresol 167d and 4-tert-butylphenol 167e for the THF ring-opening in CH2Cl2–toluene (4:1) 
(Scheme 36).  The solubility of these two new potassium phenoxides was indeed higher than the 
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solubility of PhOK. However, the yields of THF-ring opening products 169d,e (35% and 34%) 
were identical to the yield of 163 in case of PhOK (33%) (entry 3, Table 10).  
 
Scheme 36. The THF ring-opening with 119 and 4-alkyl substituted phenoxides 167d,e. 
After varying the phenoxide part, we turned to the NHC-boryl triflate partner. NHC-boryl iodide 
dipp-Imd-BH2I 116 was previously shown to behave analogously to dipp-Imd-BH2OTf 119 in 
nucleophilic substitutions (Section 4.1). The reaction of 116 with PhOK in THF gave the 
products 162 and 163 in 22% and 32% yields, respectively (Scheme 37). The ratio of 162 to 163 
(0.69) is similar to this ratio in case of dipp-Imd-BH2OTf 119 and PhOK (0.75, see Table 12, 
entry 3). The lower overall yield in case of 116 may be caused by the lower stability of 
dipp-Imd-BH2I towards hydrolysis and decomposition. 
 
Scheme 37. The reaction of dipp-Imd-BH2I 116 with PhOK in THF. 
The complex diCy-Imd-BH3 75 was treated with TfOH (1 equiv) in CDCl3, and the complete 
conversion into diCy-Imd-BH2OTf 170 after 5 min was confirmed by the 
11
B NMR spectroscopy 
(Scheme 38, top). The signal of 75 (q, –37 ppm) disappeared and a new broad singlet at –10 ppm 
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was ascribed to 170. Boryl triflate diCy-Imd-BH2OTf 170, containing less sterically shielded 
carbene ligand than 119, was also less stable in CDCl3 and THF solutions. Upon the addition of a 
solution of PhOLi in THF to 170, the evolution of gas was observed and the 
11
B NMR spectrum 
unexpectedly showed the formation of starting diCy-Imd-BH3 75. This was recovered in 44% 
yield after column chromatography. We speculate that diCy-Imd-BH2OTf 170 may partially 
disassociate to diCy-Imd and unstable BH2OTf. This borane may reduce remaining 170 to 75. 
The slow hydrolysis of BH2OTf resulted in releasing hydrogen gas. 
 
 
Scheme 38. The instability of diCy-Imd-BH2OTf 170 and Ph3P-BH2OTf 171 in THF. 
Finally, we replaced the carbene with a phosphine. Ph3P-BH2OTf 171 was prepared from 
Ph3P-BH3 172 and TfOH (1 equiv) and was very stable in a CDCl3 solution, showing no signs of 
decomposition after 1 day at rt (Scheme 38, bottom). However, the addition of either a solution 
of PhOLi in THF or even pure THF immediately resulted in the evolution of gas. The 
31
B and 
31
P 
NMR spectroscopic analysis showed the formation of Ph3P-BH3 172, Ph3P 173, and B(OR)3 in a 
1:2:2 ratio. The mechanism of the decomposition may be the same as in case of diCy-Imd-
BH2OTf 170.  
A known phosphine-boryl triflate Cy3P-BH2OTf 174
81
 was stable in CDCl3 and THF 
solutions, but the only product isolated from its reaction with PhOLi was PhO(CH2)4OH 
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(29% yield based on PhOLi or 57% based on Cy3P-BH2OTf). Apparently, 174 opened the THF 
ring similarly to dipp-Imd-BH2OTf 119, but the Cy3P-BH2O(CH2)4OPh product decomposed. 
This result once again demonstrates the difference between phosphine-boranes and 
NHC-boranes. 
Collected experimental data help answer the question why the THF ring-opening reaction 
occurs only with certain nucleophiles. Strong Brønsted (HBr) or Lewis (B(C6F5)3 136) acids are 
known to cleave the THF ring by coordinating to the Lewis basic oxygen atom.
106
 By analog, a 
possible intermediate of the reaction reported in Scheme 32 might be complex 175 where a 
molecule of THF is coordinated to the boron center (Scheme 39). Triflate is a good leaving 
group and an oxygen lone pair of THF can potentially substitute triflate in 
dipp-Imd-BH2OTf 119.  
 
Scheme 39. Coordination of 119 with THF and two sites of the nucleophilic attack on 175. 
Dipp-Imd-BH2OTf 119 and [dipp-Imd-BH2(THF)]OTf 175 are expected to have very similar 
11
B 
NMR shifts (around –9 ppm). So the 11B NMR spectroscopy is not a useful tool to detect this 
equilibrium. However, dipp-Imd-BH2I 116 has a very different shift (–32 ppm) from dipp-Imd-
BH2OR compounds. As shown in the end of Section 4.1, the chemical shift of 116 remained 
unchanged in THF in contrast to solutions of 116 in such Lewis basic solvents as DMSO, DMF, 
CH3CN. Nevertheless, we assume that some [dipp-Imd-BH2(THF)]OTf 175 may form in THF 
solutions of 119. The complex 175 has two potential sites for the nucleophilic attack: “a” – the 
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boron atom; “b” – the α-carbons of the coordinated THF molecule. The attack by a nucleophile 
at boron gives the products of the direct substitution such as dipp-Imd-BH2OPh 162 and 143–154 
(Table 7, Section 4.1). The attack at carbon “b” would leads to a THF ring-opening product such 
as 163. Since both 162 and 163 were isolated and were shown not to interconvert into each other, 
the ratio of products is due to kinetic competition between paths “a” and “b”. 
Why is the path “b” common for PhO– but not for other tested nucleophiles? The site of 
the attack has no apparent correlation with the conventional scale of nucleophilicity n(CH3I).
107
 
The behavior of PhO
–
 (n = 5.75) is different from reagents that are better (CN
–
; n = 6.70), the 
same (N3
–
; n = 5.78), or worse (Cl
–
; n = 4.37) nucleophiles. Thus, the chief factor seems to be the 
steric demand of the boron atom in 175. Bulky nucleophiles prefer to attack a more accessible 
α-carbon of THF, as was demonstrated in Scheme 35 in the reaction with 2,6-Me2C6H3OK 164.  
The association of PhO
–
 with Li
+
 counterions is tighter than with Na
+
 and especially K
+
. 
This makes PhOLi more soluble in CH2Cl2–toluene than PhOK but also makes PhOLi 
effectively a bulkier nucleophile. This explains the preference of the PhOLi to attack the THF 
site of 175 and the formation of both 162 and 163 with effectively smaller PhOK (Table 12). 
Less coordinated PhOK is not only smaller but also more reactive than PhOLi (Table 10). The 
sequestration of K
+
 into a complex with 18-crown-6 produces a naked PhO
–
 anion that shows 
even greater predominance of the attack on the boron atom (Schemes 33 and 34). Similarly, the 
formation of dipp-Imd-BH2SPh 144 rather than dipp-Imd-BH2O(CH2)4SPh is explained by a 
weaker coordination of a hard acid Li
+
 with a soft base PhS
–
 than with a hard base PhO
–
.
 
When the phenoxide counterion is the same (for example, Na
+
, see Table 13), the degree 
of the association depends on the basicity of a phenoxide anion. Basic PhO
–
 (pKa = 10.0) and 
4-ClC6H4O
–
 (pKa = 9.4) are, at the same time, bulk nucleophiles due to a tighter coordination 
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with Na
+
 counterions. Consequently, the only isolated products are THF ring-opening 163 and 
169a. The least basic 4-O2NC6H4O
–
 (pKa = 7.2) is less coordinated and is small enough to attack 
the boron atom of 119. No THF ring-opening product 169c was observed in this case. Finally, 
4-NCC6H4O
–
 (pKa = 8.0) constitutes an intermediate state in size and, as a consequence, in 
reactivity. Both 168b (the boron attack) and 169b (the THF attack) products were obtained.  
Phenoxide PhO
–
 was the most basic among the nucleophiles surveyed. The respective 
pKa’s of conjugated acids are PhO
–
 (10.0); CN
–
 (9.3); N3
–
 (4.74); Cl
–
 (–5.7).107 As predicted, the 
high basicity and/or the size of a nucleophile may favor the THF ring-opening over the direct 
substitution at boron. 
Reactions of dipp-Imd-BH2OTf 119 with more basic nucleophiles including PhC≡CLi, 
LiNH2, NaHMDS, t-BuOLi, LiCH2NO2, LiCH(CN)2, (TMS)3SiK failed to give any isolable 
products. In the reaction of dipp-Imd-BH2OTf 119 and EtOLi, dipp-Imd-BH2OEt 176 was 
isolated in 33% yield (Scheme 40). The 
1
H NMR spectrum contained dipp-Imd signals, a triplet 
at 0.52 ppm (3H), a quartet at 2.82 ppm (2H), and no signals of an –O(CH2)4O– fragment. The 
quick decomposition of 176 to an imidazolium compound in solution prevented its full 
characterization. The THF ring-opening product dipp-Imd-BH2O(CH2)4OEt 177 was not 
observed. 
 
Scheme 40. The formation of unstable dipp-Imd-BH2OEt 176. 
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Alkyl thiolates such as EtSLi (pKa of PhSH is 10.6) has a similar basicity with PhOLi. The 
treatment of 119 with 2 equiv of EtSLi gave two products dipp-Imd-BH2SEt 178 and 
dipp-Imd-BH2O(CH2)4SEt 179 that were separated by chromatography (Scheme 41). Their 
11
B NMR spectra showed triplets at –24.0 ppm (B–S) and –9.3 ppm (B–O), respectively. Thus, 
THF ring-opening reactions of 119 are not limited to phenoxides.  
 
Scheme 41. The reaction of dipp-Imd-BH2OTf 119 with EtSLi in THF. 
The reaction of 119 with potassium trimethylsilanoate TMSOK in THF gave the free alcohol 
dipp-Imd-BH2O(CH2)4OH 180 in 37% (Scheme 42). Hydrolysis of initially formed 
dipp-Imd-BH2O(CH2)4OTMS could lead to 180. The product of the direct substitution 
dipp-Imd-BH2OTMS 181 was not observed in this reaction (see below, Scheme 48). 
 
Scheme 42. The reaction of dipp-Imd-BH2OTf 119 with TMSOK in THF. 
The discovery of THF ring-opening by a dipp-Imd-BH2OTf/PhOLi pair has analogy in the 
chemistry of frustrated Lewis pairs (FLPs).
108
 A bulky Lewis base (amine, phosphine 182, 
carbene 183, etc.) and a bulky Lewis acid (borane 136, alane) constitute an FLP when they 
cannot form a classical Lewis adduct due to steric repulsion.
109
 They can quench their reactivity 
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(“frustrated energy”) by the activation of a small molecule from the medium such as THF110 or 
H2 to salts 184 and 185 (Scheme 43).
111
 Many other reactions of FLPs include additions to 
alkenes,
112
 alkynes,
113
 CO2,
114
 and activation N–H111b and B–H115 bonds. 
 
 
Scheme 43. Activation of H2 and THF by FLPs. 
While the mechanism of the dihydrogen cleavage by FLPs remains the object of study,
116
 the 
THF ring-opening reaction may proceed via the mechanism resembling that outlined in 
Scheme 39 for the 119/PhO
–
 pair (Scheme 44). For example, Lewis acidic B(C6F5)3 136 
coordinates to THF forming a complex 187. The direct attack (“a”) of Lewis basic carbene 
ditBu-Imd 183 at the boron atom is impossible because of steric clashing between 
pentafluorophenyl and tert-butyl groups. The potential product 188 is not stable. Alternatively, 
the attack at the THF part (“b”) occurs generating the zwitterionic product 186. In the absence of 
THF, 136 and 183 slowly form an adduct 189.
111c
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Scheme 44. A possible mechanism of the THF cleavage by FLPs. 
Despite the resemblance in the cleavage of THF, our system is different from FLPs in several 
aspects. All reported FLPs consist of a neutral Lewis base and a neutral Lewis acid. They 
activate neutral molecules giving an ionic or zwitterionic product such as 186. In our case, the 
THF ring is formally cleaved by a cationic borenium [dipp-Imd-BH2]
+
 and an anionic PhO
–
 ion 
generating a neutral product dipp-Imd-BH2O(CH2)4OPh 163. Most reported FLPs do not form a 
Lewis adduct such as 188 because of the bulkiness of FLP components. In contrast, 
dipp-Imd-BH2OPh 162 is a stable compound and its absence among the products of the reaction 
of 119 and PhOLi in THF requires a kinetic rather than thermodynamic explanation. 
Inspired by the broad scope of the FLP reactivity, we tested the ability of the dipp-Imd-
BH2OTf/PhO
–
 pair to activate other molecules besides THF. When ethyl acetate was used as a 
solvent in the reaction between 119 and PhOLi (Scheme 45), acetoxyborane 
dipp-Imd-BH2OAc 190 was isolated in 31% yield. This compound cannot be obtained by the 
direct reaction of dipp-Imd-BH3 40 with AcOH (Section 3.3).  
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Scheme 45. The reaction of 119 with PhOLi in EtOAc. 
The plausible mechanism for this reaction is shown in Scheme 46. The coordination of boryl 
triflate 119 to the carbonyl oxygen atom of EtOAc leads to an intermediate 191. The ethyl group 
is now connected to a good leaving group. The attack by the phenoxide anion produces 190 and 
PhOEt (not isolated). 
 
Scheme 46. A proposed mechanism of the EtOAc cleavage with 119 and PhOLi. 
The reaction of 119, PhOLi (2 equiv) and oxetane (20 equiv) in CH2Cl2–PhH (1:1) gave a 
ring-opening product dipp-Imd-BH2O(CH2)3OPh 192 in 43% yield and about 90% purity 
(Scheme 47). Compound 192 is a lower homolog of the THF ring-opening product 163. While 
the ring-opening of lactones was performed with FLPs,
117
 the cleavage of aliphatic esters and 
oxetanes has not been reported for FLPs, though many Lewis acids can convert esters to free 
carboxylic acids.
118
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Scheme 47. The ring-opening of oxetane with 119 and PhOLi. 
Other cyclic ethers were more reluctant towards activation by the 119/phenoxide pair. The 
reaction of 119 and PhOK in 1,4-dioxane gave dipp-Imd-BH2OPh 162 in 45% yield and no 
dioxane-ring opening product 193 (Scheme 48, top). When PhOK was changed to PhOLi, 162 
was not isolated. Surprisingly, the only product of the reaction was dipp-Imd-BH2OTMS 181 
(Scheme 48, bottom). The mechanism of its formation is puzzling. The TMS group must come 
from the LiHMDS base used for the in situ preparation of PhOLi. The reactions of 119 with 
LiHMDS or TMSOK did not give 181 (see Scheme 42). 
 
 
Scheme 48. The reaction of 119 with phenoxides in 1,4-dioxane. 
The H–H bond cleaving is a distinct feature of FLPs that allowed chemists to use them as 
catalysts for metal-free hydrogenation of imines.
119
  However, bubbling of H2 gas through the 
 84 
suspension of dipp-Imd-BH2OTf 119 and PhOK in CH2Cl2–toluene (4:1) did not result in 
formation of dipp-Imd-BH3 40 (Scheme 49, top). Another important reaction carried out with 
FLPs is 1,2-addition to alkenes.
112
 The reaction of dipp-Imd-BH2OTf 119 and PhOK with 
norbornene 194 did not lead to the addition product 195 (Scheme 49, bottom). No compounds 
containing NHC-BH2–C bonds were observed by the 
11
B NMR of the reaction mixture. The 
failure of the dipp-Imd-BH2OTf 119/PhO
–
 to activate H2 and norbornene can be accounted by 
the weaker Lewis acidity of 119 compared to that of B(C6F5)3 136. 
 
Scheme 49. Unsuccessful attempts to activate H2 and norbornene. 
In summary, an unexpected THF ring-opening reaction was discovered during the studies on the 
substitution of dipp-Imd-BH2OTf 119 with PhOLi. The influence of various factors on the yield 
and the structure of products was investigated. A possible mechanism of THF ring-opening and 
an explanation of the observed trends are proposed. The cleavage of THF ring was observed with 
other nucleophiles besides phenoxides. Other molecules including ethyl acetate and oxetane can 
be activated under similar conditions. 
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4.3 NHC-STABILIZED DIHYDROXYBORENIUM CATION 
The new NHC-supported dihydroxyborenium triflate 196 (Figure 17) was unexpectedly isolated 
during the studies of acid/base reactions of NHC-boranes (Section 3.3). Since the proposed 
mechanism of its formation includes nucleophilic substitutions at boron atom, we report its 
synthesis and characterization in this Section.  
Borenium cations are tricoordinate boron species with a general formula [L–BR2]
+
, where 
L is a Lewis base.
120
 Dicoordinate [BR2]
+
 and tetracoordinate [L2BR2]
+
 cations are called 
boriniums and boroniums, respectively. The solution structures of NHC-borenium cations 
[dipp-Imd-BH2][AlCl4] 141 and [dipp-Imd-BCl2][AlCl4] 142 were assigned based on their 
11
B NMR spectral data (Scheme 29, Section 3.3). The five NHC-borenium cations 197–201 that 
have been reported in the literature are shown in Figure 17. For these complexes, the 
tetracoordinate NHC-BR2–X state is destabilized by the steric repulsion, X is a good leaving 
group, and the tricoordinate state [NHC-BR2]X is stabilized by -donating ligands R. Purely 
steric factors are responsible for the formation of Gabbaï’s NHC-diarylborenium 197121 and 
Lindsay’s NHC-dialkylborenium 198.122 Both steric and electronic effects favor the formation of 
Weber’s NHC-diaminoborenium 199,123 Robinson’s NHC-aminochloroborenium 200,124 and 
Aldridge’s NHC-dibromoborenium.125  
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Figure 17. The structures of novel [dipp-Imd-B(OH)2]OTf 196 and literature NHC-borenium cations. 
The main ways to synthesize complexes 197–201 are the substitution of X in R2B–X by free 
NHC,
123,124
  and the reaction of NHC-BR2–H with a strong acid H–X.
122
 For all these complexes, 
there are known amine-borenium analogs: [DMAP-BMes2]
+
,
126
 [Py-9-BBN]
+
,
127
 
[Py-B(NR2)2]
+
,
128
 β-diketiminate-supported chloroborenium [L-B(NR2)Cl]
+
,
129
 and 
[2,6-diMes-Py-BBr2]
+
.
125
  
While trying to prepare dipp-Imd-B(OTf)3 131 and dipp-Imd-B(OTf)2Cl 202, we studied 
the reactions of dipp-Imd-BH3 40 and dipp-Imd-BH2Cl 114 with excess triflic acid. When TfOH 
(5 equiv) was added to a solution of 40 in CDCl3, the complete conversion of 40 to dipp-Imd-
BH(OTf)2 130 was observed by the 
11
B NMR spectroscopy after 10 min. An analogous reaction 
between TfOH (5 equiv) and 114 gave dipp-Imd-BH(OTf)Cl 132 as the sole product (see also 
Schemes 26 and 27, Section 3.3). No signals attributable to dipp-Imd-B(OTf)3 131 and 
dipp-Imd-B(OTf)2Cl 202 were detected. However, a new singlet at +22.5 ppm appeared and its 
intensity slowly increased in the 
11
B NMR spectra of both crude mixtures. The conversion of all 
NHC-borane species to the new compound 196 was complete after 5 days at rt (Scheme 50). 
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Scheme 50. The preparation of [dipp-Imd-B(OH)2]OTf 196. 
The low-field signal at +22.5 ppm in the 
11
B NMR spectrum of 196 suggests a tricoordinate 
boron environment. The signal of the triflate group was observed at –78.9 ppm in the 19F NMR 
spectrum of 196. This value is different from the chemical shifts of triflates bound to the boron 
atom (about –76 ppm in 119, 130, and 132) and is characteristic for the free TfO– anion. 
Colorless crystals of 196 (33% yield) were grown directly from the reaction mixture starting 
from 40. The compound was stable enough to be handled in air but decomposed to imidazolium 
triflate after dissolving in Et2O or the application to silica gel. The X-ray crystallographic 
analysis solved the structure of 196 as NHC-dihydroxyborenium triflate (Figure 18).  
 
Figure 18. The X-ray crystal structure of [dipp-Imd-B(OH)2]OTf 196.  
Selected bond lengths and distances (Å), angles (deg), and torsion angles are listed. Left molecule: B(1)–
C(1) 1.591(6), B(1)–O(7) 1.310(6), B(1)–O(8) 1.307(4), O(4)–S(2) 1.433(3),  O(5)–S(2) 1.433(2), O(6)–S(2) 
1.425(3), O(5)–O(7) 2.681(4), O(4)–O(8) 2.780(4), N(1)–C(1)–N(2) 106.5(2), C(1)–B(1)–O(7) 114.8(3), C(1)–
B(1)–O(8) 117.0(3), O(7)–B(1)–O(8) 128.2(4), N(1)–C(1)–B(1)–O(7) 32.6(5), N(2)–C(1)–B(1)–O(8) 32.9(5).  
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Right molecule: B(2)–C(29) 1.602(4), B(2)–O(9) 1.294(6), B(2)–O(10) 1.313(6), O(1)–S(1) 1.424(2),  
O(2)–S(1) 1.433(3), O(3)–S(1) 1.431(3), O(3)–O(9) 2.767(3), O(2)–O(10) 2.737(3), N(3)–C(29)–N(4) 106.3(2), 
C(29)–B(2)–O(9) 117.1(3), C(29)–B(2)–O(10) 114.9(3), O(9)–B(2)–O(10) 127.9(4), N(3)–C(29)–B(2)–O(10) 
27.2(5); N(4)–C(29)–B(2)–O(9) 22.0(5). 
Like in case of dipp-Imd-BH2OTs 117 (Figure 10, Section 3.2), there were two independent 
molecules in crystal of 196. Their geometrical parameters were very close except the dihedral 
angle between NHC and O–B–O planes: 33° in the left molecule and 22° and 27° in the right 
molecule (Figure 18). Parameters of the left molecules will be used in the following discussion. 
The value of the N(1)–C(1)–N(2) angle (106.5°) lies between the values of this angle in 
NHC-BH3 40 (104.1°)
33
 and in imidazolium chloride [dipp-Imd-H]Cl 38 (107.7°).130 Hydroxy 
groups of 196 form hydrogen bonds with the triflate counterion to assemble an eight-membered 
ring with O–H···O bond distances of 2.681 and 2.780 Å. These hydrogens resonate in the 
1
H NMR spectrum as a broad singlet at 8.23 ppm. 
We speculate that the nucleophilic substitution of triflate and chloride groups in 130 and 
132 by adventitious water leads to the dihydroxyborane NHC-BH(OH)2 intermediate that then 
reacts with the excess triflic acid producing [dipp-Imd-B(OH)2]OTf 196. 
Although the relative stability of [H3N–B(OH)2]
+
 compared to other [H3N-BR2]
+
 cations 
was predicted by quantum calculations,
131
 no dihydroxyboreniums [L-B(OH)2]
+
 have been 
prepared for any other Lewis base. The closest analogs of [dipp-Imd-B(OH)2]OTf 196 are 
catecholborenium cations 203–205 ([CatB–L]+; Figure 19) prepared and characterized by 
Stephan (L = t-Bu3P)
115
, Ingleson (L = NEt3),
88d
 and Aldridge (L = 2,6-diMes-Py).
125
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Figure 19.  The structures of catecholborenium cations 203–205. 
The B–O distances (1.310 and 1.307 Å) in 196 are shorter than B–O bonds in catecholborenium 
cations 203 (1.350 Å),115 204 (1.364 and 1.370 Å),88d and 205 (1.364 and 1.367 Å)125 or B–O 
bonds in PhB(OH)2 (1.37 Å)
132
 and significantly shorter than B–O bonds in dipp-Imd-BH2OTs 
117 (1.522 Å) (Figure 10) and dipp-BH2ONO 151 (1.512 Å) (Figure 15). Evidently, there is a 
partial double bond character of B–O bonds in 196. For comparison, the length of the B=O bond 
in a coordinated oxoborane (β-diketiminate)–B=O–AlCl3 was found to be 1.304(2) Å.
133
 We 
conclude that the borenium center in 196 is stabilized by the π-donation of hydroxy groups in a 
manner analogous to the stabilization of borenium by two amine nitrogens in 199. However, the 
diazaborole and NHC rings of 199 are orthogonal, while the dihedral angle between the O–B–O 
plane and the plane of the NHC ring in 196 is about 30°. So NHC-borenium ion 196 has an 
additional conjugative stabilization by the NHC ring that is absent in 199.  
In summary, we showed that in the presence of triflic acid, dipp-Imd-BH(OTf)2 130 and 
dipp-Imd-BH(OTf)Cl 132 slowly convert into [dipp-Imd-B(OH)2]OTf 196. This product was 
isolated and its structure was established by the spectroscopic and X-ray crystallographic 
methods. This compound is the first representative of a new class of dihydroxyborenium cations.  
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5.0  FORMATION OF LITHIATED NHC-BORANES AND THEIR REACTIONS 
WITH ELECTROPHILES 
In this Section, the preparation of lithiated NHC-boranes is reported. Their trapping with 
electrophiles is an important new way to make substituted NHC-boranes.  These reactions can be 
divided to two categories based on the site of functionalization. First, the reductive lithiation of 
NHC-boryl iodide and subsequent substitutions at the boron atom will be described 
(Section 5.1). Second, Section 5.2 deals with the substitutions at the NHC part. A neutral 
NHC-borane is first deprotonated with a strong base BuLi and then the resulting anion is 
quenched with an electrophile. Deboronation of the resulting ring-substituted NHC-BH3 
complexes provides correspondingly substituted imidazolium salts. 
5.1 NHC-BORYL LITHIUM AND ITS REACTIONS WITH ELECTROPHILES 
Tricoordinate boron compounds commonly possess a vacant p-orbital and exert Lewis acidic and 
electrophilic properties. Nucleophilic and Lewis basic boryl anions that bear a lone electron pair 
are extremely rare.
134
 The best studied class of boryl anions are dicoordinate boron species 206 
(Scheme 51). The Nozaki group reported the synthesis and the X-ray structure of the NHB anion 
208 (Figure 20), isoelectronic with NHCs. This anion reacts with electrophiles and coordinates to 
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metals forming NHB-metal complexes.
135
 The [NHB-BH3]Li complex isoelectronic to 
NHC-BH3 has been prepared.
136
 
 
Scheme 51. The general structures of boryl anions (L is a Lewis base). 
Since R2B
–
 retains an empty orbital, it can coordinate to Lewis bases giving tricoordinate boryl 
anions 207. Only two representatives of this class have been described in the literature. Imamoto 
studied the reactions of the Cy3P-BH2Li complex 209 with electrophiles;
137
 however, this boryl 
lithium compound was too unstable to be characterized by crystallographic or spectroscopic 
methods. Recently, Braunschweig reported the X-ray structure and the reaction with MeI of the 
NHC-borole anion 210.
138
 This species is a boron analog of the tetraphenylcyclopentadienyl 
anion and is stabilized by the aromaticity.
139
 
 
Figure 20. The structures of known di- and tricoordinate boryl anions (formal charges are omitted for 
clarity). 
We envisioned that the dipp-Imd-BH2
–
 anion 211 could be a starting material for novel 
dipp-Imd-BH2E complexes. Initial attempts to prepare 211 by the deprotonation of NHC-boranes 
at the boron atom with strong bases or by the electrochemical reduction of dipp-Imd-BH2I 116 
(Dr. Hélène Bonin-Dubarle and Prof. Marc Robert, CNRS) were not successful.140 Because both 
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209 and 210 were prepared by reductive metallation of corresponding L-BR2X complexes, where 
X is halide, we attempted an analogous method for the synthesis of NHC-BH2
–
 211. Many 
reactions described in this section were performed in duplicate with Dr. Julien Monot to assure 
the reproducibility of the results. 
A solution of dipp-Imd-BH2I 116 was added to a freshly prepared solution of lithium 
di-tert-butyl biphenylide (LDBB)
141
 and TMEDA (a chelating agent for lithium) in THF at –
78 °C. The low-temperature 11B NMR spectroscopic studies of the resulting dark solution 
showed the disappearance of NHC-boryl iodide signal at –33 ppm and the formation of a new 
triplet at –18.1 ppm. We ascribe this signal to [dipp-Imd-BH2]Li complex 212. The degree of 
boron–lithium association was not studied.  
 This new boryl anion was very sensitive to air, moisture, and temperature. Slow heating 
of the sample to rt resulted in the complete transformation of [dipp-Imd-BH2]Li 212 to dipp-Imd-
BH3 40 presumably by the abstraction of protons from the solvent or the NHC ring (see Section 
5.2). The DFT calculations performed by Étienne Derat (UPMC, France) showed that the 
electron density in dipp-Imd-BH2
–
 211 is significantly delocalized over the boron atom and the 
NHC ring (Figure 21). 
 
Figure 21. Calculated HOMO of anion 211. 
The results of the electrophilic trapping experiments of [dipp-Imd-BH2]Li 212 are collected in 
Table 14. In a typical experiment, a THF solution of dipp-Imd-BH2I 116 was added to a solution 
of LDBB (4 equiv) and TMEDA (4 equiv) in THF at –78 °C. After 5 min, the formation of 
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[dipp-Imd-BH2]Li 212 was assumed and the excess of diethyl carbonate (12 equiv) was added 
(entry 1). After 30 min, the reaction mixture was allowed to warm to rt. Direct flash 
chromatography of the crude mixture provided the stable dipp-Imd-BH2CO2Et 213 complex in 
61% yield. The main by-product of most experiments was dipp-Imd-BH3 40 but its yield was not 
assessed. 
Table 14. Synthesis of dipp-Imd-BH2E by the reaction of 212 with electrophiles. 
 
Entry Electrophile Product, NHC = dipp-Imd Isolated yield, % 
1 (EtO)2C=O 213, NHC-BH2CO2Et 64 
2 EtOAc 214, NHC-BH2Ac 39 
3
a 
4-ClC6H4CHO 
215,  
44
b 
4
a 
C4H9CHO 
216,  
45
b 
5 PhCN 
217,  
51
b 
6 PhCO2Me 
218,  
10
b,c 
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7 4-MeC6H4CO2Me 
219,  
22
c 
8 C4H9X (X = Cl or I) 220, NHC-BH2Bu 46 (X = Cl); 35 (X = I) 
9 i-C3H7I 221, NHC-BH2-i-Pr 57
b 
10 adamantyl iodide 
222,  
50
b 
11 CH2=CHCH2Br 223, NHC-BH2CH2CH=CH2 36 
12 C4F9I 224, NHC-BH2C4F9 7
c 
13 C6F6 225, NHC-BH2C6F5 27 
14
a 
2-cyclohexen-1-one 
226,  
14
c 
15
a,d 
 227,  
34 
  
228,  
30 
a
 The crude mixture was quenched with MeOH; 
b
 The product was obtained and characterized by 
Dr. Julien Monot; 
c
 The result is unpublished; 
d
 Two products 227 and 228 were isolated. 
 
The reaction with ethyl acetate afforded dipp-Imd-BH2Ac 214 in 39% yield (entry 2). The 
compound 214 is an example of a rare class of acylboranes.
142
 The co-existence of the ketone 
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group C=O and borohydride B–H in one structure is remarkable. The absorbance band of the 
C=O group in the IR spectrum was observed at 1622 cm
–1
. The X-ray crystal structure of 214 
was solved (Figure 22). 
 
Figure 22. The X-ray crystal structure of dipp-Imd-BH2Ac 214.  
Selected bond lengths (Å), angles (deg), and torsion angles: B–C(28) 1.607(3), O–C(28) 1.226(3), B–C(1) 
1.601(3), B–C(28)–O 125.4(2), C(1)–B–C(28) 110.1(2), C(1)–B–C(28)–C(29) –168.2(2), C(28)–B–C(1)–N(1) –
93.3(2), C(28)–B–C(1)–N(2) 81.6(2). 
Boryllithium 212 added to 4-chlorobenzaldehyde and valeraldehyde giving α-boryl alcohols 215 
and 216 in 44% and 45% yields, respectively (entries 3,4). These complexes can be viewed as 
products of the C=O hydroboration with the reverse regioselectivity when a hydride adds to the 
oxygen end and a boryl group adds to the carbon atom.  
Interestingly, benzonitrile and methyl benzoate did not give the standard 1,2-addition 
products. Instead, the para-substituted products 217 and 218 formed in 51% and 10% yields, 
respectively (entries 5,6). Imamoto observed similar products in the reactions of anion 
Cy3P-BH2Li 209. The mechanism of their formation may involve the electron transfer from the 
NHC-BH2
–
 anion to an electron-deficient aromatic system followed by the radical coupling and 
oxidative rearomatization. The reaction of 212 with methyl p-toluate in which the para position 
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is blocked resulted in the B-acyl product 219 analogous to the compound 214 (yield 22%, 
entry 7). 
The reactions with alkyl halides delivered the corresponding B-alkyl derivatives 220-223. 
1-Chlorobutane gave dipp-Imd-BH2Bu 220
70b
 in 46% yield (entry 8). Surprisingly, the product 
yields were higher with a secondary halide (isopropyl iodide, 57% yield of 221, entry 9) and a 
bridgehead halide (adamantyl iodide, 50% yield of 222, entry 10) but lower with allyl bromide 
(36% yield of 223, entry 11). According to the 
11
B NMR spectrum of the crude mixture, the 
major by-product in the reaction with allyl bromide was dipp-Imd-BH2Br 115. These results 
suggest that the mechanism of the transformation is not simple SN2 or SN1 substitution. Such 
reactions would be slow with the bridgehead substituted adamantyl iodide. The likely 
mechanism of the formation of dipp-Imd-BH2Ad 222 is single electron transfer (SET) 
(Scheme 52). Complex 222 cannot be prepared by the hydroboration reaction because a 
bridgehead alkene would be needed. The only known way to adamantyl boranes is the reduction 
of derivatives of adamantyl boronic acid.
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Scheme 52. The SET mechanism of substitution of alkyl iodides with boryl anion. 
The possibility of the SET mechanism was supported by the isolation of dipp-Imd-BH2C4F9 224 
(7% yield, entry 12) in the reaction of 212 with C4F9I. Perfluoroiodides are known to be inert 
towards the nucleophilic substitution.
144
 The reaction of boryllithium 212 with 
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hexafluorobenzene is likely to proceed by the classical SNAr addition/elimination mechanism. 
The dipp-Imd-BH2C6F5 complex was isolated in 27% yield (entry 13). 
The reactions of 212 with α,β-unsaturated compounds suffered from the anionic 
oligomerization or polymerization of an electrophile. The only product isolated in the reaction 
with 2-cyclohexen-1-one was 226 (14% yield; an inseparable mixture of diastereomers; entry 
14). Finally, the reaction with ethyloxirane gave two products 227 (34% yield) and 228 
(30% yield) that were separated by column chromatography (entry 15). Two diastereomers of 
228 were indistinguishable by the NMR spectroscopy and could not be separated by HPLC. The 
B-substituted 227 is the product of standard epoxide ring-opening with a nucleophile. The 
formation of C,B-disubstituted 228 was more interesting. We suggest that quenching of 
[dipp-Imd-BH2]Li 212 and unreacted LDBB with ethyloxirane is slow and these strong bases can 
deprotonate the newly formed product 227 at the C-4 atom of the NHC ring. Trapping of the 
resulting anion with epoxide gave 228. This result inspired the further development of such 
ring-functionalization reactions, which is described in Section 5.2. 
Metallation of NHC complexes of boron di- and trihalides can also proceed via 
intermediate NHC-boryl anions. Several research groups reported such transformations (Figure 
23).  Prior to our work, Robinson and coworkers reported the reductive dimerization of 
dipp-Imd-BBr3 126 with potassium graphite KC8 in Et2O to NHC-BH=BH-NHC 36 and 
NHC-BH2BH2-NHC 229.
33
 After our work, the reduction of CAAC-BBr3 (CAAC = cyclic 
amino alkyl carbene) allowed Bertrand and co-workers to isolate and characterize the stable 
borylene (CAAC)2BH 230, a boron analog of carbene :CH2.
145
 Braunschweig suggested the 
formation of the borylene supported by a single Lewis base ligand NHC-BH: as an intermediate 
of diMe-Imd-BHCl2 reduction with sodium naphthalide that gave the diastereomeric 
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boracyclopropane products of the addition to naphthalene 231.
146
 Finally, the product 232 of the 
C–H insertion to an isopropyl group was obtained by the reduction of [dipp-Imd-B(Ni-Pr2)Cl]Cl 
200 with KC8.
124
 
 
Figure 23. Products of reductive metallation of carbene-boryl polyhalides. 
In summary, the reductive metallation of dipp-Imd-BH2I 116 gave boryl lithium complex 
[dipp-Imd-BH2]Li 212. This is the first tricoordinate boryl anion that is not stabilized by the 
aromaticity and was observed in solution by 
11
B NMR spectroscopy. The reaction of 
NHC-boryllithium 212 with electrophiles provided various dipp-Imd-BH2E complexes, many of 
which could not be prepared by previously known methods. Their availability opens the door to 
study their application as acylation, alkylation, and arylation reagents. 
5.2 NHC-RING SUBSTITUTION REACTIONS 
Following the isolation of the ring-substituted product 4-EtCH(OH)CH2-dipp-Imd-BH2-
CH2CH(OH)Et  228 (entry 15, Table 7, Section 5.1), we decided to investigate its formation by 
the deliberate deprotonation of the NHC ring at the C4 carbon. This section describes the 
lithiation of the carbene ring of imidazol-2-ylidene-boranes with BuLi. Functionalized NHC-
boranes were prepared by quenching the lithiated intermediates with electrophiles. The two-step 
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deboronation procedure (TfOH, then MeOH) was applied to convert substituted NHC-BH3 
complexes to corresponding imidazolium salts. 
The functionalization at C4,5 in free imidazol-2-ylidenes or their complexes allows for 
tuning their steric or electronic properties.
147
 Also it provides a handle for further 
functionalization, easier separation or recycling of carbene-based reagent. The main strategy to 
introduce such substituents is the multistep synthesis of a corresponding imidazolium salt from 
acyclic precursors.
148
 It would be convenient to develop a general method for the direct 
C4,5-functionalization of easily available unsubstituted imidazolium salts, carbenes or their 
complexes. The ring metallation followed by the electrophilic trapping is an attractive 
strategy.
149
 However, the direct application of this strategy to imidazolium salts is problematic 
because the hydrogen atom at C2 is much more acidic than hydrogen at C4.  Indeed, the 
deprotonation at C2 is the main way for the carbene preparation (Scheme 7, Section 1.2). 
Bertrand and co-workers discovered that upon the treatment of certain C-2 substituted 
imidazolium salts 233 (E = PhC(=O), Cl, TMS, etc.) with a strong base (KHMDS), the C-2 
substituents migrates to the C-4 position giving carbene 234 (Scheme 53, equation 1).
150
 This 
transformation presumably proceeds via so-called abnormal N-heterocyclic carbenes 235.
151
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Scheme 53. Literature examples of C4,5-carbene functionalization. 
Robinson and coworkers deprotonated the C4 position of the free carbene 39.
152
  The resulting 
lithiocarbene 236 was quenched with BEt3 and TMSCl to give carbenes 237 and 238 
(equation 2). The limitation of these two approaches is the sensitivity of the reaction products. 
Imidazol-2-ones
153
 and -2-thiones 239
154
 are useful NHC precursors that can be functionalized 
by the metallation/trapping sequence (equation 3). Metallated carbene-lanthanide
155
 and carbene-
phosphinidene
156
 complexes have also been described. 
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The first clue that ring-metallation of NHC-boranes might be possible was the Cavell’s 
observation of the H/D exchange on the imidazolylidene rings of bis-carbene trifluoroborane 240 
in DMSO-d6 promoted by basic CsF (equation 4).
157
 However, this reaction required harsh 
conditions (100 °C, 100 h). Clyburne’s analysis of the X-ray structure of diMes-Imd-BH3 241 
revealed the dihydrogen bonding B–H···H–C4, implying the basicity of the B–H hydrides and 
the acidity of C4–H bonds.158  
Preliminary experiments showed that that BuLi was a convenient base for deprotonation 
of NHC-boranes at C-4. (NaHMDS and t-BuOK were not efficient.) Table 15 shows the results 
of lithiation and silylation of readily available imidazol-2-ylidene-BH3 complexes 40, 41, 45, 75, 
and 241 bearing different N-substituents.  
Table 15. Reactions of deprotonated NHC-BH3 complexes with TMSCl. 
 
Entry Starting material Product Isolated yield, % 
1 dipp-Imd-BH3, 40 243a 89
a 
2 diMe-Imd-BH3, 41 243b 85 
3
 
diiPr-Imd-BH3, 45 243c 93 
4
 
diCy-Imd-BH3, 75 243d 92 
5 diMes-Imd-BH3, 241 243e 52 
a
 Residual 40 (about 10%) was not separated. 
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In a typical experiment, BuLi (1 equiv) was added to a solution of dipp-Imd-BH3 40 in THF. 
After 5 min, the resulting anion 242a was quenched by addition of trimethylsilyl chloride (1.1 
equiv). Standard workup and flash chromatography provided C4-silylated product 4-TMS-dipp-
Imd-BH3 243a in 89% isolated yield (entry 1). Unfortunately, in this case about 10% of 
unreacted starting 40 could not be separated from 243a because both compounds are very 
nonpolar. 
In all other cases, flash chromatography afforded pure silylated products 243b-e. The 
yields of N-alkyl substituted complexes were very good (85–93%, entries 2–4). The yield of 
243e bearing N-mesityl groups was moderate (52%, entry 5). These results show that the 
metallation reaction works with a wide range of imidazol-2-ylidene-boranes. After this work was 
finished, Roesky and Stalke independently reported the deprotonation of dipp-Imd-BH3 40 by 
BuLi and solved the crystal structure of the lithiated intermediate 242a.
159 
The scope of the electrophilic trapping reactions was studied with dipp-Imd-BH3 40 and 
diiPr-Imd-BH3 45. Lithiated boranes 242a (R = dipp) and 242c (R = i-Pr) were quenched with 
five different electrophiles. The results of these experiments are summarized in Table 16. All 
products were isolated by flash chromatography and corresponding yields are reported.  Like 
TMSCl, benzaldehyde is an excellent trapping reagent to give 244a,c (entry 1, 82% and 88%).  
The reactions with ethyloxirane afforded 245a,c (entry 2, 62% and 40%). This synthesis of 245a 
strongly supports the C-4 deprotonation pathway for the formation of the product 228 (entry 15, 
Table 7, Section 5.1). 
Primary alkyl bromides give alkylation products 246a,c and 247c in variable yields 
(entries 3, 4), though even these yields are surprisingly good given that no transmetalation was 
performed.  An azide group, useful for further functionalization by click chemistry, survives the 
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reaction and purification (entry 3). Reactions with diphenylphosphinyl chloride gave expected 
phosphorylated products 248a (75%) and 248c (33%) (entry 5). The reaction of 
4-Li-dipp-Imd-BH3 242a with iodine gave an inseparable mixture of products and starting 40, 
and 4-I-diiPr-Imd-BH3 249c was isolated in 18% yield in the reaction of I2 with 242c (entry 6). 
 
Table 16. Reactions of deprotonated NHC-BH3 complexes 40 and 45 with electrophiles. 
Entry Electrophile E =  R = dipp, yield (%) R = i-Pr, yield (%) 
1
 a
 PhCHO PhCH(OH)– 244a, 82 244c, 88 
2
 a
 
 
EtCH(OH)CH2– 245a, 62 245c, 40 
3
 
N3(CH2)6Br
 b 
N3(CH2)6– 246a, 61 246c, 9 
4
 
5-bromo-1-pentene CH2=CH(CH2)3– 247a, 37
c 
247c, 69 
5 Ph2P(O)Cl Ph2P(O)– 248a, 75 248c, 33 
6 I2 I– –
d 249c, 18 
a
 The reaction was quenched with MeOH; 
b
 5 equiv; 
c 
NMR yield: 247a and residual 40 were 
inseparable; 
d
 a mixture of inseparable products and 40. 
 
The reactions of lithiated NHC-boranes with several other electrophiles were not so successful. 
Only starting C-4 unsubstituted NHC-boranes were isolated in the reactions with EtOAc, 
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C6F13CH2CH2I, B(Oi-Pr)3, and BrCH2CH2Br. The reactions with (EtO)2CO, and BnBr gave 
inseparable mixtures of products. 
Dipp-Imd-BF3 138 complex, prepared by Dr. Anne Boussonnière, could also be lithiated 
and then functionalized with trimethylsilyl chloride or ethyloxirane (Scheme 54).  Conditions 
were identical to those described in Tables 15 and 16. Silylated product 250 was isolated in 85% 
yield, though it again could not be separated from 10% of unreacted 138 because both 
compounds are very nonpolar.  The product of reaction with ethyloxirane 251 was readily 
isolated in pure form in 66% yield.  The yields of 4-E-dipp-Imd-BF3 250 and 251 are very 
similar to the yields of their BH3 analogs 243a (entry 1, Table 15) and 245a (entry 2, Table 16). 
 
Scheme 54.  Lithiation and electrophile trapping of dipp-Imd-BF3 138. 
The monofunctionalized products can be deprotonated and functionalized for a second time.  
Metallation of 4-CH2=CH(CH2)3-diiPr-Imd-BH3 247c (entry 4, Table 16) followed by the 
addition of benzaldehyde gave disubstituted product 252 in 61% isolated yield (Scheme 55, top).  
Signals in the 
1
H NMR spectrum of 252 are broad at rt but sharpen on heating showing the 
evidence of dynamic processes. These may be a slow rotation around either the C5–CH(OH)Ph 
or the N1–i-Pr bond.160 When deprotonated 247c reacted with 5-bromo-1-pentene, new complex 
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253 bearing identical alkenyl groups at C4 and C5 atoms was prepared, though in a low yield 
(10%) (Scheme 55, bottom). 
 
Scheme 55. Preparation of C4,5-functionalized complexes from C4-substituted 247c. 
Several C4,5-functionalized complexes formed unexpectedly from unsubstituted NHC-boranes 
in one step. For example, metallation of 45 followed by the addition of tosyl chloride gave 
4,5-Cl2-diiPr-Imd-BH3 254 in 45% yield (Scheme 56, equation 1). In this reaction, TsCl acts as a 
chlorinating rather than a sulfonylating agent.
161
 The initially formed monochlorinated product is 
presumably more acidic than the precursor 45 and is deprotonated by the remaining lithiated 
carbene-borane. This eventually leads to the dichlorinated product 254.  Thus, the yield of 254 
based on BuLi was 90% in this experiment. 
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Scheme 56. Preparation of C4,5-functionalized complexes from unsubstituted NHC-boranes. 
Carbene-boranes can also be treated with excess BuLi followed by the addition of 
bis(electrophiles).  For example, the treatment of 40 with 3 equiv of BuLi and then the addition 
of bromide 255 provided the interesting tetracycle 256 in 67% isolated yield (equation 2).  
A similar reaction of deprotonated 40 with homolog bromide 257 gave the corresponding 
eight-membered ring analog 258, though only in 8% yield.  
Finally, in the reaction of deprotonated diiPr-Imd-BH3 45 with PhSSPh, three variously 
substituted products 259–261 were separated by flash chromatography (equation 3). The 
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reduction of diphenyl disulfide with diiPr-Imd-BH3 45 accounts for the formation of the 
compound diiPr-Imd-BH2SPh 259 (32%). The formation of 259 was observed by 
11
B NMR 
spectroscopy in the reaction between 45 and PhSSPh in a THF solution even in the absence of 
BuLi (see reactions of NHC-BH3 with other electrophiles in Section 3). Compound 260 (13%) 
formed due to an analogous substitution of one of hydrogens at the boron atom but it also bears a 
second SPh group at C-4 as the result of trapping of the C-4 anion with PhSSPh. In complex 261 
(14%), three hydrogen atoms of starting 45 are substituted with SPh groups. 
This lithiation/electrophile trapping reactions open the way to new carbene-borane 
complexes. The ring-substituted NHC-BH3 could also be convenient precursors of imidazolium 
salts and, in turn, carbenes and carbene complexes. The use of boranes as protecting/activating 
groups for carbenes has analogy in some uses of phosphine-boranes (Scheme 4, Section 1.1).
12
  
In both cases, the last step is a deboronation. We previously observed that treatment of 
dipp-Imd-BH3 40 with I2 or TfOH produced dipp-Imd-BH2I 116 and dipp-Imd-BH2OTf 119 
(Section 3.3) and that upon treatment with water (or methanol), these compounds undergo fast 
hydrolysis (or methanolysis) to the corresponding imidazolium salts (Section 3.2). 
We applied this deboronation protocol to 6-bromohexyl-substituted NHC-BH3 262, 
which was prepared from 40 and 1,6-dibromohexane in 64% yield under conditions described in 
Table 16.  The reaction of 262 with triflic acid (1 equiv) followed by the addition of excess 
methanol provided imidazolium salt 263 (Scheme 57). The volatiles were removed and colorless 
hygroscopic oil was obtained (115% crude yield of 263). The compound was pure by 
13
C and 
19
F NMR spectroscopy and there were no signals in the 
11
B NMR spectrum. We assume that the 
broad signal in the 
1
H NMR spectrum at 4–6 ppm is water that is also responsible for the 
exceeding mass of the product. 
 108 
 
Scheme 57.  Deboronation of a functionalized carbene-borane 262. 
Deboronation of azide 246a (entry 3, Table 16) was initially performed with iodine (0.6 equiv) 
instead of triflic acid (Scheme 58). Methanolysis gave imidazolium salt 264 in 81% yield. IR and 
HRMS analyses revealed that the azide functionality did not survive the deboronation procedure 
and was reduced to an amine group, presumably by an active borane generated during the 
reaction. Thus, we first reacted azide 246a with p-bromophenylethyne under copper-catalyzed 
click conditions (CuSO4, sodium ascorbate, tert-butanol/water)
162
 to provide triazole-containing 
NHC-borane 265 (94% yield).  Now treatment of 265 with triflic acid and methanol gave salt 
266 with the intact triazole in 92% yield. The compound was washed with Et2O and was pure by 
NMR spectroscopy. 
 
Scheme 58.  Deboronations of functionalized carbene-boranes 246a and 265.  
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In summary, we developed a simple procedure for the C4 or C4,5 functionalization of 
imidazol-2-ylidene-borane complexes by lithiation and electrophile trapping.
163
 The scope of the 
reaction is broader than the scope of the direct metallation of free carbenes. Handling and 
purification of products are facilitated because of their chromatographic stability. This opens the 
way for the preparation of carbene-borane reagents possessing improved reactivity, solubility, 
separation or other properties. The deboronation of the functionalized NHC-BH3 complexes by 
their treatment with triflic acid or iodine and then methanol provided C4-functionalized 
imidazolium salts. They are valuable precursors of substituted imidazol-2-ylidenes and their 
complexes that can be difficult to prepare by other methods. 
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6.0  CONCLUSIONS 
NHC-boranes are an emerging class of reagents for the organic synthesis. The studies on various 
aspects of their chemistry have been presented. The radical chain mechanism of Barton–
McCombie deoxygenation with NHC-boranes was established by the evaluation of rate constants 
of the hydrogen abstraction, the isolation of the boron-derived by-product, and the EPR detection 
of NHC-boryl radicals. Ionic reductions of alkyl halides and sulfonates with NHC-BH3 
complexes were discovered. The reactions of NHC-boranes with strong halogenation agents and 
Brønsted and Lewis acids were described. Nucleophilic substitutions of NHC-BH2I and 
NHC-BH2OTf complexes at the boron atom provided substituted boranes with rare or unique  
structural motifs, including boryl azides, nitrosooxyborane, and nitroborane. The reaction of 
NHC-boryl triflate with lithium phenoxide in THF gave the unexpected product of THF ring-
opening. A novel dihydroxyborenium cation [NHC-B(OH)2]OTf was prepared from NHC-BHX2 
complexes under acidic conditions. Reductive lithiation of the NHC-BH2I complex gave a boryl 
anion NHC-BH2Li. This was trapped with several electrophiles to obtain various B-substituted 
complexes, including acyl boranes. Deprotonation of imidazol-2-ylidene-boranes with BuLi was 
employed for the synthesis of C-4 functionalized NHC-boranes. Application of the deboronation 
protocol provided corresponding imidazolium salts. This understanding of many reactions of 
NHC-boranes provides a strong foundation for their future development. 
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7.0  EXPERIMENTAL 
7.1 GENERAL REMARKS AND METHODS 
Reactions with air-sensitive compounds and reagents were performed under argon. THF, 
CH2Cl2, Et2O, and toluene were dried by passing through an activated alumina column. TMEDA 
was purified by distillation over KOH. THF used for the preparation and reactions of 
[dipp-Imd-BH2]Li 212 was distilled over Na/benzophenone. Other chemicals and solvents were 
purchased from commercial suppliers and used as received. 
Reactions were monitored by TLC analysis (Merck 60 F254 glass-coated plates) and 
11
B 
NMR spectroscopy (see below). Visualization of TLC plates was accomplished with a 254 nm 
UV lamp or by staining with vanillin, p-anisaldehyde, or phosphomolybdic acid solutions. 
Products were purified by column chromatography on silica gel as the stationary phase (Sorbent 
Technologies, 230–400 mesh) or by the CombiFlash®Rf flash chromatography system 
(Teledyne ISCO) with prepacked RediSep®Rf columns. 
Melting points (mp) were determined with a Mel-Temp II apparatus and are uncorrected. 
Infrared (IR) spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer as thin films 
(CH2Cl2) on NaCl plates.  
Proton (
1
H) and carbon (
13
C) nuclear magnetic resonance (NMR) spectra were measured 
on Bruker Avance 300, 400 and 500 instruments at 300, 400, 500 and 75, 100, 125 MHz, 
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respectively. The chemical shifts in spectra
 
were measured in parts per million (ppm) on the delta 
(δ) scale relative to the resonance of the solvent peak (CDCl3: 
1
H = 7.27 ppm, 
13
C = 77.0 ppm; 
CD2Cl2: 
1
H = 5.32 ppm, 
13
C = 54.0 ppm; acetone-d6: 
1
H = 2.05 ppm, 
13
C = 29.84 ppm; DMSO-
d6:  
1
H = 2.50 ppm, 
13
C = 39.5 ppm; C6D6: 
1
H = 7.15 ppm, 
13
C = 128.0 ppm). Boron (
11
B), 
fluorine (
19
F), and phosphorus (
31
P) NMR spectra were measured on Bruker Avance III 300 and 
Bruker Avance III 400 instruments at 96.3 (128.4), 282 (376), and 121.4 (161.9) MHz, 
respectively. The 
11
B chemical shifts are given relative to BF3·OEt2 (
11
B = 0 ppm). 
The 
19
F chemical shifts are given relative to CFCl3 (
19
F = 0 ppm). The 
31
P chemical shifts are 
given relative to 85% H3PO4 (
31
P = 0 ppm). Unless noted otherwise, all NMR spectra were 
recorded at 293 K. The following abbreviations are used to describe coupling: s = singlet; d = 
doublet; t = triplet; q = quartet; dd = doublet of doublets; m = multiplet; br = broad; app = 
apparent.  The resonances of hydrogen atoms connected to the boron atom often cannot be 
observed in 
1
H NMR spectra because of quadrupole broadening. For the same reason, the 
resonances of carbon atoms connected to the boron atom were not observed in 
13
C NMR spectra 
of all NHC-boranes.  
Literature references are provided for published NMR spectra. Copies of unpublished 
NMR spectra can be found on a supporting DVD. 
High resolution mass spectra (HRMS) were obtained by electrospray ionization (ESI) on 
the Q-Tof Ultima API, Micromass UK Limited instrument or by electron impact ionization (EI) 
on the VG Autospec FISIONS instrument. 
X-ray diffraction was recorded and crystal structures were solved by Dr. Steve Geib 
(University of Pittsburgh). 
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7.2 COMPOUND DATA FOR SECTION 2 
Complexes 71 and 72 were synthesized and characterized by Dr. Julien Monot;
62
 complexes 41, 
74, 76, 79–81, 86 were prepared and characterized by Dr. Shau-Hua Ueng.34,62,64,70a  
Compounds 53,
34
 82,
164
 and 85
165
 were prepared according to the known procedures. NMR 
spectral data matched those reported in the literature. 
 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene borane (dipp-Imd-BH3) (40): Potassium 
tert-butoxide (0.87 g, 7.8 mmol, 1.1 equiv) was added to a suspension of imidazolium chloride 
38 (3.0 g, 7.1 mmol) in THF (15 mL) at 0 °C. After stirring for 30 min, the yellow cloudy 
solution was obtained. The mixture was filtered thorugh a layer of Celite. The Celite pad was 
washed with EtOAc (100 mL). The yellow filtrate was concentrated at 30 °C under vacuum. The 
light yellow residue of 39 was dissolved in anhydrous PhH (15 mL). Solid Me3N-BH3 (0.51 g, 
7.1 mmol) was added and the brown reaction mixture was refluxed for 18 h. The solvents were 
removed by rotary evaporation to give a yellow residue. Chromatography purification (elution 
with hexane-Et2O 9:1 to pure Et2O) gave dipp-Imd-BH3 40 as a white solid (2.04 g mg, 72%): IR 
(thin film, cm
–1
) νmax 3157, 3118, 3087, 2962, 2926, 2868, 2404, 2340, 2295, 2244, 1472, 1429, 
1414, 1383, 1361, 1216, 1154, 1122, 1109, 950, 849, 801, 756; 
1
H NMR (400 MHz, CDCl3) δ 
7.46 (t, J = 7.8 Hz, 2H), 7.29 (d, J = 8.0 Hz, 4H), 7.03 (s, 2H), 2.57 (sept., J = 6.9 Hz, 4H), 1.29 
(d, J = 6.8 Hz, 12H), 1.19 (d, J = 6.8 Hz, 12H), 0.56 (br q, JB–H = 83 Hz, 3H). 
13
C
 
NMR (75 
 114 
MHz, CDCl3) δ 145.4, 134.3, 129.9, 123.8, 121.5, 28.7, 24.5, 23.0; 
11
B NMR (96.3 MHz, 
CDCl3) δ –36.4 (q, JB–H = 88 Hz). The NMR sprectra were also recorded in C6D6 and they were 
identical to those reported in the literature.
33
 
 
General Procedure 1: Synthesis of NHC-BH3 complexes (GP1): A solution of NaHMDS (1 M 
in THF, 1.05 equiv) was added to a suspension of an imidazolium salt (1 equiv) in THF at –78 
°C under argon. After stirring of the reaction mixture for 1 h at –78 °C, a solution of BH3-THF 
(1 M in THF, 1 equiv) was added. The resulting mixture was allowed to warm from –78 °C to rt 
and stirred for 20 h. The solvent was removed by rotary evaporation. The residue was dried 
under vacuum and purified by column chromatography to give a NHC-BH3 complex. 
 
1,3-Diisopropylimidazol-2-ylidene borane (diiPr-Imd-BH3) (45):
62
 Following GP1 with 
chloride 267 (510 mg, 2.7 mmol), the compound 45 was obtained by flash chromatography 
(elution with hexane : EtOAc = 19:1) as a white solid (350 mg, 78%): mp 85–87 °C; IR (thin 
film, cm
–1
) νmax 3154, 3124, 3098, 2977, 2931, 2284, 1469, 1392, 1368, 1213, 1176, 884, 759; 
1
H NMR (400 MHz, CDCl3) δ 6.93 (s, 2H), 5.13 (septet, 2H, J= 6.8 Hz), 1.40 (d, 12H, J= 6.8 
Hz), 1.08 (q, JB–H = 86 Hz, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 114.8, 48.9, 22.4; 
11
B NMR (133 
 115 
MHz, CDCl3) δ –37.5 (q, JB–H = 89 Hz); HRMS (EI) calcd. for C9H19
11
BN2 ([M]
+
)
 
166.1641, 
found 166.1643. Compound 45 has been prepared previously by a different route and NMR 
spectroscopy data in C6D6 have been reported.
43 
 
1-Allyl-3-methylbenzimidazolium chloride (269): A solution of 1-methyl-1H- 
benzo[d]imidazole 268 (1.0 g, 7.6 mmol) and allyl chloride (6.2 mL, 76 mmol) was heated in a 
sealed pressure tube at 90 °C for 3 days. After the tube was cooled to rt, a pink precipitate was 
filtered and washed with Et2O (2×10 mL) to give salt 269 (1.0 g, 63%): mp 118–119 °C; 
1
H 
NMR (300 MHz, DMSO-d6) δ 10.11 (s, 1H), 8.10–7.95 (m, 2H), 7.75–7.60 (m, 2H), 6.10 (ddt, J 
= 16.2 Hz, 10.8 Hz, 5.7 Hz, 1H), 5.42 (d, J = 18 Hz, 1H), 5.37 (d, J = 10.5 Hz, 1H), 5.23 (d, J = 
5.7 Hz, 2H), 4.11 (s, 3H). This product was introduced to the next step without further 
purification. 
1-Allyl-3-methylbenzimidazol-2-ylidene borane (AllylMe-BImd-BH3) (73):
62
 Following GP1 
with chloride 269 (0.5 g, 2.4 mmol), the compound 73 was obtained by flash chromatography 
(elution with hexane : EtOAc = 8:1 to 3:1) as a yellow solid (92.0 mg, 21%): mp 68–70 °C; IR 
(thin film, cm
–1
) νmax 3078, 2979, 2944, 2279 (B–H), 1448, 1430, 1415, 1112, 1033, 999, 936, 
739; 
1
H NMR (300 MHz, CDCl3) δ 7.50–7.30 (m, 4H), 5.99 (ddt, J = 16.2 Hz, 10.5 Hz, 5.7 Hz, 
1H), 5.25 (d, J = 10.5 Hz, 1H), 5.20 (d, J = 17.7 Hz, 1H), 5.08 (d, J = 5.4 Hz, 2H), 3.96 (s, 3H). 
1.24 (q, JB–H = 87 Hz, 3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 133.3, 132.4, 131.6, 123.9, 123.9, 
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118.4, 111.2, 110.6, 48.2, 32.2; 
11
B NMR (96.3 MHz, CDCl3) δ –37.0 (q, JB–H = 87 Hz); HRMS 
(EI) calcd. for C11H15
11
BN2 ([M]
+
)
 
186.1328, found 186.1325. 
  
1,3-Dicyclohexylimidazol-2-ylidene borane (diCy-Imd-BH3) (75):
62
 Following GP1 with 
tetrafluoroborate 270 (320 mg, 1.0 mmol), the compound 75 was obtained by flash 
chromatography (elution with hexane : EtOAc = 4:1) as a white solid (130 mg, 53%): mp 162–
164 °C; IR (thin film, cm–1) νmax 3157, 3124, 3102, 2935, 2858, 2340, 2280, 2213 (B–H), 1448, 
1394, 1248, 1202, 1114, 750; 
1
H NMR (300 MHz, CDCl3) δ 6.90 (s, 2H), 4.72–4.65 (m, 2H), 
2.10–2.00 (m, 4H), 1.90–1.80 (m, 4H), 1.80-1.70 (m, 2H), 1.50–1.35 (m, 8H), 1.25–1.10 (m, 
2H), 1.06 (q, JB–H = 85 Hz, 3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 115.4, 56.6, 33.3, 25.4, 25.3; 
11
B 
NMR (96.3 MHz, CDCl3) δ –37.3 (q, JB–H = 86 Hz); HRMS (ESI) calcd. for C15H27
11
BN2Na ([M 
+ Na]
+
)
 
269.2165, found 269.2149. 
 
1-Allyl-3-(2,4,6-trimethylphenyl)imidazolium chloride (272): A solution of 1-(2,4,6-
trimethylphenyl)imidazole 271
166
 (1.00 g, 5.37 mmol) in allyl chloride (8.8 mL, 8.2 g, 
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110 mmol) was heated in a screw-cap pressure tube at 60 °C for 3 days. Volatiles were removed 
by rotary evaporation, and the light brown residue was dissolved in CH2Cl2 (2 mL). Hexane (5 
mL) was added to this solution, and then the resulting white precipitate was filtered and dried in 
air to give salt 272 (1.02 g, 72%): 
1
H NMR (300 MHz, CDCl3) δ 10.88 (s, 1H), 7.59 (s, 1H), 7.16 
(s, 1H), 7.00 (s, 2H), 6.12 (ddt, J = 16.8 Hz, 10.2 Hz, 6.6 Hz, 1H), 5.52–5.45 (m, 4H), 2.34 (s, 
3H), 2.08 (s, 6H). This product was introduced into the next step without further purification. 
1-Allyl-3-(2,4,6-trimethylphenyl)imidazol-2-ylidene borane (AllylMes-Imd-BH3) (77):
70a
 
Following GP1 with chloride 272 (0.300 g, 1.14 mmol), the compound 77 was obtained by 
filtration of the reaction mixture and evaporation of the filtrate as a white solid (0.254 g, 92%): 
mp 126–128.5 °C; IR (thin film, cm–1)  νmax 3170, 3140, 2920, 2857, 2362 (B–H), 2277 (B–H), 
1647, 1556, 1494, 1454, 1378, 1253, 1156, 1113, 916, 869, 728; 
1
H NMR (300 MHz, CDCl3) δ 
7.02 (d, J = 1.8 Hz, 1H), 6.97 (s, 2H), 6.81 (d, J = 2.1 Hz, 1H), 6.05 (ddt, J = 16.8 Hz, 10.4 Hz, 
5.9 Hz, 1H), 5.33 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 5.22 (dd, J = 17.1 Hz, 1.2 Hz, 1H), 4.86 (dd, J = 
5.7 Hz, 1.2 Hz, 2H), 2.34 (s, 3H), 1.98 (s, 6H), 0.79 (q, JB–H = 86 Hz, 3H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 138.9, 134.9, 134.7, 132.4, 129.0, 120.0, 119.3, 118.8, 51.1, 21.1, 17.7; 
11
B NMR (96.3 
MHz, CDCl3) δ –37.4 (q, JB–H = 87 Hz); HRMS (ESI) calcd. for C15H21
11
BN2Na ([M + Na]
+
)
 
263.1695, found 263.1709. 
 
1-(But-3-enyl)-3-(2,4,6-trimethylphenyl)imidazolium bromide (273): Alkylation of 1-(2,4,6-
trimethylphenyl)imidazole 271
166
 (267 mg, 1.43 mmol) with 4-bromobut-1-ene (0.73 mL, 970 
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mg, 7.2 mmol, 5 equiv) was conducted according to the procedure for the compound 272. After 
heating of the mixture at 90 °C for 3 days and removing of the volatiles, the salt 273 (512 mg, 
80% purity by 
1
H NMR, about 90% yield) was obtained as a brown semisolid: 
1
H NMR (300 
MHz, CDCl3) δ 10.23 (s, 1H), 8.00 (s, 1H), 7.16 (s, 1H), 6.97 (s, 2H), 6.03–5.88 (m, 1H), 5.04–
4.98 (m, 2H), 4.85 (t, J = 6.3 Hz, 2H), 2.75–2.72 (m, 2H), 2.32 (s, 3H), 2.02 (s, 6H). This 
product was introduced into the next step without further purification. 
1-(But-3-enyl)-3-(2,4,6-trimethylphenyl)imidazol-2-ylidene borane (HAllylMes-Imd-BH3) 
(78):
62
 Following GP1 with bromide 273 (337 mg, 1.05 mmol) (deprotonation with NaHMDS 
was performed in THF (3 mL)–CH2Cl2 (2 mL)), the compound 78 was obtained by flash 
chromatography (elution with hexane : EtOAc = 6:1 to 3:1) as colorless liquid that crystallized to 
a white solid after several days at rt (86.5 mg, 32%): mp 79–80 °C; 1H NMR (300 MHz, CDCl3) 
δ 7.00 (s, 1H), 6.96 (s, 2H), 6.76 (s, 1H), 6.05 (ddt, J = 17.1 Hz, 10.2 Hz, 6.9 Hz, 1H), 5.10–5.05 
(m, 2H), 4.30 (t, J = 6.9 Hz, 2H), 2.64 (dt, J = 6.8 Hz, 6.8 Hz, 2H), 2.33 (s, 3H), 1.96 (s, 6H), 
0.80 (q, JB–H = 86 Hz, 3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 138.9, 135.0, 134.7, 133.9, 128.9, 
119.9, 119.5, 118.1, 48.2, 34.4, 21.1, 17.6; 
11
B NMR (96.3 MHz, CDCl3) δ –37.2 (q, JB–H = 87 
Hz); HRMS (ESI) calcd. for C16H23
11
BN2Na ([M + Na]
+
)
 
277.1852, found 277.1878. 
 
2-Thioxopyridin-1(2H)-yl decanoate (65):
62
 Sodium 2-thioxopyridin-1(2H)-olate 274 (370 mg, 
2.5 mmol) was added to a solution of decanoyl chloride (0.57 mL, 530 mg, 2.8 mmol, 1.1 equiv) 
in CH2Cl2 (5 mL). The mixture was stirred for 3 h at rt in the flask wrapped into the aluminum 
foil. The volatiles were removed by rotary evaporation. The yellow residue was purified by 
 119 
column chromatography (elution with CH2Cl2) to give of PTOC ester 65 as yellow liquid that 
crystallized to a yellow solid after several days in the refrigerator (440 mg, 62%): 
1
H NMR (300 
MHz, CDCl3)  7.66 (dd, J = 8.7 Hz, 1.5 Hz, 1H), 7.57 (dd, J = 6.9 Hz, 1.2 Hz, 1H), 7.19 (ddd, J 
= 8.7 Hz, 6.9 Hz, 1.0 Hz, 1H), 6.63 (ddd, J = 6.9 Hz, 6.9 Hz, 1.0 Hz, 1H), 2.70 (t, J =7.5 Hz, 
2H), 2.70 (app quintet, J =7.5 Hz, 2H), 1.50–1.35 (m, 2H), 1.26 (s, 10H), 0.87 (t, J = 6.9 Hz, 
3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 175.8, 169.1, 137.7, 137.3, 133.6, 112.6, 31.8, 31.6, 29.3, 
29.2, 29.1, 29.0, 24.3, 22.6, 14.1. The product was stored in the refrigerator in the flask wrapped 
into aluminum foil. 
 
2-(Nonylthio)pyridine (69):
62
 A yellow solution of PTOC ester 65 (50 mg, 0.18 mmol) in 
benzene (2 mL) was irradiated with a sunlamp (275 W) for 12 min until the solution became 
colorless. The product was purified by column chromatography (elution with hexane : EtOAc = 
10:1) to give of compound 69 as colorless oil (20 mg, 47%): IR (neat, cm
–1
) νmax 3045, 2955, 
2925, 2854, 1728, 1579, 1556, 1453, 1414, 1378, 1281, 1125, 1042, 756, 725; 
1
H NMR (300 
MHz, CDCl3)  8.43 (ddd, J = 5.1 Hz, 1.8 Hz, 0.9 Hz, 1H), 7.47 (ddd, J = 8.1 Hz, 7.2 Hz, 2.1 
Hz, 1H), 7.17 (ddd, J = 8.1 Hz, 0.9 Hz, 0.9 Hz, 1H), 6.96 (ddd, J = 7.2 Hz, 4.8 Hz, 0.9 Hz, 1H), 
3.16 (t, J =7.4 Hz, 2H), 1.76–1.66 (m, 2H), 1.48–1.40 (m, 2H), 1.27 (s, 10H), 0.89 (t, J = 6.8 Hz, 
3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 159.6, 149.4, 135.8, 122.1, 119.1, 31.9, 30.1, 29.5, 29.3, 29.3, 
29.2, 29.0, 22.7, 14.1; HRMS (EI) calcd. for C14H23NS ([M]
+
)
 
237.1551, found 237.1542. 
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Kinetic Experiments and Calculations
62
 
Gas chromatography analysis was performed with an Agilent 6850 GC under the following 
conditions: initial oven temp. 50 °C, first ramp 20 °C/min to 300 °C, held at this temperature for 
5 min. All GC yields were determined using dodecane or pentadecane as an internal standard. 
The response factors were calculated from GC analysis of the mixture of the authentic samples 
and an internal standard. 
 
Determination of kH for dipp-Imd-BH3 (40) by the PTOC Method: Stock solutions of PTOC 
ester 65 (0.10 M in PhH) and dodecane (0.02 M in PhH) were prepared. A yellow solution of 
dipp-Imd-BH3 40 (8.0 mg, 0.020 mmol, 2 equiv), PTOC ester 65 (0.1 M solution in PhH, 0.10 
mL, 0.010 mmol), and dodecane (0.02 M solution in PhH, 0.50 mL, 0.010 mmol) in PhH (0.40 
mL) (total volume is about 1 mL) was irradiated with a sunlamp (275 W) for 5 min. During 
irradiation, temperature increased from 23° to 28 °C. The colorless reaction mixture was 
analyzed by GC. Products were identified by comparing their retention times (tR) with those of 
authentic samples:  68 – 2.3 min; dodecane – 4.1 min, 69 – 8.3 min. The yields were calculated 
from areas of peaks using previously determined response factors: dodecane – 1.00; 68 – 1.00; 
69 – 1.15. Such GC analysis of the reaction mixture showed the formation of nonane 68 (6.4 %) 
and 2-(nonylthio)pyridine 69 (56.9 %).  
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The following equation was used to calculate kH: 
 
The yield of nonane 68 was corrected by subtraction of 4% because this amount of nonane 
formed in the control experiment without a hydrogen donor (“background” reduction). The 
average concentration of PTOC ester 65 during the reaction is approximated by half of starting 
concentration C0(65). The average concentration of a hydrogen donor during the reaction, [NHC-
BH3], is approximated as the average between the starting and final concentrations C(NHC-BH3) 
assuming that the hydrogen donor is consumed only for formation of nonane 68. When NHC-
BH3 is dipp-Imd-BH3 40, calculations are following: 
kH (at 25
oC) =
1.4 x 106 M-1 s-1 x (6.4% - 4 %) x 0.01 M / 2
56.9% x [0.02 M - (6.4% - 4%) x 0.01 M / 2]
= 2 x 104 M-1 s-1
 
Rate constants kH for all other hydrogen donors were determined by similar experiments and 
using the same equation (Table 17; see also Figure 5, Section 2.2). 
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Table 17. Kinetic measurement data for NHC-boranes. 
Entry Compound Yield of 68, % Yield of 69, % kH (25 °C) (calc.), M
–1 
s
–1
 
a
 
1 40 6.4 56.9 2 × 10
4
 
2 41 15.0 52.9 8 × 10
4
 
3 45 11.2 49.3 5 × 10
4
 
4 53 14.9 65.7 6 × 10
4
 
5 71 6.7 61.5 2 × 10
4
 
6 72 6.6 54.8 2 × 10
4
 
7 73 12.3 60.7 5 × 10
4
 
8 74 15.1 56.5 7 × 10
4
 
9 75 13.4 50.4 7 × 10
4
 
10 76 11.5 50.8 5 × 10
4
 
11 77 14.0 64.3 6 × 10
4
 
12 78 13.6 57.4 6 × 10
4
 
13 79 12.9 53.6 6 × 10
4
 
14 80 13.9 58.0 6 × 10
4
 
15 81 16.7 59.7 
7 × 104 
16 84 4.5 63.3 < 1 × 10
4
 
17 114 4.4 75.7 < 1 × 10
4
 
a
 Values of kH are not statistically corrected for the number of B–H bond. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [(methylthiocarbonyl)thio]borane (dipp-
Imd-BH2SC(=O)SMe) (84):
63
  
1) from reduction of xanthate 82: Triethylborane (1 M solution in hexane, 0.15 mL, 0.15 mmol) 
was added to a solution of 1-cyclobutyldodec-1-yl xanthate 82
 
(48.0 mg, 0.145 mmol) and dipp-
Imd-BH3 40 (58.4 mg, 0.145 mmol) in PhH (0.85 mL). The solution was exposed to air by 
piercing the septum stopper with a needle. The mixture was stirred at rt for 20 h. The reaction 
mixture was loaded onto a silica gel column. The hydrocarbon products of reduction 275 and 276 
were eluted with CH2Cl2. Elution with CH2Cl2:MeOH = 8:1 gave dipp-Imd-BH2SC(=O)SMe 84 
(58.0 mg, 79%) as a white solid: mp 201–202 °C; IR (thin film, cm–1)  νmax 3165, 3132, 2963, 
2927, 2870, 2458 (B–H), 2390 (B–H), 1631 (C=O), 1471, 1036, 855; 1H NMR (300 MHz, 
CDCl3) δ 7.47 (t, J = 7.7 Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 7.09 (s, 2H), 2.55 (septet, J = 6.9 Hz, 
4H), 2.07 (s, 3H), 1.35 (d, J = 6.6 Hz, 12H), 1.15 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 191.9, 145.4, 133.3, 130.4, 124.0, 123.0, 28.9, 25.5, 22.6, 13.6; 
11
B NMR (96.3 MHz, 
CDCl3) δ –25.6 (br s); LRMS (EI) m/z 508 ([M]
+
, 0.4), 493 ([M – CH3]
+
, 2.4), 447 (11), 433 
(97), 399 (100), 389 (20), 357 (26), 186 (15), 75 (35); HRMS (EI) calcd. for C28H38
11
BN2OS2 
([M – CH3]
+
)
 
493.2519, found 493.2517. 
Crystals of 84 for X-Ray crystallographic analysis were grown from methanol. 
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2) from reduction of xanthate 85: The reaction between  S-methyl O-octan-2-yl xanthate 85
 
(24.9 
mg, 0.113 mmol) and dipp-Imd-BH3 40 (43.7 mg, 0.109 mmol) initiated with triethylborane 
(1 M solution in hexane, 0.11 mL, 0.11 mmol) in benzene (0.66 mL) was conducted according to 
the procedure of the conversion of xanthate 85 to the complex 84. The products were separated 
by column chromatography on silica gel. Octane was eluted with CH2Cl2. Elution with 
hexane:EtOAc = 4:1 gave dipp-Imd-BH2SC(=O)SMe 84 (38.8 mg, 70%) as a white solid. Its 
spectral data were identical with the previously isolated and characterized sample of 84. 
 
3) from reduction of xanthate 86: Triethylborane (1 M solution in hexane, 0.12 mL, 0.12 mmol) 
was added to a solution of O-[(8-benzyloxy-2-methyl)-oct-3-yl] S-methyl xanthate 86
 
(58.2 mg, 
0.171 mmol, 1.5 equiv) and dipp-Imd-BH3 40 (45.9 mg, 0.114 mmol) in benzene-d6 (0.55 mL) in 
an NMR tube. The tube was kept open to air at rt for 4.5 h. Then more triethylborane (0.05 
mmol, 0.5 equiv) was added. The reaction process was monitored by NMR spectroscopy. After 
30 min at rt, the reaction mixture was loaded onto a silica gel column. The reduction product 277 
was eluted with CH2Cl2. Elution with hexane:EtOAc = 6:1 gave dipp-Imd-BH2SC(=O)SMe 84 
(38.2 mg, 66 %) as a white solid. Its spectral data were identical with the previously isolated and 
characterized sample of 84. 
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7.3 COMPOUND DATA FOR SECTION 3 
Compounds 98,
167
 99,
168
 101,
169
 102,
170
 105,
171
 and 109
172
 were prepared according to the known 
procedures. NMR spectral data matched those reported in the literature. 
 
(Z)-Heptadeca-1,5-diene (279): NaHMDS (1 M solution in THF, 14.5 mL, 14.5 mmol) was 
added to a suspension of pent-4-enyltriphenylphosphonium bromide 278
173
 (5.90 g, 14.3 mmol) 
in THF (25 mL) at rt. After 30 min, a solution of dodecanal (3.80 mL, 3.16 g, 17.2 mmol) in 
THF (5 mL) was added to the orange solution. The yellow reaction mixture was stirred at rt for 
18 h, then concentrated by rotary evaporation. The residue was loaded onto a silica gel column. 
Elution with hexane gave diene 279 (2.66 g, 79%) as colorless liquid:  IR (neat, cm
–1)  νmax 3078, 
3006, 2924, 2854, 1641, 1466, 993, 911, 721; 
1
H NMR (300 MHz, CDCl3)  5.92.78 (m, 1H), 
5.46.31 (m, 2H), 5.08.96 (m, 2H), 2.14.01 (m, 6H), 1.29 (s,  18H), 0.91 (t, J = 6.6 Hz, 
3H); 
13
C
 
NMR (75 MHz, CDCl3) δ 138.5, 130.5, 128.8, 114.5, 33.9, 32.0, 29.7, 29.6, 29.4, 29.3, 
27.3, 26.7, 22.7, 14.2. 
(Z)-Heptadec-5-en-1-ol (280): 9-BBN (0.5 M solution in THF, 5.0 mL, 2.5 mmol) was added to 
neat (Z)-heptadeca-1,5-diene 279 (500 mg, 2.11 mmol) at 0 °C. The reaction mixture was stirred 
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at rt for 2 h, then refluxed for 1 h, and finally cooled to 0 °C. EtOH (2.5 mL), NaOH (2 M in 
water, 5 mL, 10 mmol), and H2O2 (30% in water, 5.0 mL, 49 mmol) were added to the mixture. 
The cloudy mixture was stirred at rt for 20 h and then diluted with Et2O (20 mL). The aqueous 
layer was separated and extracted with Et2O (20 mL). The organic layers were combined, 
washed with 1 M NaOH (20 mL) and brine (20 mL), dried over MgSO4, and concentrated by 
rotary evaporation. The residue was loaded onto a silica gel column. Elution with hexane:Et2O = 
1:2 gave (Z)-heptadec-5-en-1-ol 280 (366 mg, 68%) as colorless liquid: 
1
H NMR (300 MHz, 
CDCl3)  5.43.30 (m, 2H), 3.66 (t, J = 6.6 Hz, 2H), 2.11 (m, 4H), 1.64.54 (m, 2H), 
1.47–1.40 (m, 3H), 1.27 (s, 18H), 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 130.4, 
129.3, 62.9, 32.8, 32.4, 31.9, 29.7, 29.4, 29.3, 27.3, 26.9, 25.8, 22.7, 14.1. 
(Z)-1-Iodoheptadec-5-ene (94):
35
 Triphenylphosphine (721 mg, 2.75 mmol) was added to a 
purple solution of iodine (698 mg, 2.75 mmol) in CH2Cl2 (12 mL) at rt. The resulting brown 
reaction mixture was stirred for 10 min. A solution of (Z)-heptadec-5-en-1-ol 280 (350 mg, 1.38 
mmol) and imidazole (206 mg, 3.03 mmol) in CH2Cl2 (3 mL) was added at rt. A precipitate was 
formed and the yellow mixture was stirred at rt for 1.5 h. Then the mixture was washed with 
Na2S2O3 (aq. sat., 10 mL). The light yellow organic layer was dried over MgSO4, filtered, and 
concentrated by rotary evaporation. The residue was loaded onto a silica gel column. Elution 
with hexane:CH2Cl2 = 4:1 gave (Z)-1-iodoheptadec-5-ene 94 (465 mg, 93%) as colorless liquid: 
1
H NMR (300 MHz, CDCl3)  5.45.29 (m, 2H), 3.20 (t, J = 7.1 Hz, 2H), 2.11 (m, 4H), 
1.90.80 (m, 2H), 1.55.42 (m, 2H), 1.28 (m, 18H), 0.90 (t, J = 6.8 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 130.8, 128.8, 33.1, 32.0, 30.5, 29.7, 29.6, 29.4, 29.3, 27.3, 26.1, 22.7, 14.2, 7.0. 
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The synthesis of standards for GC analysis:
35
 
 
(Z)-Heptadec-5-ene (97): NaHMDS (1 M solution in THF, 2.4 mL, 2.4 mmol) was added to a 
suspension of pentyltriphenylphosphonium bromide (1.0 g, 2.4 mmol) in THF (5 mL) at rt. After 
30 min, a solution of dodecanal (0.64 mL, 530 mg, 2.9 mmol) in THF (2 mL) was added to the 
orange solution. The cloudy yellow mixture was stirred at rt for 18 h, then concentrated by rotary 
evaporation, and the residue was loaded onto a silica gel column. Elution with hexane gave (Z)-
heptadec-5-ene 97 (450 mg, 78%) as colorless liquid: 
1
H NMR (300 MHz, CDCl3)  5.43.33 
(m, 2H), 2.10–1.95 (m, 4H), 1.45–1.29 (m, 22H), 0.95–0.89 (m, 6H); 13C NMR (75 MHz, 
CDCl3) δ 129.9, 129.8, 32.0, 31.9, 29.8, 29.7, 29.6, 29.4, 29.3, 27.2, 26.9, 22.7, 14.1, 14.0. 
 
Dodecylcyclopentane (96): NaHMDS (1 M solution in THF, 3.0 mL, 3.0 mmol) was added to a 
solution of dodecyltriphenylphosphonium bromide (1.5 g, 2.9 mmol) in THF (10 mL) at rt. After 
30 min, the orange mixture was cooled to 0 °C and a solution of cyclopentanone (0.31 mL, 300 
mg, 3.5 mmol) in THF (2 mL) was added. The resulting yellow/orange reaction mixture was 
stirred at rt for 20 h, and then concentrated by rotary evaporation. The residue was loaded onto a 
silica gel column and elution with hexane gave a mixture of unsaturated products 281 (210 mg, 
31%) as colorless liquid. Pd/C (10%, 10 mg) was added to the solution of this mixture (100 mg, 
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0.42 mmol) in hexane (1 mL). The mixture was stirred under the atmosphere of hydrogen at rt 
for 4 h, and then filtered through a cotton plug. The filtrate was evaporated to give 
dodecylcyclopentane 96 (94 mg, 94%) as a white solid: mp 45–46 °C; 1H NMR (300 MHz, 
CDCl3)  1.80.70 (m, 1H), 1.651.20 (m, 30H), 0.90 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 40.2, 36.3, 32.8, 31.9, 30.0, 29.7, 29.4, 28.8, 25.2, 22.7, 14.1. 
 
Reduction of 1-iodoheptadec-5-ene (94) with dipp-Imd-BH3 without radical initiators 
(Scheme 17):
35
 A solution of (Z)-1-iodoheptadec-5-ene 94 (57.3 mg, 0.157 mmol) and dipp-Imd-
BH3 40 (63.3 mg, 0.157 mmol) in BTF (0.27 mL) was heated in a screw-cap pressure tube at 
125 °C for 18 h. After cooling to rt, one drop of the mixture was dissolved in CH2Cl2. GC 
analysis of this sample showed no starting iodide 94 and (Z)-heptadec-5-ene 97 as the only 
product. The mixture was loaded onto a silica gel column for flash chromatography. Elution with 
hexane gave (Z)-heptadec-5-ene 97 (21.8 mg, 58%) as colorless liquid. Its 
1
H NMR data were 
consistent with those of the sample prepared for GC standardization. 
 
6-(Benzyloxy)hexyl trifluoromethanesulfonate (103):
35
 Trifluoromethanesulfonyl anhydride 
(0.47 mL, 2.8 mmol) was added dropwise to a solution of 6-benzyloxy-1-hexanol 282
169
 (292 
mg, 1.40 mmol) and pyridine (0.28 mL, 3.5 mmol) in CH2Cl2 (5 mL) at –40 °C. The resulting 
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yellow/pink mixture was stirred at rt for 1 h and then loaded onto a silica gel column. Elution 
with hexane:EtOAc = 4:1 gave 6-(benzyloxy)hexyl trifluoromethanesulfonate 103 (317 mg, 
66%) as light brown liquid: 
1
H NMR (300 MHz, CDCl3)  7.417.28 (m, 5H), 4.55 (t, J = 6.6 
Hz, 2H), 4.53 (s, 2H), 3.51 (t, J = 6.5 Hz, 2H), 1.901.80 (m, 2H), 1.701.60 (m, 2H), 1.501.40 
(m, 4H); 
13
C
 
NMR (75 MHz, CDCl3) δ 138.5, 128.4, 127.7, 127.6, 118.7 (q, JC–F = 317 Hz), 
77.7, 73.0, 70.0, 29.5, 29.2, 25.6, 24.9; 
19
F NMR (282 MHz, CDCl3) δ –74.9 (s). 
 
General Procedure 2: Reduction of alkyl sulfonates with dipp-Imd-BH3 (40) (GP2): A 
solution of alkyl sulfonate and dipp-Imd-BH3 40 (1 equiv) in toluene was heated in a screw-cap 
pressure tube at 140 °C for 48 h. The mixture was loaded onto a silica gel column. Elution with 
pentane gave reduced product as colorless liquid. 
 
Reduction of dodecyl 4-methylbenzenesulfonate (98) to dodecane (91):
35
 Following GP2 with 
dodecyl 4-methylbenzenesulfonate 98 (33.2 mg, 0.0975 mmol) and dipp-Imd-BH3 40 (39.2 mg, 
0.0974 mmol) in toluene (0.34 mL), dodecane 91 (9.4 mg, 57%) was obtained as colorless liquid: 
1
H NMR (300 MHz, CDCl3)  1.27 (s, 20H), 0.89 (t, J = 6.8 Hz, 6H); 13C NMR (75 MHz, 
CDCl3) δ 31.9, 29.7, 29.6, 29.4, 22.7, 14.1. 
Reduction of dodecyl methanesulfonate (100) to dodecane (91): Following GP2 with dodecyl 
methanesulfonate 100 (27.1 mg, 0.103 mmol) and dipp-Imd-BH3 40 (41.2 mg, 0.102 mmol) in 
toluene (0.38 mL), dodecane 91 (10.5 mg, 60%) was obtained as colorless liquid. 
 130 
Reduction of dodecyl trifluoromethanesulfonate (102) to dodecane (91): A solution of 
dodecyl trifluoromethanesulfonate 102 (7.8 mg, 0.025 mmol), dipp-Imd-BH3 40 (9.9 mg, 0.025 
mmol), and pentadecane (an internal GC standard, 12.1 mg, 0.057 mmol) in 1,4-dioxane (0.09 
mL) was stirred at rt for 24 h. The mixture was diluted with CH2Cl2 (1.5 mL) and analyzed by 
GC (tR: dodecane 91 – 4.1 min, pentadecane – 6.3 min; response factors: dodecane 91 – 1.00; 
pentadecane – 0.79). The GC yield of dodecane 91 was 76 %. 
 
 
Reduction of 6-(benzyloxy)hexyl 4-methylbenzenesulfonate (99) to 
(hexyloxymethyl)benzene (104):
35
 Following GP2 with 6-(benzyloxy)hexyl 4-
methylbenzenesulfonate 99 (38.3 mg, 0.106 mmol) and dipp-Imd-BH3 40 (42.5 mg, 0.106 mmol) 
in toluene (0.45 mL), elution with hexane:CH2Cl2 = 2:3 gave (hexyloxymethyl)benzene 104 
(13.7 mg, 67%) as colorless liquid: 
1
H NMR (300 MHz, CDCl3)  7.377.29 (m, 5H), 4.53 (s, 
2H), 3.49 (t, J = 6.6 Hz, 2H), 1.68–1.57 (m, 2H), 1.441.24 (m, 6H), 0.91 (t, J = 6.9 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 138.8, 128.3, 127.6, 127.4, 72.9, 70.5, 31.7, 29.7, 25.9, 22.6, 14.0. 
These
 1
H NMR data are consistent with the previously reported characterization.
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Reduction of 6-(benzyloxy)hexyl methanesulfonate (101) to (hexyloxymethyl)benzene (104): 
Following GP2 with 6-(benzyloxy)hexyl methanesulfonate 95 (31.3 mg, 0.109 mmol) and dipp-
Imd-BH3 40 (44.0 mg, 0.109 mmol) in toluene (0.47 mL), elution with hexane:CH2Cl2 = 2:3 
gave (hexyloxymethyl)benzene 104 (12.9 mg, 61%) as colorless liquid. 
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Reduction of 6-(benzyloxy)hexyl trifluoromethanesulfonate (103) to 
(hexyloxymethyl)benzene (104):  
1) In toluene: A solution of 6-(benzyloxy)hexyl trifluoromethanesulfonate 103 (31.6 mg, 0.0928 
mmol) and dipp-Imd-BH3 40 (37.4 mg, 0.0929 mmol) in toluene (0.90 mL) was stirred in a 
screw-cap vial at rt for 24 h. The mixture was loaded onto a silica gel column. Elution with 
hexane:CH2Cl2 = 2:3 gave (hexyloxymethyl)benzene 104 (11.5 mg, 64%) as colorless liquid. 
2) In toluene–(t-BuO)2: Reduction of 6-(benzyloxy)hexyl trifluoromethanesulfonate 103 (21.6 
mg, 0.0635 mmol) with dipp-Imd-BH3 40 (25.5 mg, 0.0634 mmol) was conducted in the mixture 
of t-BuOOt-Bu (1.0 mL, 5.5 mmol, 85 equiv) and toluene (0.5 mL) under the same conditions as 
the reduction of 103 in pure toluene. Elution with hexane:CH2Cl2 = 2:3 gave 
(hexyloxymethyl)benzene 104 (9.4 mg, 77%) as colorless liquid. 
 
3-(4-Acetylphenoxy)propyl trifluoromethanesulfonate (106):
35
 Trifluoromethanesulfonyl 
anhydride (0.040 mL, 0.24 mmol) was added dropwise to a solution of 1-[4-(3-
hydroxypropoxy)phenyl]ethanone 105 (23.8 mg, 0.123 mmol) and pyridine (0.025 mL, 0.31 
mmol) in CH2Cl2 (1 mL) at –40 °C resulting in the formation of a white precipitate. The red 
mixture was stirred at rt for 1 h and then was loaded onto a silica gel column. Elution with 
hexane:EtOAc = 2:1 gave the solution of 3-(4-acetylphenoxy)propyl trifluoromethanesulfonate 
106 in 50 mL of the eluent. All attempts to concentrate these fractions and thus isolate the pure 
triflate 106 resulted in its fast decomposition. Nevertheless, the 
1
H NMR spectrum of the crude 
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product could be recorded before the decomposition:  
1
H NMR (300 MHz, CDCl3)  7.97 (d, J = 
9.0 Hz, 2H), 6.95 (d, J = 8.7 Hz, 2H), 4.78 (t, J = 5.9 Hz, 2H), 4.19 (t, J = 5.7 Hz, 2H), 2.60 (s, 
3H), 2.39–2.31 (m, 2H). The solution of triflate 106 in hexane:EtOAc = 2:1 was transferred to a 
round-bottom flask and used in the next experiment. 
1-(4-Propoxyphenyl)ethanone (107): Dipp-Imd-BH3 40  (49.3 mg, 0.123 mmol) was added to a 
solution of 3-(4-acetylphenoxy)propyl trifluoromethanesulfonate 106 in hexane:EtOAc = 2:1 (50 
mL) from the previous experiment. The colorless reaction mixture was stirred at rt for 15 h and 
then was concentrated to the total volume of about 5 mL and stirred at 50 °C for 3 h. The 
resulting mixture was loaded onto a silica gel column. Elution with hexane:EtOAc = 6:1 gave 1-
(4-propoxyphenyl)ethanone 107 (6.7 mg, 31% for 2 steps) as colorless liquid: 
1
H NMR (300 
MHz, CDCl3)  7.93 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.7 Hz, 2H), 3.99 (t, J = 6.5 Hz, 2H), 2.56 
(s, 3H), 1.90–1.78 (m, 2H), 1.05 (t, J = 7.2 Hz, 3H). These 1H NMR data are consistent with the 
previously reported characterization.
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2-(N-Allyl-4-methylphenylsulfonamido)ethyl trifluoromethanesulfonate (108):
35
 
Trifluoromethanesulfonyl anhydride (0.090 mL, 0.54 mmol) was added dropwise to a solution of 
N-allyl-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide 109 (69.8 mg, 0.273 mmol) and 
pyridine (0.055 mL, 0.68 mmol) in CH2Cl2 (2 mL) at –40 °C. A white precipitate was formed, 
and the resulting mixture was stirred at rt for 1 h and then was loaded onto a silica gel column. 
Elution with hexane:EtOAc = 4:1 gave 2-(N-allyl-4-methylphenylsulfonamido)ethyl trifluoro-
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methanesulfonate 108 (78.5 mg, 74%) as light yellow liquid: 
1
H NMR (300 MHz, CDCl3)  7.71 
(d, J = 8.1 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 5.71–5.57 (m, 1H), 5.26–5.18 (m, 2H), 4.64 (t, 
J = 6.1 Hz, 2H), 3.82 (d, J = 6.3 Hz, 2H), 3.46 (t, J = 6.0 Hz, 2H), , 2.45 (s, 3H); 
13
C
 
NMR (75 
MHz, CDCl3) δ 144.2, 135.6, 132.2, 130.0, 127.3, 120.6, 118.5 (q, JC–F = 318 Hz), 74.6, 52.5, 
45.7, 21.5;
 19
F NMR (282 MHz, CDCl3) δ –74.6 (s). 
Reduction of 2-(N-Allyl-4-methylphenylsulfonamido)ethyl trifluoromethanesulfonate (108) 
to N-Allyl-N-ethyl-4-methylbenzenesulfonamide (110): A solution of 2-(N-allyl-4-
methylphenylsulfonamido)ethyl trifluoromethanesulfonate 108 (19.3 mg, 0.0498 mmol) and 
dipp-Imd-BH3 40 (20.1 mg, 0.0499 mmol) in toluene (0.5 mL) was stirred at rt for 18 h and then 
at 50 °C for 20 h. The product was isolated by silica gel column chromatography. Elution with 
hexane:EtOAc = 8:1 gave N-allyl-N-ethyl-4-methylbenzenesulfonamide 110 (7.0 mg, 59%) as 
colorless liquid: 
1
H NMR (CDCl3, 300 MHz) d 7.70 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.1 Hz, 
2H), 5.67 (ddt, J = 16.5 Hz, 10.2 Hz, 6.6 Hz, 1H), 5.19 (dd, J = 17.1 Hz, 1.2 Hz, 1H), 5.15 (dd, J 
= 10.2 Hz, 0.9 Hz, 1H), 3.81 (d, J = 6.6 Hz, 2H), 3.22 (q, J = 7.1 Hz, 2H), 2.43 (s, 3H), 1.09 (t, J 
= 7.1 Hz, 3H). These spectral data were identical with those reported in the literature for 110.
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene chloroborane (dipp-Imd-BH2Cl) (114):
77
 
A solution of dipp-Imd-BH3 40 (32.5 mg, 0.0808 mmol) in tetrachloromethane (0.50 mL, 0.79 g, 
5.2 mmol, 64 equiv) and C6D6 (0.1 mL) was heated in an NMR tube at 80 °C for 19 h. CDCl3 
(0.2 mL) was added to dissolve the white precipitate and the colorless solution was heated at 
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80 °C for 56 h.  The product was isolated by column chromatography. Elution with 
hexane:EtOAc = 4:1 gave dipp-Imd-BH2Cl 114 (29.5 mg, 84%) as a white solid: mp 270–272 
°C; IR (thin film, cm–1)  νmax 3169, 2966, 2929, 2869, 2442 (B–H), 2349 (B–H), 1557, 1470, 
1266, 1181, 1066, 936, 805, 762, 740; 
1
H NMR (300 MHz, CDCl3) δ 7.50 (t, J = 7.8 Hz, 2H), 
7.31 (d, J = 7.5 Hz, 4H), 7.12 (s, 2H), 2.57 (septet, J = 6.8 Hz, 4H), 1.33 (d, J = 6.9 Hz, 12H), 
1.18 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.4, 133.2, 130.5, 124.0, 122.8, 28.9, 
25.3, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ –18.7 (br s); HRMS (ESI) calcd. for 
C27H38
11
B
35
ClN2Na ([M + Na]
+
)
 
459.2714, found 459.2714. 
 
General Procedure 3: Functionalization of dipp-Imd-BH3 (40) with alkyl halides and 
sulfonates (GP3): A solution of alkyl halide or sulfonate (1.5 equiv) and dipp-Imd-BH3 40 (1 
equiv) in toluene (0.18 mL) was heated in a screw-cap pressure tube at 140 °C for 48 h. The 
mixture was cooled to rt, diluted with hexane (2 mL) and filtered. The product was obtained 
either by this filtration or column chromatography was required. 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene bromoborane (dipp-Imd-BH2Br) (115):
77
 
Following GP3 with 1-bromododecane 92 (41.0 mg, 0.164 mmol) and dipp-Imd-BH3 40 
(44.1 mg, 0.110 mmol), 
1
H NMR spectroscopic analysis of the precipitate showed a 10:1 mixture 
of dipp-Imd-BH2Br 115 and [dipp-Imd-H]Br. The product was purified by column 
chromatography. Elution with hexane:EtOAc = 1:1 gave pure dipp-Imd-BH2Br 115 (10.1 mg, 
19%) as white solid: mp 242–245 °C; IR (thin film, cm–1)  νmax 3168, 2967, 2929, 2868, 2467 
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(B–H), 2430 (B–H), 1468, 1451, 1363, 1180, 1033, 804, 762; 1H NMR (300 MHz, CDCl3) δ 
7.50 (t, J = 7.7 Hz, 2H), 7.32 (d, J = 7.8 Hz, 4H), 7.13 (s, 2H), 2.59 (septet, J = 6.8 Hz, 4H), 1.35 
(d, J = 6.9 Hz, 12H), 1.17 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.4, 133.2, 
130.5, 124.1, 123.0, 28.9, 25.5, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ –23.0 (br s); HRMS (ESI) 
calcd. for C27H38
11
B
79
BrN2Na ([M + Na]
+
)
 
503.2209, found 503.2173. 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (tosyloxy)borane (dipp-Imd-BH2OTs) 
(117):
77
 Following GP3 with dodecyl 4-methylbenzenesulfonate 98 (50.1 mg, 0.147 mmol) and 
dipp-Imd-BH3 40 (39.5 mg, 0.098 mmol), dipp-Imd-BH2OTs 117 (39.2 mg, 70%) was obtained 
as a white solid by filtering the resulting mixture: mp 247–249 °C; IR (thin film, cm–1)  νmax 
3162, 3136, 3059, 2964, 2928, 2869, 2434 (B–H), 2368 (B–H), 1460, 1317, 1190, 1154, 1097, 
951, 806, 757, 732; 
1
H NMR (300 MHz, CDCl3) δ 7.48 (t, J = 7.7 Hz, 2H), 7.26 (d, J = 7.5 Hz, 
4H), 7.10 (d, J = 9.3 Hz, 2H), 7.09 (s, 2H), 6.96 (d, J = 8.1 Hz, 2H), 2.46 (septet, J = 6.7 Hz, 
4H), 2.32 (s, 3H), 1.21 (d, J = 6.9 Hz, 12H), 1.15 (d, J = 6.6 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 145.1, 140.9, 136.5, 133.1, 130.4, 128.3, 127.3, 124.0, 123.0, 28.8, 25.0, 22.6, 21.4; 
11
B NMR (96.3 MHz, CDCl3) δ –10.8 (br s); HRMS (ESI) calcd. for C34H45
11
BN2NaO3S ([M + 
Na]
+
)
 
595.3142, found 595.3262. 
Crystals of 117 for the X-Ray crystallographic analysis were grown from EtOAc. 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (methylsulfonyloxy)borane (dipp-Imd-
BH2OMs) (118):
77
  Following GP3 with dodecyl methanesulfonate 100 (42.4 mg, 0.160 mmol) 
and dipp-Imd-BH3 40 (43.0 mg, 0.107 mmol), 
1
H NMR spectroscopic analysis of the precipitate 
showed a 4:1 mixture of dipp-Imd-BH2OMs 118 and [dipp-Imd-H]OMs. The product was 
purified by column chromatography. Elution with hexane:EtOAc = 1:1 gave pure dipp-Imd-
BH2OMs 118 (32.0 mg, 60%) as a white solid: mp 254–257 °C; 
1
H NMR (300 MHz, CDCl3) δ 
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7.50 (t, J = 7.8 Hz, 2H), 7.32 (d, J = 7.6 Hz, 4H), 7.16 (s, 2H), 2.56–2.46 (m, 4H), 2.09 (s, 3H), 
1.32 (d, J = 6.9 Hz, 12H), 1.19 (d, J = 6.6 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.3, 133.0, 
130.6, 124.0, 123.2, 34.5, 28.9, 25.0, 22.7; 
11
B NMR (96.3 MHz, CDCl3) δ –11.3 (br s); HRMS 
(ESI) calcd. for C28H41
11
BN2NaO3S ([M + Na]
+
)
 
519.2829, found 519.2825. 
[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene]–(trifluoromethylsulfonyloxy)borane 
(dipp-Imd-BH2OTf) (119):
77
 A solution of dodecyl trifluoromethanesulfonate 102 (7.8 mg, 
0.025 mmol) and dipp-Imd-BH3 40 (9.9 mg, 0.025 mmol) in 1,4-dioxane (0.09 mL) was stirred 
at rt for 24 h. The solvent was removed by rotary evaporation, and the resulting white solid was 
washed with pentane to remove dodecane 91. Crude dipp-Imd-BH2OTf 119 was characterized by 
NMR spectroscopy: 
1
H NMR (300 MHz, CDCl3) δ 7.52 (t, J = 7.8 Hz, 2H), 7.32 (d, J = 7.8 Hz, 
4H), 7.17 (s, 2H), 2.48 (septet, J = 6.9, 4H), 1.29 (d, J = 6.9 Hz, 12H), 1.19 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.0, 132.6, 130.8, 124.2, 123.5, 28.9, 25.1, 22.6; 
11
B NMR (96.3 
MHz, CDCl3) δ –8.7 (br s); 
19
F NMR (282 MHz, CDCl3) δ –75.8 (s). 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene bromoborane (dipp-Imd-BH2Br) (115): A 
solution of tetrabromomethane (23 mg, 0.071 mmol) and dipp-Imd-BH3 40 (27 mg, 0.067 mmol) 
in C6D6 (0.6 mL) was heated in an NMR tube at 80 °C for 72 h. The mixture was diluted with 
hexane (1 mL), and the resulting white precipitate was filtered and washed with hexane (2×1 
mL) to give dipp-Imd-BH2Br 115 as a white solid (18 mg, 56%). Its spectral data were identical 
with those of the previously isolated and characterized sample of 115. 
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Methanolysis of dipp-Imd-BH2I (116): Methanol was added to a solution of dipp-Imd-BH2I 
116
140
 in benzene. The evolution of gas (H2) was observed. The 
11
B NMR spectrum of the 
resulting solution showed that signal at –33.0 ppm completely disappeared and a new singlet at 
+18.7 ppm (B(OMe)3) was present. Volatiles were removed under vacuum and the residue was 
confirmed to be 1,3-bis(2,6-diisopropylphenyl)imidazolium iodide [dipp-Imd-H]I 120 by NMR 
spectroscopy: 
1
H NMR (400 MHz, DMSO-d6) δ 10.15 (s, 1H), 8.55 (s, 2H), 7.69 (t, J = 7.8 Hz, 
2H), 7.53 (d, J = 8.0 Hz, 4H), 2.34 (septet, J = 6.5, 4H), 1.26 (d, J = 6.4 Hz, 12H), 1.16 (d, J = 
6.8 Hz, 12H); 
13
C
 
NMR (100 MHz, DMSO-d6) δ 145.3, 139.7, 132.4, 130.5, 126.7, 125.1, 29.1, 
24.6, 23.6. 
 
Radical reduction of dipp-Imd-BH2Br (115) to dipp-Imd-BH3 (40): A solution of dipp-Imd-
BH2Br 115 (24 mg, 0.05 mmol), Bu3SnH (0.02 mL, 0.075 mmol), and AIBN (0.8 mg, 0.005 
mmol) in C6D6 was heated at 80 °C for 5 h. The reaction was complete according to the 
1
H and 
11
B NMR spectra. The product was purified by column chromatography. Elution with 
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hexane:EtOAc = 6:1 gave dipp-Imd-BH3 40 as a white solid (16.3 mg, 81%). Its NMR spectra 
matched those of previously prepared samples of 40. 
 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene iodoborane (dipp-Imd-BH2I) (116):
140
  
1) With I2: A solution of iodine (95 mg, 0.37 mmol) in PhH (5 mL) was added slowly to a 
suspension of dipp-Imd-BH3 40 (300 mg, 0.75 mmol) in PhH (1 mL). The yellow solution was 
stirred for 20 min at rt. The solvent was evaporated to afford dipp-Imd-BH2I 116 as a pale yellow 
solid (400 mg, 100%) pure by NMR spectroscopy: mp >330 °C; IR (neat) ν = 3165, 2964, 2928, 
2869, 2486, 2442, 2359 (B-H), 1595, 1557, 1469, 1428, 1385, 1180, 1002, 980, 803, 761, 728 
cm
-1
; 
1
H NMR (300 MHz, C6D6) δ 7.21 (t, J = 7.2 Hz, 2H), 7.08 (d, J = 7.2 Hz, 4H), 6.44 (s, 
2H), 2.77 (septet, J = 6.9 Hz, 4H), 1.40 (d, J = 6.9 Hz, 12H), 0.99 (d, J = 6.9 Hz, 12H); 
13
C 
NMR (75 MHz, C6D6): δ 145.9, 134.1, 131.3, 124.9, 123.5, 29.4, 26.0, 23.6; 
11
B NMR (96.3 
MHz, C6D6): δ -31.9 (br s); HRMS (ESI) calcd. for C27H38
11
BN2I: 528.2172, found: 528.2163.
 
2) With NIS: A solution of N-iodosuccinimide (8.4 mg, 37 µmol) in 0.7 mL of C6D6 was added 
to a solution of dipp-Imd-BH3 40 (15 mg, 0.037 µmol) in C6D6 (0.1 mL) at rt. The mixture 
became yellow and a brown precipitate formed. After standing at rt for 20 h, 
1
H and 
11
B NMR 
spectroscopy showed the complete conversion of 40 into dipp-Imd-BH2I 116. 
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1) With Br2: A solution of bromine (1.8 M in CDCl3, 26 µL, 46 µmol, 0.5 equiv) was added to a 
solution of dipp-Imd-BH3 40 (37 mg, 91 µmol) in CDCl3 (0.5 mL) at 0 °C. Slow bubbling of a 
gas was observed. After 10 min of stirring of the orange solution at 0 °C to rt,  1H and 11B NMR 
spectroscopy showed the formation of a mixture dipp-Imd-BH2Br 115 (br s, –23 ppm), dipp-
Imd-BHBr2 125 (br s, –16 ppm), and unreacted dipp-Imd-BH3 40 (q, –36.5 ppm) in the 1 : 1 : 2 
ratio. A solution of bromine (1.8 M in CDCl3, 77 µL, 140 µmol, 1.5 equiv) was added to that 
solution in an NMR tube. The solvent was evaporated by rotary evaporation. Dipp-Imd-BBr3 126 
(57 mg, 97%) was obtained as an orange solid. 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene tribromoborane (dipp-Imd-BBr3) (126): 
1
H NMR (300 MHz, C6D6) δ 7.18 (t, J = 7.5 Hz, 2H), 7.02 (d, J = 7.8 Hz, 4H), 6.29 (s, 2H), 2.83 
(septet, J = 6.9 Hz, 4H), 1.41 (d, J = 6.6 Hz, 12H), 0.94 (d, J = 6.9 Hz, 12H); 
11
B NMR (96.3 
MHz, C6D6) δ –15.9 (s). These
 1
H and 
11
B NMR data are consistent with the previously reported 
characterization.
33 
2) With NBS: A solution of N-bromosuccinimide (6.6 mg, 37 µmol) in 0.6 mL of C6D6 was 
added to a solution of dipp-Imd-BH3 40 (15 mg, 0.037 µmol) in C6D6 (0.1 mL) at rt. After 20 
min, a precipitate formed. 
1
H and 
11
B NMR spectroscopy showed a mixture dipp-Imd-BH2Br 
115 (br s, –23 ppm), dipp-Imd-BHBr2 125 (br s, –16 ppm), and unreacted dipp-Imd-BH3 40 (q, –
36.5 ppm) in the 1 : 1 : 2 ratio.
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General Procedure 4: Reactions with strong acids (GP4): A strong acid was added to a 
solution of dipp-Imd-BH3 40 in CDCl3 (0.5 mL) inside an NMR tube. A vigorous evolution of 
hydrogen gas was observed in case of strong acids (pKa < 2). In case of weaker acids or solid 
acids, the mixture was heated at 60 °C for 18 h. The products stable towards silica gel were 
purified by column chromatography. 
 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (trifluoromethylsulfonyloxy)borane (dipp-
Imd-BH2OTf) (119): A solution of triflate 119 in CDCl3 was prepared according to GP4 from 
TfOH (9.0 µL, 0.10 mmol) and dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol). Its spectral data were 
identical with those of the previously isolated and characterized sample of 119. 
An attempt to isolate pure dipp-Imd-BH2OTf 119 by recrystallization or column chromatography 
resulted in its decomposition to 1,3-bis(2,6-diisopropylpenyl)imidazolium trifluoromethyl-
sulfonate [dipp-Imd-H]OTf.  
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene bromoborane (dipp-Imd-BH2Br) (115): A 
solution of bromide 115 in CDCl3 was prepared according to GP4 from HBr (33% solution in 
AcOH, 0.01 mL, 0.06 mmol) and dipp-Imd-BH3 40 (25 mg, 0.06 mmol). Its spectral data were 
identical with those of the previously isolated and characterized sample of 115. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene chloroborane (dipp-Imd-BH2Cl) (114): 
Chloride 114 was prepared according to GP4 from HCl (4 M solution in 1,4-dioxane, 53 µL, 
0.21 mmol) and dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol). Chromatographic separation (elution 
with hexane : EtOAc = 8 : 1 to 3 : 1) gave a white solid (36 mg, 81%). Its spectral data were 
identical with those of the previously isolated and characterized sample of 114. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (tosyloxy)borane (dipp-Imd-BH2OTs) 
(117): A solution of tosylate 117 in CDCl3 was prepared according to GP4 from solid TsOH-
H2O (5.0 mg, 26 µmol) and dipp-Imd-BH3 40 (10 mg, 25 µmol) after heating at 60 °C at 18 h. Its 
spectral data were identical with those of the previously isolated and characterized sample of 
117. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (methylsulfonyloxy)borane  
(dipp-Imd-BH2OMs) (118):  Mesylate 118 was prepared according to GP4 from MsOH (15 µL, 
0.23 mmol) and dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol). Chromatographic separation (elution 
with hexane : EtOAc = 4 : 1 to 1 : 1) gave a white solid (44 mg, 88%). Its spectral data were 
identical with those of the previously isolated and characterized sample of 118. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (trifluoroacetoxy)borane (dipp-Imd-BH2- 
OC(=O)CF3) (127):
77
 Trifluoroacetate 127 was prepared according to GP4 from CF3COOH (9.6 
µL, 0.13 mmol) and dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol). Chromatographic separation 
(elution with hexane : EtOAc = 8 : 1 to 5 : 1) gave dipp-Imd-BH2OC(=O)CF3 127 as a white 
solid (44 mg, 85%): mp 188–190 °C; IR (thin film, cm–1)  νmax 3165, 2965, 2928, 2872, 2427 (B–
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H), 2361 (B–H), 1737 (C=O), 1460, 1402, 1197, 1153, 1124; 1H NMR (300 MHz, CDCl3) δ 7.48 
(t, J = 7.8 Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 7.11 (s, 2H), 2.56 (septet, J = 6.9 Hz, 4H), 1.26 (d, J 
= 6.9 Hz, 12H), 1.19 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 181.0, 144.9, 133.1, 
130.5, 124.1, 123.2, 28.8, 24.9, 22.7; 
11
B NMR (96.3 MHz, CDCl3) δ –11.4 (br s); 
19
F NMR (282 
MHz, CDCl3) δ –75.5 (s); HRMS (ESI) calcd. for C29H38
11
BF3N2NaO2 ([M + Na]
+
)
 
537.2876, 
found 537.2852. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (dichloroacetoxy)borane (dipp-Imd-BH2- 
OC(=O)CHCl2) (128):
77
 Dichloroacetate 128 was prepared according to GP4 from 
Cl2CHCOOH (11 µL, 0.13 mmol) and dipp-Imd-BH3 40 (42.3 mg, 0.105 mmol) after heating at 
50 °C for 18 h. Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 4 : 1) gave 
dipp-Imd-BH2OC(=O)CHCl2 128 as a white solid (37.5 mg, 67%): mp 215–216 °C; IR (thin 
film, cm
–1
)  νmax 3173, 3018, 2961, 2928, 2871, 2361 (B–H), 2343 (B–H), 1723 (C=O), 1471, 
1459, 1426, 1365, 1344, 1207, 1152, 1121, 1103, 1085, 853, 805, 763; 
1
H NMR (300 MHz, 
CDCl3) δ 7.50 (t, J = 7.8 Hz, 2H), 7.30 (d, J = 7.5 Hz, 4H), 7.09 (s, 2H), 4.65 (s, 1H), 2.56 
(septet, J = 6.8 Hz, 4H), 1.28 (d, J = 6.9 Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 164.8, 145.1, 133.3, 130.4, 124.1, 123.0, 66.1, 28.9, 24.8, 23.0; 
11
B NMR (96.3 MHz, 
CDCl3)  δ –11.2 (br s); HRMS (ESI) calcd. for C29H39
11
B
35
Cl2N2NaO2 ([M + Na]
+
)
 
551.2379, 
found 551.2360. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (cyanoacetoxy)borane (dipp-Imd-BH2- 
OC(=O)CH2CN) (129):
77
 Cyanoacetate 129 was prepared according to GP4 from solid 
NCCH2COOH (9.7 mg, 0.11 mmol) and dipp-Imd-BH3 40 (37 mg, 0.09 mmol) after heating at 
60 °C for 20 h. Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 2 : 1) gave 
dipp-Imd-BH2OC(=O)CH2CN 129 as a white solid (11 mg, 24%): mp 197–199 °C; IR (thin film, 
cm
–1
)  νmax 3163, 3136, 2964, 2928, 2870, 2358 (B–H), 2263 (C≡N), 1708 (C=O), 1471, 1348, 
1253, 1159, 1106, 1088, 805, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.49 (t, J = 7.8 Hz, 2H), 7.31 
(d, J = 7.8 Hz, 4H), 7.10 (s, 2H), 2.56 (septet, J = 6.9 Hz, 4H), 2,46 (s, 2H), 1.29 (d, J = 6.9 Hz, 
12H), 1.19 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 163.1, 145.2, 133.3, 130.4, 124.1, 
122.9, 114.9, 28.8, 25.2, 24.9, 22.9; 
11
B NMR (96.3 MHz, CDCl3) δ –11.9 (br s); HRMS (EI) 
calcd. for C30H40
11
BN3O2 ([M]
+
)
 
485.3214, found 485.3195. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene bis(trifluoromethylsulfonyloxy)borane 
 (dipp-Imd-BH(OTf)2) (130):
77
 Triflic acid (22 µL, 0.25 mmol) was added to a solution of dipp-
Imd-BH3 40 (40.5 mg, 0.10 mmol) in CH2Cl2 (1 mL) at rt. The vigorous evolution of H2 gas was 
immediately observed. After 15 min, the reaction was complete according to the 
11
B NMR 
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analysis. The volatiles were removed under vacuum and the residue was loaded onto silica gel. 
The product was purified by flash chromatography. Elution with hexane:EtOAc = 80:20 gave 
dipp-Imd-BH(OTf)2 130 as a white solid (38.5 mg, 54%): mp 254–256 °C; IR (thin film, cm
–1
)  
νmax 3183, 3159, 2971, 2931, 2872, 2540 (B–H), 1464, 1447, 1383, 1338, 1250, 1198, 1161, 
1113, 1080, 1000, 979, 802, 759; 
1
H NMR (400 MHz, CDCl3) δ 7.56 (t, J = 7.8 Hz, 2H), 7.37 (d, 
J = 7.6 Hz, 4H), 7.27 (s, 2H), 3.56 (br q, 1H), 2.54 (septet, J = 6.7, 4H), 1.38 (d, J = 6.4 Hz, 
12H), 1.15 (d, J = 6.8 Hz, 12H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.0, 131.9, 131.4, 125.1, 
124.5, 29.0, 26.4, 22.0; 
11
B NMR (128.4 MHz, CDCl3) δ –2.1 (br s); 
19
F NMR (376 MHz, 
CDCl3) δ –76.0 (s); HRMS (ESI) calcd. for C29H37
11
BF6N2NaO6S2 ([M + Na]
+
)
 
721.1988, found 
721.2013. 
 
A solution of hydrochloric acid in dioxane (4 M, 25 µL, 0.10 mmol) was added to a solution of 
dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) in CH2Cl2 (1 mL) at rt. The vigorous evolution of H2 
gas was immediately observed. After 10 min, the 
11
B NMR spectroscopy showed the complete 
conversion into dipp-Imd-BH2Cl 114: a broad signal at –18 ppm.
2
 Then triflic acid (13 µL, 0.15 
mmol) was added to the resulting solution of 114 at rt. The evolution of H2 gas was again 
observed. After 20 min, the reaction was complete according to the 
11
B NMR analysis. The 
volatiles were removed under vacuum and the residue was loaded onto silica gel. The products 
were purified by flash chromatography.  
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene dichloroborane (dipp-Imd-BHCl2) (133): 
Elution with hexane:EtOAc = 85:15 gave dipp-Imd -BHCl2 133 as a white solid (5.4 mg, 11%): 
mp 302–304 °C; IR (thin film, cm–1)  νmax 3164, 3133, 3095, 2965, 2927, 2868, 2479 (B–H), 
1560, 1468, 1456, 1428, 1383, 1363, 1328, 1258, 1173, 1162, 1056, 1037, 1023, 949, 803, 761; 
1
H NMR (500 MHz, CDCl3) δ 7.50 (t, J = 7.8 Hz, 2H), 7.31 (d, J = 7.5 Hz, 4H), 7.12 (s, 2H), 
3.54 (br q, 1H), 2.62 (septet, J = 6.8, 4H), 1.36 (d, J = 6.5 Hz, 12H), 1.16 (d, J = 7.0 Hz, 12H); 
13
C
 
NMR (125 MHz, CDCl3) δ 145.5, 132.9, 130.7, 123.9, 123.7, 29.0, 25.6, 22.5; 
11
B NMR 
(128.4 MHz, CDCl3) δ –8.0 (br d, J = 78 Hz); HRMS (ESI) calcd. for C27H37
11
B
35
Cl2N2Na ([M + 
Na]
+
)
 
493.2325, found 493.2346. 
These data are identical with previously reported for dipp-Imd-BHCl2.
83 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene chloro(trifluoromethylsulfonyloxy)borane 
(dipp-Imd-BH(OTf)Cl) (132): Further elution with hexane:EtOAc = 80:20 gave dipp-Imd-
BH(OTf)Cl 132 as a white solid (11.5 mg, 20%): mp 223–226 °C; IR (thin film, cm–1)  νmax 
3173, 3149, 2965, 2930, 2873, 2524 (B–H), 1460, 1429, 1389, 1371, 1327, 1259, 1202, 1173, 
1052, 1037, 818, 805, 761; 
1
H NMR (400 MHz, CDCl3) δ 7.53 (t, J = 7.8 Hz, 2H), 7.33 (d, J = 
7.6 Hz, 4H), 7.17 (s, 2H), 3.54 (br q, 1H), 2.66 (septet, J = 6.8 Hz, 2H), 2.47 (septet, J = 6.7 Hz, 
2H), 1.36 (d, J = 6.8 Hz, 6H), 1.35 (d, J = 5.6 Hz, 6H), 1.18 (d, J = 6.8 Hz, 6H), 1.15 (d, J = 6.8 
Hz, 6H); 
13
C
 
NMR (125 MHz, CDCl3) δ 145.2, 145.0, 132.3, 131.0, 124.3, 124.2, 124.2, 29.0, 
29.0, 25.9, 25.7, 22.3, 22.3; 
11
B NMR (128.4 MHz, CDCl3) δ –2.8 (br s); 
19
F NMR (376 MHz, 
CDCl3) δ –76.3 (s).  
Crystals of dipp-Imd-BH(OTf)Cl 132 for the X-ray analysis were grown from 1,2-
dichloroethane. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene dichloroborane (dipp-Imd-BHCl2) (133): 
Potassium tert-butoxide (87 mg, 0.78 mmol, 1.1 equiv) was added to a suspension of 
imidazolium chloride [dipp-Imd-H]Cl 39 (300 mg, 0.71 mmol) in THF (3 mL) at 0 °C under 
argon. After stirring for 30 min, the light yellow cloudy solution was obtained. The mixture was 
filtered through a 0.5-inch layer of Celite. The Celite pad was washed with EtOAc (30 mL). The 
yellow filtrate was concentrated by rotary evaporation at 30 °C and the residue was dried under 
vacuum. Then it was suspended in hexane (10 mL) and a solution of dioxane-dichloroborane in 
CH2Cl2 (3 M, 0.24 mL, 0.71 mmol) was added at rt. The resulting yellow reaction mixture was 
stirred for 20 h. Then volatiles were removed under vacuum and the residue was loaded onto 
silica gel. The product was purified by flash chromatography. Elution with hexane:EtOAc = 
90:10 to 80:20 gave dipp-Imd-BHCl2 133 as a white solid (151 mg, 45%): The spectral data were 
identical with those of the previously isolated sample of 133.  
 
(µ-Hydrido)bis(1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene borenium) ([NHC-BH2-H-
BH2-NHC]
+
) (140):  
1) Reaction with TiCl4 (1 equiv): 
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A solution of TiCl4 (1 M in CH2Cl2, 0.1 mL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 
40 (40.5 mg, 0.10 mmol) in CH2Cl2 (1 mL) at rt. The vigorous evolution of H2 gas was 
immediately observed. After 5 min, the 
11
B NMR analysis of the yellow crude mixture showed 
the complete conversion of 40 to 140: 
13
C
 
NMR (100 MHz, CH2Cl2) δ 145.0, 132.4, 131.2, 
124.6, 124.5, 28.8, 25.5, 22.2; 
11
B NMR (128.4 MHz, CH2Cl2) δ –24.6 (br s). 
NMR data are identical with those reported for [NHC-BH2···H···BH2-NHC]
+
[HB(C6F5)3]
–
.
85
 
The structure of the counterion of 140 was not established. 
2) Reaction with AlCl3: 
CD2Cl2 (0.5 mL) was added to a mixture of solid dipp-Imd-BH3 40 (30 mg, 0.075 mmol) and 
AlCl3 (10 mg, 0.075 mmol). Intense gas bubbling was observed. The 
13
C and 
11
B NMR spectra 
of the light yellow reaction mixture were identical to those of 140 obtained in the reaction with 
TiCl4. 
1
H NMR (400 MHz, CD2Cl2) δ 7.47 (br t, J = 7.2 Hz, 2H), 7.18 (br d, J = 6.0 Hz, 4H), 
7.12 (s, 2H), 2.12 (br s, 4H), 1.02 (d, J = 4.4 Hz, 12H), 0.96 (d, J = 4.4 Hz, 12H); 
13
C
 
NMR (100 
MHz, CD2Cl2) δ 145.3, 132.8, 131.5, 125.0, 124.8, 29.2, 25.8, 22.6; 
11
B NMR (128.4 MHz, 
CD2Cl2) δ –24.3 (br s). 
 
The complex 140 was stable in CH2Cl2 solution at rt for 1 day. After 7 days, the formation of 
dipp-Imd-BH2Cl 114 and dipp-Imd-BHCl2 133 in a 1:2 ratio was observed by 
11
B NMR 
spectroscopy.  
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The addition of D2O to a freshly prepared solution of 140 gave dipp-Imd-BH3 40 and dipp-Imd-
BH2Cl 114 in a 2:1 ratio according to 
11
B NMR analysis. 
After the addition of AcOH to a freshly prepared solution of 140, dipp-Imd-BH2Cl 114 was the 
only product observed by 
11
B NMR spectroscopy. 
 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene borenium ([dipp-Imd-BH2]
+
) (141): 
1) The reaction of dipp-Imd-BH3 40 with AlCl3: 
CH2Cl2 (0.5 mL) was added to a mixture of solid dipp-Imd-BH2Cl 114 (27 mg, 0.06 mmol) and 
AlCl3 (32 mg, 0.24 mmol). Intense gas bubbling was observed. 
11
B NMR analysis of the light 
yellow reaction mixture showed a major signal at +11.4 ppm. The tentative structure of [dipp-
Imd-BH2]
+
[AlCl4]
–
 141 was assigned. 
13
C
 
NMR (100 MHz, CH2Cl2) δ 143.8, 133.6, 129.7, 
129.3, 125.7, 29.1, 24.5, 23.1; 
11
B NMR (128.4 MHz, CH2Cl2) δ +11.4 (br s). 
2) The reaction of dipp-Imd-BH2Cl 114 with AlCl3: 
CH2Cl2 (0.5 mL) was added to a mixture of solid dipp-Imd-BH2Cl 114 (27 mg, 0.06 mmol) and 
AlCl3 (8 mg, 0.06 mmol). The NMR spectra of the light yellow reaction mixture was very close 
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to those recorded for [dipp-Imd-BH2]
+
[AlCl4]
–
 141: 
13
C
 
NMR (100 MHz, CH2Cl2) δ 143.8, 
133.5, 129.8, 129.3, 125.7, 29.1, 24.5, 23.1; 
11
B NMR (128.4 MHz, CH2Cl2) δ +12.4 (br s). 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene dichloroborenium ([dipp-Imd-BCl2]
+
) 
(142): A solution of [dipp-Imd-BH2]
+
 141 in CH2Cl2 was prepared according to the previously 
described procedure from dipp-Imd-BH3 40. This solution was kept at rt overnight. The 
transformation was monitored by the 
11
B NMR spectroscopy. The starting signal at +11 ppm 
slowly disappeared, a small signal at +28 ppm ([dipp-Imd-BHCl]
+
?) was observed and then 
disappeared as well. After 24 h, the only signal in the 
11
B NMR (96.3 MHz, CH2Cl2) was a 
singlet at +47.3 ppm. The tentative structure of [dipp-Imd-BCl2]
+
[AlCl4]
–
 142 was assigned. An 
attempt to grow crystals of 142 for the X-ray crystallographic analysis resulted in the complete 
conversion of 142 to an imidazolium salt after 12 days in solution at rt. 
7.4 COMPOUND DATA FOR SECTION 4 
Compound 174 was prepared according to the known procedure.
81
 Its NMR spectral data 
matched those reported in the literature. 
 
General Procedure 5: Nucleophilic substitutions of dipp-Imd-BH2X (GP5): An electrophile 
dipp-Imd-BH2X 116, 118, or 119 was prepared from dipp-Imd-BH3 40 according to procedures 
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described above: dipp-Imd-BH2I 116 by the reaction with I2; dipp-Imd-BH2OMs 118 by the 
reaction with MsOH; dipp-Imd-BH2OTf 119 by the reaction with TfOH. They were used as 
solutions in CDCl3 or the solvent was removed under vacuum before the addition of a 
nucleophile. A solution or a suspension of a nucleophile was added to a solution of dipp-Imd-
BH2X (the total volume was about 2 mL) and the resulting mixture was stirred at rt for 20 h. 
When the solvent was DMSO, EtOAc (10 mL) was added and the organic layer was washed with 
water, dried over Na2SO4 and filtered before the removal of solvents under vacuum. The residue 
was purified by column chromatography. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene fluoroborane (dipp-Imd-BH2F) (143):
77
 
Fluoride 143 was prepared according to GP5 from tetrabutylammonium fluoride (1 M solution in 
THF, 0.20 mL, 0.20 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol; a solution in CDCl3 
(1 mL)). Chromatographic separation (elution with hexane : EtOAc = 4 : 1 to 3 : 1) gave dipp-
Imd-BH2F 143 as a white solid (17 mg, 40%):  mp 228–231 °C; IR (thin film, cm
–1
)  νmax 3160, 
3129, 3095, 2959, 2926, 2868, 2404 (B–H), 2360 (B–H), 2300 (B–H), 2250 (B–H), 1470, 1168, 
809, 755; 
1
H NMR (300 MHz, CDCl3) δ 7.48 (t, J = 7.7 Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 7.07 
(s, 2H), 2.59 (septet, J = 6.9 Hz, 4H), 1.30 (d, J = 6.6 Hz, 12H), 1.20 (d, J = 7.2 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.2, 133.4, 130.2, 123.8, 122.6, 28.8, 24.7, 23.0; 
11
B NMR (96.3 
MHz, CDCl3) δ –6.1 (app q, JB–F = JB–H = 92 Hz);
 19
F NMR (282 MHz, CDCl3) δ –248.0 (triplet 
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of quartets, JF–H = 36 Hz, JF–B = 73 Hz); 
19
F{
1
H} NMR (282 MHz, CDCl3) δ –248.0 (q (1:1:1:1), 
JF–B = 72 Hz); HRMS (ESI) calcd. for C27H38
11
BN2FNa ([M + Na]
+
)
 
443.3010, found 443.3012. 
 
Figure 24. Analysis of the 
11
B, 
19
F and 
19
F{
1
H} NMR spectra of dipp-Imd-BH2F. 
 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene chloroborane (dipp-Imd-BH2Cl) (114): 
Chloride 114 was prepared according to GP5 from benzyltriethylammonium chloride (19 mg, 
0.10 mmol) and dipp-Imd-BH2I 116 (53 mg, 0.10 mmol) in a THF (1 mL)–CH2Cl2 (1 mL) 
solution. Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 5 : 1) gave dipp-
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Imd-BH2Cl 114 as a white solid (17 mg, 38%). Its spectral data were identical with those of the 
previously isolated and characterized sample of 114. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene bromoborane (dipp-Imd-BH2Br) (115): 
Bromide 115 was prepared according to GP5 from phenylmagnesium bromide (1 M solution in 
THF, 0.18 mL, 0.18 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a THF (2 mL) 
solution. Chromatographic separation (elution with hexane : EtOAc = 9 : 1 to 7 : 1) gave dipp-
Imd-BH2Br 115 as a white solid (14 mg, 31%). Its spectral data were identical with those of the 
previously isolated and characterized sample of 115. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (phenylthio)borane (dipp-Imd-BH2SPh) 
(144):
77
 Lithium benzenethiolate PhSLi was prepared by addition of BuLi (1.6 M solution in 
hexanes, 0.13 mL, 0.21 mmol) to a solution of thiophenol (20 µL, 0.20 mmol) in THF (0.2 mL) 
at 0 °C. Then sulfide 144 was prepared according to GP5 from resulting PhSLi (0.20 mmol) and 
dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a THF–CDCl3 solution (2.5 mL + 0.5 mL). 
Chromatographic separation (elution with hexane : EtOAc = 8 : 1) gave dipp-Imd-BH2SPh 15 as 
a white solid (30 mg, 58%):  mp 175–178 °C; IR (thin film, cm–1)  νmax 3168, 3137, 2963, 2927, 
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2870, 2388 (B–H), 1583, 1474, 1364, 1157, 1036, 805, 762, 735, 691; 1H NMR (300 MHz, 
CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 4H), 7.09 (s, 2H), 6.89 (d, J = 7.2 Hz, 2H), 
6.82 (t, J = 7.4 Hz, 2H), 6.72 (t, J = 6.9 Hz, 1H), 2.64 (septet, J = 6.8 Hz, 4H), 1.31 (d, J = 6.6 
Hz, 12H), 1.17 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.4, 144.1, 133.7, 130.3, 
128.9, 127.1, 124.0, 122.8, 121.2, 28.9, 25.5, 22.6; 
11
B NMR (96.3 MHz, CDCl3) δ –24.9 (br s at 
293 K; t, J = 98 Hz at 323 K); HRMS (EI) calcd. for C33H43
11
BN2S ([M]
+
)
 
510.3240, found 
510.3245. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (1-phenyl-1H-tetrazol-5-ylthio)borane 
(dipp-Imd-BH2SPT) (145):
77
 Lithium 1-phenyl-1H-tetrazole-5-thiolate PTSLi was prepared by 
addition of BuLi (1.6 M solution in hexanes, 0.07 mL, 0.11 mmol) to a solution of 1-phenyl-1H-
tetrazole-5-thiol (18 mg, 0.10 mmol) in THF (0.5 mL) at 0 °C. Then sulfide 145 was prepared 
according to GP5 from resulting PTSLi (0.10 mmol) and dipp-Imd-BH2I 116 (53 mg, 0.10 
mmol) in a THF solution (1.5 mL). Chromatographic separation (elution with hexane : EtOAc = 
4 : 1 to 1 : 1) gave dipp-Imd-BH2SPT 145 as a white solid (25 mg, 42%):  mp 188–189 °C; IR 
(thin film, cm
–1
)  νmax 2965, 2929, 2870, 2431 (B–H), 1598, 1500, 1461, 1383, 1036, 760; 
1
H 
NMR (300 MHz, CDCl3) δ 7.49–7.43 (m, 4H), 7.40–7.37 (m, 3H), 7.26 (d, J = 7.5 Hz, 4H), 7.12 
(s, 2H), 2.70 (septet, J = 6.8 Hz, 4H), 1.19 (d, J = 6.6 Hz, 12H), 1.14 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 158.9, 145.6, 135.1, 133.4, 130.4, 128.8, 128.6, 124.3, 124.0, 123.2, 
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28.7, 25.6, 22.5; 
11
B NMR (96.3 MHz, CDCl3) δ –23.5 (br s); HRMS (ESI) calcd. for 
C34H43
11
BN6NaS ([M + Na]
+
)
 
601.3261, found 601.3268. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (ethoxycarbonothioylthio)borane (dipp-
Imd-BH2SC(=S)OEt) (146):
77
 Dithiocarbonate 146 was prepared according to GP5 from 
potassium ethyl xanthogenate KSC(=S)OEt (32 mg, 0.20 mmol) and dipp-Imd-BH2OTf 119 (55 
mg, 0.10 mmol) in a THF–CDCl3 solution (1 mL + 0.5 mL). Chromatographic separation 
(elution with hexane : EtOAc = 8 : 1) gave dipp-Imd-BH2SC(=S)OEt 146 as a white solid (18 
mg, 35%): mp 190–192 °C; IR (thin film, cm–1)  νmax 3151, 2964, 2928, 2869, 2456 (B–H), 2400 
(B–H), 1558, 1470, 1210, 1026, 805, 762; 1H NMR (300 MHz, CDCl3) δ 7.47 (t, J = 7.5 Hz, 
2H), 7.29 (d, J = 7.5 Hz, 4H), 7.09 (s, 2H), 4.25 (q, J = 7.1 Hz, 2H), 2.57 (septet, J = 6.9 Hz, 
4H), 1.35 (d, J = 6.9 Hz, 12H), 1.15 (d, J = 6.6 Hz, 12H), 1.14 (t, J = 7.1 Hz, 3H); 
13
C
 
NMR (75 
MHz, CDCl3) δ 221.3, 145.4, 133.4, 130.4, 124.0, 123.0, 68.5, 29.0, 25.5, 22.7, 13.7; 
11
B NMR 
(96.3 MHz, CDCl3) δ –24.4 (br s); HRMS (ESI) calcd. for C30H43
11
BN2ONaS2 ([M + Na]
+
)
 
545.2808, found 545.2800. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (phenylthiocarbonothioylthio)borane 
(dipp-Imd-BH2SC(=S)SPh) (147):
77
 Lithium phenyl carbonotrithioate PhSC(=S)SLi was 
prepared by addition of BuLi (1.6 M solution in hexanes, 0.13 mL, 0.21 mmol) to a solution of 
thiophenol (20 µL, 0.20 mmol) in THF (1 mL) at 0 °C followed by addition of carbon disulfide 
CS2 (0.05 mL, 0.8 mmol). Then trithiocarbonate 147 was prepared according to GP3 from 
resulting PhSC(=S)SLi (0.20 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a THF–
CH2Cl2 solution (1 mL – 0.5 mL). Chromatographic separation (elution with hexane : EtOAc = 7 
: 1 to 3 : 1) gave dipp-Imd-BH2SC(=S)SPh 147 as a yellow solid (39 mg, 65%): mp 208–210 °C; 
IR (thin film, cm
–1
)  νmax 3151, 3073, 2963, 2927, 2868, 2437 (B–H), 2398 (B–H), 1471, 1053, 
1019, 982, 856, 803, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.50 (t, J = 7.8 Hz, 2H), 7.35–7.27 (m, 
9H), 7.11 (s, 2H), 2.57 (septet, J = 6.8 Hz, 4H), 1.33 (d, J = 6.9 Hz, 12H), 1.15 (d, J = 6.6 Hz, 
12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 230.9, 145.5, 135.6, 134.2, 133.3, 130.6, 129.2, 128.7, 
124.1, 123.2, 29.0, 25.7, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ –22.9 (br s); HRMS (ESI) calcd. 
for C34H43
11
BN2NaS3 ([M + Na]
+
)
 
609.2579, found 609.2543. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene isothiocyanatoborane (dipp-Imd-BH2- 
NCS) (148):
77
 Isothiocyanate 148 was prepared according to GP5 from sodium thiocyanate (8.7 
mg, 0.11 mmol) and dipp-Imd-BH2I 116 (57 mg, 0.11 mmol) in a DMSO solution (2 mL). 
Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 3 : 1) gave dipp-Imd-
BH2NCS 148 as a white solid (18 mg, 24%): mp 196–197 °C; IR (thin film, cm
–1
)  νmax 3137, 
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2966, 2928, 2871, 2395 (B–H), 2362 (B–H), 2142 (NCS), 1463, 1385, 1363, 1331, 1158, 1104, 
803, 763; 
1
H NMR (300 MHz, CDCl3) δ 7.52 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 7.8 Hz, 4H), 7.10 
(s, 2H), 2.49 (septet, J = 7.2 Hz, 4H), 1.33 (d, J = 6.9 Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 144.9, 132.5, 131.0, 124.3, 123.0, 29.0, 25.0, 22.8; 
11
B NMR (96.3 
MHz, CDCl3) δ –23.2 (br s); HRMS (ESI) calcd. for C28H38
11
BN3NaS ([M + Na]
+
)
 
482.2777, 
found 482.2822. Crystals of 148 for the X-Ray analysis were grown from CH2Cl2. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene isocyanatoborane (dipp-Imd-BH2NCO) 
(149):
77
 Isocyanate 149 was prepared according to GP5 from potassium cyanate (16 mg, 0.20 
mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a DMSO–CH2Cl2 solution (3 mL + 1 
mL). Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 4 : 1) gave dipp-Imd-
BH2NCO 149 as a white solid (16 mg, 35%): mp 226–230 °C (decomp.); IR (thin film, cm
–1
)  
νmax 3169, 2965, 2928, 2871, 2382 (B–H), 2295 (NCO), 1474, 1366, 1155, 1108, 809, 765; 
1
H 
NMR (300 MHz, CDCl3) δ 7.52 (t, J = 7.8 Hz, 2H), 7.33 (d, J = 7.8 Hz, 4H), 7.08 (s, 2H), 2.53 
(septet, J = 6.8 Hz, 4H), 1.32 (d, J = 6.9 Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 145.0, 133.0, 130.6, 124.1, 122.7, 28.9, 24.9, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ      
–22.8 (t, JB–H = 96 Hz); HRMS (ESI) calcd. for C28H38
11
BN3NaO ([M + Na]
+
)
 
466.3006, found 
466.3024. Crystals of 149 for the X-Ray analysis were grown by vapor diffusion of hexane to 
1,2-dichloroethane. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene azidoborane (dipp-Imd-BH2N3) (150):
77
  
1) From iodide: Azide 150 was prepared according to GP5 from sodium azide (11 mg, 0.16 
mmol) and dipp-Imd-BH2I 116 (79 mg, 0.15 mmol) in a DMSO solution (3 mL). 
Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 5 : 1) gave dipp-Imd-BH2N3 
21 as a white solid (49 mg, 74%): mp 177–179 °C; IR (thin film, cm–1)  νmax 2965, 2928, 2872, 
2387 (B–H), 2096 (N3), 1469, 1326, 1149, 1086, 803, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.51 
(t, J = 7.7 Hz, 2H), 7.33 (d, J = 7.8 Hz, 4H), 7.09 (s, 2H), 2.53 (septet, J = 6.9 Hz, 4H), 1.32 (d, J 
= 6.9 Hz, 12H), 1.19 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.2, 133.1, 130.5, 
124.0, 122.7, 28.9, 25.0, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ –17.2 (t, JB–H = 100 Hz); HRMS 
(EI) calcd. for C27H38
11
BN5Na ([M + Na]
+
)
 
466.3118, found 466.3124. Crystals of 150 for the X-
Ray analysis were grown by vapor diffusion of hexane to 1,2-dichloroethane. 
2) From triflate:  Azide 150 was prepared according to GP5 from sodium azide (13 mg, 0.20 
mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a DMSO–CDCl3 solution (0.3 mL + 1 
mL). Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 5 : 1) gave dipp-Imd-
BH2N3 21 as a white solid (19 mg, 42%). Its spectral data were identical with those of the 
previously isolated and characterized sample of 150. 
3) From mesylate:  Azide 150 was prepared according to GP5 from sodium azide (6.9 mg, 0.11 
mmol) and dipp-Imd-BH2OMs 118 (35 mg, 0.07 mmol) in a DMSO solution (3 mL) after 
stirring at 80 °C for 24 h. Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 5 : 
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1) gave dipp-Imd-BH2N3 150 as a white solid (26 mg, 83%). Its spectral data were identical with 
those of the previously isolated and characterized sample of 150. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene nitrosooxyborane (dipp-Imd-BH2ONO) 
(151) and 1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene nitroborane (dipp-Imd-
BH2NO2) (152):
77
 
1) With NaNO2: Nitrous ester 151 and nitro compound 152 were prepared according to GP5 
from sodium nitrite (14 mg, 0.20 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a 
DMSO–CH2Cl2 solution (1.5 mL + 1 mL). Chromatographic separation (elution with hexane : 
EtOAc = 7 : 1 to 4 : 1) gave dipp-Imd-BH2ONO 151 as a white solid (5.4 mg, 12%): mp 212–
217 °C (decomp.); IR (thin film, cm–1)  νmax 2965, 2928, 2871, 2400 (B–H), 1682 (ONO), 1530, 
1470, 1365, 1161, 1032, 895, 804, 762; 
1
H NMR (300 MHz, CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 
7.27 (d, J = 7.8 Hz, 4H), 7.11 (s, 2H), 2.52 (septet, J = 6.8 Hz, 4H), 1.28 (d, J = 6.9 Hz, 12H), 
1.17 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.2, 133.0, 130.5, 124.0, 122.9, 28.8, 
25.1, 22.7; 
11
B NMR (96.3 MHz, CDCl3) δ –10.1 (t, JB–H = 105 Hz); HRMS (ESI) calcd. for 
C27H38
11
BN3NaO3 ([M + Na]
+
)
 
470.2955, found 470.2985. Crystals of 151 for the X-Ray 
analysis were grown by vapor diffusion of hexane to 1,2-dichloroethane. 
Further elution gave more polar dipp-Imd-BH2NO2 152 as a white solid (3.3 mg, 7%): mp 157–
159 °C; IR (thin film, cm–1)  νmax 2965, 2929, 2872, 2447 (B–H), 2420 (B–H), 2358 (B–H), 2340 
(B–H), 1460, 1433, 1364, 1177, 1086, 807; 1H NMR (300 MHz, CDCl3) δ 7.48 (t, J = 7.8 Hz, 
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2H), 7.29 (d, J = 7.8 Hz, 4H), 7.20 (s, 2H), 2.56 (septet, J = 6.8 Hz, 4H), 1.24 (d, J = 6.6 Hz, 
12H), 1.15 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.6, 132.8, 130.8, 124.3, 123.3, 
28.8, 25.7, 22.7; 
11
B NMR (96.3 MHz, CDCl3) δ –13.6 (br s); HRMS (EI) calcd. for 
C27H38
11
BN3NaO2 ([M + Na]
+
)
 
470.2955, found 470.2926. Crystals of 152 for the X-Ray 
analysis were grown by vapor diffusion of hexane to 1,2-dichloroethane. 
2) With AgNO2: Nitrous ester 151 and nitro compound 152 were prepared according to GP5 from 
silver nitrite (36 mg, 0.23 mmol) and dipp-Imd-BH2I 116 (123 mg, 0.23 mmol) in a DMSO 
solution (4 mL). Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 2 : 1) gave 
dipp-Imd-BH2ONO 151 as a pale yellow solid (28 mg, 27%). Further elution gave more polar 
dipp-Imd-BH2NO2 152 as a white solid (11 mg, 10%). Their spectral data were identical with 
those of the previously isolated and characterized samples of 151 and 152. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene cyanoborane (dipp-Imd-BH2CN) (153):
77
 
Cyanide 153 was prepared according to GP5 from sodium cyanide (11 mg, 0.23 mmol) and dipp-
Imd-BH2I 116 (109 mg, 0.21 mmol) in a DMSO solution (2 mL). Chromatographic separation 
(elution with hexane : EtOAc = 4 : 1 to 1 : 1) gave dipp-Imd-BH2CN 153 as a white solid (18 
mg, 21%): mp 215–219 °C; IR (thin film, cm–1) νmax 3153, 3116, 3083, 2963, 2929, 2872, 2403 
(B–H), 2380 (B–H), 2187, 1471, 1366, 1158, 1075, 938, 804, 763; 1H NMR (400 MHz, CDCl3) 
δ 7.53 (t, J = 7.8 Hz, 2H), 7.33 (d, J = 7.6 Hz, 4H), 7.14 (s, 2H), 2.48 (septet, J = 6.8 Hz, 4H), 
1.33 (d, J = 6.8 Hz, 12H), 1.19 (d, J = 6.8 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.3, 133.0, 
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130.8, 124.2, 123.0, 28.9, 25.1, 22.8; 
11
B NMR (128.4 MHz, CDCl3) δ –36.7 (t, JB–H = 93 Hz); 
HRMS (EI) calcd. for C28H38
11
BN3 ([M]
+
)
 
427.3159, found 427.3150. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene isocyanoborane (dipp-Imd-BH2NC) 
(154):
77
 Isocyanide 154 was prepared according to GP5 from silver cyanide (43 mg, 0.32 mmol) 
and dipp-Imd-BH2I 116 (85 mg, 0.16 mmol) in a DMSO solution (2 mL) after heating at 100 °C 
for 24 h. Chromatographic separation (elution with hexane : EtOAc = 2 : 1 to 1 : 2) gave dipp-
Imd-BH2NC 154 as a colorless semi-solid that slowly crystallized (38 mg, 55%): mp 73–75 °C; 
IR (thin film, cm
–1
)  νmax 3163, 3075, 2965, 2928, 2871, 2408 (B–H), 2365 (B–H), 2192 (NC), 
1470, 1386, 1366, 1330, 1164, 1102, 1082, 804, 760; 
1
H NMR (400 MHz, CDCl3) δ 7.60 (t, J = 
7.8 Hz, 2H), 7.33 (d, J = 7.6 Hz, 4H), 7.17 (s, 2H), 2.44 (septet, J = 6.8 Hz, 4H), 1.29 (d, J = 6.8 
Hz, 12H), 1.21 (d, J = 6.8 Hz, 12H); 
13
C
 
NMR (100 MHz, CDCl3) δ 144.9, 132.0, 131.1, 124.0, 
123.0, 28.5, 24.5, 22.7; 
11
B NMR (128.4 MHz, CDCl3) δ –24.0 (br s); HRMS (EI) calcd. for 
C28H38
11
BN3 ([M]
+
)
 
427.3159, found 427.3157. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene cyanoborane (dipp-Imd-BH2CN) (153) 
and 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene isocyanoborane (dipp-Imd-BH2NC) 
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(154): An inseparable mixture of cyanide 153 and isocyanide 154 were prepared according to 
GP5 from tetrabutylammonium cyanide (166 mg, 0.62 mmol) and dipp-Imd-BH2OTf 119 (148 
mg, 0.27 mmol) in a THF–CDCl3 solution (2 mL + 1 mL). Chromatographic separation (elution 
with hexane : EtOAc = 4 : 1 to 2 : 1) gave an inseparable mixture of dipp-Imd-BH2CN 153 and 
an impurity in a 10 : 1 ratio as a white solid (83 mg, 65% of 153). The signal of the impurity in 
the 
11
B NMR spectrum was a broad singlet at –25.4 ppm that allowed us tentatively assigned it 
as dipp-Imd-BH2NC 154. Other spectral data were identical with those of the previously isolated 
and characterized sample of 153. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene borane-d1 (dipp-Imd-BH2D) (155):
77
 
Monodeuteride 155 was prepared according to GP5 from lithium aluminum deuteride LiAlD4 (1 
M solution in THF, 96% D, 0.20 mg, 0.20 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 
mmol) in a THF solution (1 mL). Chromatographic separation (elution with hexane : EtOAc = 9 
: 1 to 5 : 1) gave dipp-Imd-BH2D 155 as a white solid (33 mg, 81%): mp 260–263 °C; IR (thin 
film, cm
–1
)  νmax 3156, 3118, 3087, 2960, 2926, 2867, 2398 (B–H), 2299 (B–H), 1783 (B–D), 
1719, 1471, 1328, 1216, 1155, 1042, 948, 802, 756; 
1
H NMR (300 MHz, CDCl3) δ 7.48 (t, J = 
7.8 Hz, 2H), 7.30 (d, J = 7.8 Hz, 4H), 7.04 (s, 2H), 2.58 (septet, J = 6.8 Hz, 4H), 1.31 (d, J = 6.6 
Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.4, 134.3, 130.0, 123.9, 
121.6, 28.7, 24.6, 23.0; 
11
B NMR (96.3 MHz, CDCl3) δ –36.6 (t, JB–H = 79 Hz); HRMS (ESI) 
calcd. for C27
1
H38
2
H
11
BN2Na ([M + Na]
+
)
 
426.3167, found 426.3182. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (1-phenyl-1H-tetrazol-5-ylsulfonyl)borane 
(dipp-Imd-BH2SO2PT) (156):
77
 A solution of mCPBA (70% purity, 18 mg, 7.3 µmol) in 
CH2Cl2 (1 mL) was added to a solution of dipp-Imd-BH2SPT 145 at 0 °C. After 30 min of 
stirring at this temperature, the solvent was removed under vacuum. Chromatographic separation 
(elution with hexane : EtOAc = 4 : 1 to 1 : 2) gave dipp-Imd-BH2SO2PT 156 as a white solid (16 
mg, 71%): mp 178–181 °C; IR (thin film, cm–1)  νmax 3167, 3132, 3074, 2965, 2930, 2871, 2479 
(B–H), 2430 (B–H), 2360 (B–H), 1726, 1460, 1264 (S=O), 1213, 1119 (S=O), 1060, 1037, 804, 
760, 735, 689; 
1
H NMR (300 MHz, CDCl3) δ 7.53–7.47 (m, 4H), 7.42–7.34 (m, 3H), 7.28 (d, J = 
7.5 Hz, 4H), 7.23 (s, 2H), 2.54 (septet, J = 6.8 Hz, 4H), 1.23 (d, J = 6.9 Hz, 12H), 1.12 (d, J = 
6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 158.7, 145.4, 134.3, 132.8, 131.0, 129.9, 128.7, 
125.6, 124.4, 124.3, 28.8, 25.9, 22.4; 
11
B NMR (96.3 MHz, CDCl3) δ –17.5 (br s); HRMS (ESI) 
calcd. for C34H43
11
BN6O2NaS ([M + Na]
+
)
 
633.3159, found 633.3177. Crystals of 156 for the X-
Ray analysis were grown from CH2Cl2. 
 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (methylaminocarbonyl)borane (dipp-Imd-
BH2C(=O)NHMe) (158):
77
 Solid Me3O
+
BF4
–
 (42 mg, 0.28 mmol) was added to a solution of 
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cyanide 153 (30 mg, 0.07 mmol) in CH2Cl2 (2 mL) at rt. The mixture was refluxed for 48 h. Then 
a solution of NaOH (1 M in water, 1.0 mL, 1.0 mmol) was added to the resulting mixture at rt. 
After 1 h of stirring at rt, CH2Cl2 (5 mL) and water (5 mL) were added. The organic layer was 
separated. The aqueous layer was extracted with CH2Cl2 (2×5 mL). Light yellow organic layers 
were combined and dried over Na2SO4. The solvent was removed under vacuum and the residue 
was purified by column chromatography. Elution with hexane : EtOAc = 1 : 1 gave dipp-Imd-
BH2C(=O)NHMe 158 as a white solid (20 mg, 61%): mp 97–99 °C; IR (thin film, cm
–1
)  νmax 
3475 (N–H), 3165, 3105, 3066, 2966, 2927, 2868, 2360 (B–H), 2329 (B–H), 1599 (C=O), 1461, 
1386, 1365, 1333, 1219, 1164, 1089, 804, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.46 (t, J = 7.8 
Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 7.07 (s, 2H), 4.92 (br s, 1H), 2.71 (septet, J = 6.8 Hz, 4H), 
2.33 (t, J = 5.1 Hz, 3H), 1.32 (d, J = 6.9 Hz, 12H), 1.14 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 145.3, 133.0, 130.8, 124.2, 123.0, 28.9, 25.1, 22.8; 
11
B NMR (96.3 MHz, CDCl3) δ –
36.7 (t, JB–H = 95 Hz); HRMS (EI) calcd. for C29H42
11
BN3O ([M]
+
)
 
459.3421, found 459.3411. 
 
General procedure 6: Double nucleophilic substitutions (GP6): Solutions of dipp-Imd-
BH(OTf)2 130 and dipp-Imd-BH(OTf)Cl 132 in CDCl3 (1 mL) were prepared from 40 by the 
reactions with TfOH (2.3 equiv) or 1) HCl (1 equiv); 2) TfOH (1.5 equiv) as described above. A 
solution of a nucleophile in THF (3 mL) was added to a solution of a bis(electrophile) and the 
resulting mixture was stirred at rt for 20 h. The solvents were removed under vacuum. The 
residue was purified by column chromatography. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene difluoroborane (dipp-Imd-BHF2) (159):
77
 
Difluoride 159 was prepared according to GP6 from tetrabutylammonium fluoride (1 M solution 
in THF, 0.40 mL, 0.40 mmol) and dipp-Imd-BH(OTf)2 130 (70 mg, 0.10 mmol). 
Chromatographic separation (elution with hexane : EtOAc = 5 : 1 to 3 : 1) gave dipp-Imd-BHF2 
159 as a white solid (12 mg, 27%): mp 199–200 °C (decomp.); IR (thin film, cm–1)  νmax 3177, 
3152, 2964, 2928, 2871, 2354 (B–H), 1471, 1331, 1154, 1110, 1082, 950, 801, 757; 1H NMR 
(300 MHz, CDCl3) δ 7.50 (t, J = 7.8 Hz, 2H), 7.31 (d, J = 7.8 Hz, 4H), 7.08 (s, 2H), 2.57 (septet, 
J = 6.8 Hz, 4H), 1.32 (d, J = 6.9 Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, 
CDCl3) δ 145.2, 133.0, 130.5, 123.8, 123.0, 28.9, 25.0, 22.9; 
11
B NMR (96.3 MHz, CDCl3) δ 
+1.8 (doublet of triplets, JB–H = 124 Hz, JB–F = 63 Hz); 
19
F NMR (282 MHz, CDCl3) δ –165.8 
(quartet of doublets, JF–B = 69 Hz,  JF–H = 58 Hz); HRMS (EI) calcd. for C27H37
11
BF2N2 ([M]
+
)
 
438.3018, found 438.3023. 
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Figure 25. Analysis of the 
11
B and 
19
F NMR spectra of dipp-Imd-BHF2. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene dicyanoborane (dipp-Imd-BH(CN)2) 
(160):
77
 Dicyanide 160 was prepared according to GP6 from tetrabutylammonium cyanide (160 
mg, 0.60 mmol) and dipp-Imd-BH(OTf)2 130 (105 mg, 0.15 mmol). Chromatographic separation 
(elution with hexane : EtOAc = 5 : 1 to 3 : 1) gave dipp-Imd-BH(CN)2 160 and an inseparable 
and unidentified impurity (about 15%) as a pale yellow solid (36 mg, 54%): mp 317–322 °C; IR 
(thin film, cm
–1
)  νmax 3155, 3116, 3085, 2966, 2929, 2873, 2421 (B–H), 2358 (B–H), 2343 (B–
 167 
H), 2131 (C≡N), 1470, 1387, 1365, 1160, 1059, 803, 758; 1H NMR (300 MHz, CDCl3) δ 7.59 (t, 
J = 7.8 Hz, 2H), 7.38 (d, J = 7.8 Hz, 4H), 7.27 (s, 2H), 2.46 (septet, J = 6.8 Hz, 4H), 1.40 (d, J = 
6.9 Hz, 12H), 1.19 (d, J = 6.9 Hz, 12H); 
13
C
 
NMR (75 MHz, CDCl3) δ 145.3, 132.0, 131.6, 
124.5, 124.5, 29.1, 25.7, 22.6; 
11
B NMR (96.3 MHz, CDCl3) δ –36.7 (d, JB–H = 96 Hz); HRMS 
(ESI) calcd. for C29H37
11
BN4Na ([M + Na]
+
)
 
475.3009, found 475.2988. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene diazidoborane (dipp-Imd-BH(N3)2) 
(161):
77
  
1) One-pot from 40: Diazide 161 was prepared according to GP6 from tetrabutylammonium 
azide (115 mg, 0.40 mmol) and dipp-Imd-BH(OTf)2 130 prepared from dipp-Imd-BH3 (40.5 mg, 
0.10 mmol). Chromatographic separation (elution with hexane : EtOAc = 7 : 1 to 3 : 1) gave 
dipp-Imd-BH(N3)2 161 as a white solid (18 mg, 37%): mp 220–222 °C (decomp. with bubbling > 
240 °C); IR (thin film, cm–1)  νmax 3163, 3138, 2969, 2930, 2872, 2388 (B–H), 2114, 2081, 1471, 
1334, 1163, 1066; 
1
H NMR (400 MHz, CDCl3) δ 7.53 (t, J = 7.8 Hz, 2H), 7.33 (d, J = 8.0 Hz, 
4H), 7.09 (s, 2H), 2.50 (septet, J = 6.8 Hz, 4H), 1.37 (d, J = 6.8 Hz, 12H), 1.16 (d, J = 6.8 Hz, 
12H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.2, 132.6, 130.9, 124.1, 123.6, 29.2, 25.5, 22.5; 
11
B 
NMR (128.4 MHz, CDCl3) δ –36.7 (t, JB–H = 114 Hz); HRMS (ESI) calcd. for C27H37
11
BN8Na 
([M + Na]
+
)
 
507.3132, found 507.3149. Crystals of 161 for the X-ray analysis were grown from 
1,2-dichloroethane. 
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2) From isolated 130: A solution of tetrabutylammonium azide (35 mg, 0.12 mmol, 4 equiv) in 
CDCl3 (0.5 mL) was added to a solution of dipp-Imd-BH(OTf)2 130 (21.5 mg, 0.03 mmol) 
(purified by flash chromatography) in CDCl3 (0.5 mL) at rt. After 20 h, the reaction was 
complete by 
11
B and 
19
F NMR analysis.  The volatiles were removed under vacuum and the 
residue was loaded onto silica gel. The product was purified by flash chromatography. Elution 
with hexane:EtOAc = 90:10 to 80:20 gave NHC-BH(N3)2 161 as a white solid (8.9 mg, 61%). 
The spectral data were identical with those of the previously isolated sample of 161. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene dichloroborane (NHC-BHCl2) (133): A 
solution of benzyltriethylammonium chloride (12 mg, 0.05 mmol, 2 equiv) in CDCl3 (0.5 mL) 
was added to a solution of dipp-Imd-BH(OTf)Cl 132 (15 mg, 0.025 mmol) in CDCl3 (0.5 mL) at 
rt. After 5 days, the reaction was complete by 
11
B NMR analysis.  The volatiles were removed 
under vacuum and the residue was loaded onto silica gel. The product was purified by flash 
chromatography. Elution with hexane:EtOAc = 80:20 gave dipp-Imd-BHCl2 133 as a white solid 
(1.8 mg, 15%). The spectral data were identical with those of the previously isolated sample of 
133. 
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General procedure 7: THF ring-opening reactions (GP7): A solution of base (0.2 mmol) was 
added to a solution of ArOH (0.2 mmol) in THF (0.5 mL) or toluene (0.5 mL) at rt under argon. 
After 5 min of stirring, the formation of the phenoxide ArOM was assumed. In a separate flask, 
triflic acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) 
in CH2Cl2 (1 mL) at rt. After 10 min of stirring, the formation of dipp-Imd-BH2OTf 119 was 
assumed. In some cases, CH2Cl2 was removed by rotary evaporation and the white residue was 
dissolved in THF (1 mL). Then if the phenoxide is soluble, the solution of ArOM was added to 
the resulting solution of dipp-Imd-BH2OTf 119. If the phenoxide is not soluble, the order of 
addition is reverse: 119 is added to the solution of ArOM. When necessary, the final mixture was 
diluted with additional THF or toluene. The reaction mixture was stirred at rt for 20 h. The 
volatiles were removed under vacuum and the residue was loaded onto silica gel. The products 
were purified by flash chromatography.  
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (4-phenoxybutyloxy)borane (dipp-Imd-
BH2O(CH2)4OPh) (163): Following GP7 with LiHMDS (1 M in toluene, 0.2 mL, 0.2 mmol) 
and PhOH (19 mg, 0.20 mmol) in THF (2 mL)–toluene (0.4 mL), elution with hexane:EtOAc = 
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90:10 gave dipp-Imd-BH2O(CH2)4OPh 163 as a white solid (28.9 mg, 51%): mp 121–122 °C; IR 
(thin film, cm
–1
) νmax 3071, 2964, 2928, 2870, 2250 (B–H), 1689, 1599, 1586, 1538, 1497, 1470, 
1387, 1368, 1332, 1301, 1246, 1208, 1172, 1061, 954, 936, 883, 803, 755; 
1
H NMR (400 MHz, 
CDCl3) δ 7.43 (t, J = 7.8 Hz, 2H), 7.30–7.22 (m, 6H), 7.00 (s, 2H), 6.91 (dt, J = 7.3, 1.0 Hz, 1H), 
6.85 (dd, J = 8.6, 1.0 Hz, 1H), 3.70 (t, J = 7.0 Hz, 2H), 2.85 (t, J = 6.6 Hz, 2H), 2.65 (septet, J = 
6.9 Hz, 4H), 1.32 (d, J = 6.8 Hz, 12H), 1.29 (app quintet, J = 7.8 Hz, 2H), 1.18 (d, J = 6.8 Hz, 
12H), 1.07 (app quintet, J = 7.1 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 159.3, 145.2, 134.2, 
129.7, 129.2, 123.6, 122.3, 120.0, 114.5, 68.8, 68.2, 28.7, 28.4, 25.8, 24.8, 22.9; 
11
B NMR (128.4 
MHz, CDCl3) δ –9.2 (t, JB–H = 92 Hz); HRMS (ESI) calcd. for C37H52
11
BN2O2 ([M + H]
+
) 
567.4122, found 567.4144. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene phenoxyborane (dipp-Imd-BH2OPh) 
(162):  
1) With 18-Crown-6 in toluene: A solution of KHMDS (0.5 M in toluene, 0.2 mL, 0.2 mmol) 
was added to a solution of PhOH (19 mg, 0.20 mmol) and 18-crown-6 ether (53 mg, 0.20 mmol) 
in toluene (0.1 mL) at rt under argon. After 5 min of stirring, the formation of PhOK was 
assumed. In a separate flask, triflic acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-
BH3 40 (40.5 mg, 0.10 mmol) in toluene (1 mL) at rt. After 10 min of stirring, the formation of 
dipp-Imd-BH2OTf 119 was assumed. Then the solution of dipp-Imd-BH2OTf 119 was added to a 
suspension of PhOK followed by toluene (1.5 mL). The cloudy reaction mixture was stirred at rt 
for 2 days. The volatiles were removed under vacuum and the residue was loaded onto silica gel. 
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The products were purified by flash chromatography. Elution with hexane:Et2O = 95:5 gave 
dipp-Imd-BH2OPh 162 as a white solid (31.9 mg, 64%):  mp 166–168 °C; IR (thin film, cm
–1
) 
νmax 3129, 2963, 2927, 2869, 2282 (B–H), 1596, 1496, 1471, 1460, 1427, 1385, 1364, 1331, 
1293, 1173, 1158, 1070, 998, 955, 878, 803, 759; 
1
H NMR (400 MHz, CDCl3) δ 7.50 (t, J = 7.8 
Hz, 2H), 7.29 (d, J = 8.0 Hz, 4H), 7.07 (s, 2H), 6.92 (t, J = 8.0 Hz, 2H), 6.48 (t, J = 7.2 Hz, 1H), 
6.18 (d, J = 7.6 Hz, 2H), 2.80 (br q, 2H), 2.65 (septet, J = 6.9 Hz, 4H), 1.23 (d, J = 6.8 Hz, 12H), 
1.20 (d, J = 6.8 Hz, 12H); 
13
C NMR (100 MHz, CDCl3) δ 162.1, 145.2, 134.1, 129.9, 128.1, 
123.7, 122.5, 116.4, 115.5, 28.8, 24.7, 23.0; 
11
B NMR (128.4 MHz, CDCl3) δ –11.3 (t, JB–H = 93 
Hz); HRMS (ESI) calcd. for C33H43
11
BN2NaO ([M + Na]
+
) 517.3366, found 517.3386. 
2) Without 18-Crown-6 in toluene–CH2Cl2: A solution of KHMDS (0.5 M in toluene, 0.2 mL, 
0.2 mmol) was added to a solution of PhOH (19 mg, 0.20 mmol) in toluene (0.1 mL) at rt under 
argon. After 5 min of stirring, the formation of PhOK was assumed. In a separate flask, triflic 
acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) in 
CH2Cl2 (1 mL) at rt. After 10 min of stirring, the formation of dipp-Imd-BH2OTf 119 was 
assumed. Then the solution of dipp-Imd-BH2OTf 119 was added to a suspension of PhOK. The 
heterogeneous reaction mixture was stirred at rt for 24 h. The volatiles were removed under 
vacuum and the residue was loaded onto silica gel. The products were purified by flash 
chromatography. Elution with hexane:Et2O = 95:5 to 90:10 gave dipp-Imd-BH2OPh 162 as a 
white solid (9.1 mg, 18%). The NMR data of the isolated product were identical to those of the 
previously prepared sample of 162. 
3) With 18-Crown-6 and THF: A solution of KHMDS (0.5 M in toluene, 0.2 mL, 0.2 mmol) was 
added to a solution of PhOH (19 mg, 0.20 mmol) and 18-crown-6 ether (26.6 mg, 0.1 mmol) in 
toluene (0.1 mL) at rt under argon. After 5 min of stirring, the formation of PhOK was assumed. 
 172 
In a separate flask, triflic acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 40 
(40.5 mg, 0.10 mmol) in CH2Cl2 (1 mL) at rt. After 10 min of stirring, the formation of dipp-
Imd-BH2OTf 119 was assumed. Then the solution of dipp-Imd-BH2OTf 119 was added to a 
suspension of PhOK followed by THF (0.04 mL, 0.5 mmol). The reaction mixture was stirred at 
rt for 20 h. The volatiles were removed under vacuum and the residue was loaded onto silica gel. 
The products were purified by flash chromatography. Elution with hexane:EtOAc = 90:10 gave 
163 (14.7 mg, 26%), 162 (3.4 mg, 9%), and dipp-Imd-BH2Cl 114 (11.1 mg, 25%). The NMR 
data of the isolated products were identical to those of the previously prepared samples. 
Several parameters were varied for the reaction between dipp-Imd-BH2OTf 119 (0.1 
mmol) and PhOM (0.2 mmol) in THF. Masses and isolated yields of products are reported. Their 
NMR data matched those of previously prepared samples. 
1) Different bases with excess THF: 
a) Base: BuLi (1.5 M in hexanes, 0.13 mL, 0.2 mmol). GP7 in THF (1 mL)–CH2Cl2 (0.5 
mL): 163 (21.9 mg, 39%). 
b) Commercially available PhOLi (1 M in THF, 0.2 mL, 0.2 mmol). GP7 in THF (1 mL)–
CDCl3 (0.5 mL): 163 (25.8 mg, 45%).   
c) Base: NaHMDS (0.6 M in toluene, 0.35 mL, 0.2 mmol). GP7 in THF (2 mL)–toluene 
(0.35 mL): 163 (26.4 mg, 46%). 
d) Base: KHMDS (0.5 M in toluene, 0.4 mL, 0.2 mmol). GP7 in THF (2 mL)–toluene (0.4 
mL): 163 (23 mg, 40%) and 162 (14.9 mg, 30%). 
2) Different bases with THF (0.04 mL, 0.5 mmol, 5 equiv): 
a) Base:  LiHMDS (1 M in toluene, 0.2 mL, 0.2 mmol),. GP7 in CH2Cl2 (2 mL)–toluene 
(0.5 mL): 163 (2.7 mg, 5%). 
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b) Base: NaHMDS (0.6 M in toluene, 0.35 mL, 0.2 mmol). GP7 in CH2Cl2 (2 mL)–toluene 
(0.5 mL): 163 (9.3 mg, 16%). 
c) Base: NaHMDS (0.6 M in toluene, 0.35 mL, 0.2 mmol). GP7 in toluene (2.5 mL): 163 
(6.9 mg, 12%). 
d) Base:  KHMDS (0.5 M in toluene, 0.4 mL, 0.2 mmol). GP7 in CH2Cl2 (2 mL)–toluene 
(0.5 mL): 163 (18.6 mg, 33%). 
3) Different amount of THF with NaHMDS (0.6 M in toluene, 0.35 mL, 0.2 mmol): 
a) 180 equiv: GP7 in THF (1.6 mL)–CDCl3 (1 mL): 163 (25.4 mg, 45%). 
b) 30 equiv: THF (0.25 mL, 3 mmol). GP7 in CH2Cl2 (2 mL)–toluene (0.5 mL). GP7: 
163 (25.3 mg, 44%). 
4) Time and temperature with KHMDS (0.5 M in toluene, 0.4 mL, 0.2 mmol) and THF 
(0.04 mL, 0.5 mmol) in CH2Cl2 (2 mL)–toluene (0.5 mL): 
a) 3 h: GP7: 163 (6.2 mg, 11%). 
b) 4 days: GP7: 163 (22.5 mg, 39%). 
c) at 50 °C:  GP7: after mixing, solutions of 119 and PhOK were stirred at 50 °C for 20 
h, 163 (9.7 mg, 17%). 
 
Dipp-Imd-BH2I (116) + PhOK in THF: The GP7 was followed with the KHMDS base (0.5 M 
in toluene, 0.2 mL, 0.2 mmol), PhOH (19 mg, 0.20 mmol), and dipp-Imd-BH2I 116. A solution 
of 116 in CH2Cl2 (2 mL) was prepared from dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and I2 (13 
mg, 0.05 mmol) as was described before (Section 7.3). Elution with hexane:EtOAc = 90:10 gave 
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163 (18.1 mg, 32%) and 162 (11.1 mg, 22%). Their NMR data matched those of previously 
isolated samples. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(2,6-dimethylphenoxy)butyloxy]borane 
(dipp-Imd-BH2O(CH2)4O(2,6-Me2C6H3) (165): Following GP7 with KHMDS (0.5 M in 
toluene, 0.4 mL, 0.2 mmol) and 2,6-dimethylphenol 164 (25 mg, 0.20 mmol) in THF (2 mL)–
toluene (0.4 mL), elution with hexane:EtOAc = 90:10 gave 165 as a white solid (36.1 mg, 60%): 
mp 108–110 °C; IR (thin film, cm–1) νmax 3162, 3134, 3070, 3035, 2962, 2928, 2869, 2712, 2225 
(B–H), 1699, 1593, 1562, 1472, 1426, 1384, 1361, 1332, 1296, 1262, 1207, 1172, 1123, 1108, 
1091, 1060, 1044, 983, 949, 938, 863, 802, 760; 
1
H NMR (400 MHz, CDCl3) δ 7.43 (t, J = 7.8 
Hz, 2H), 7.26 (d, J = 8.0 Hz, 4H), 7.00 (s, 2H), 6.99 (d, J = 6.4 Hz, 2H), 6.89 (t, J = 7.4 Hz, 1H), 
3.52 (t, J = 6.8 Hz, 2H), 2.86 (t, J = 6.6 Hz, 2H), 2.65 (septet, J = 6.8 Hz, 4H), 2.23 (s, 6H), 
1.40–1.30 (m, 2H), 1.32 (d, J = 6.8 Hz, 12H), 1.29 (app quintet, J = 7.8 Hz, 2H), 1.18 (d, J = 6.8 
Hz, 12H), 1.12 (app quintet, J = 7.2 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 156.2, 145.2, 
134.2, 131.0, 129.7, 128.5, 123.6, 123.2, 122.3, 72.8, 69.1, 28.7, 28.7, 27.0, 24.8, 24.8, 22.9, 
16.3; 
11
B NMR (128.4 MHz, CDCl3) δ –9.2 (t, JB–H = 91 Hz); HRMS (ESI) calcd. for 
C39H55
11
BN2NaO2 ([M + Na]
+
) 617.4254, found 617.4227. 
Dipp-Imd-BH2O(2,6-Me2C6H3) 166 was isolated as impure solid (1.3 mg, 2%) and was not 
characterized. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(4-chlorophenoxy)butyloxy]borane 
(dipp-Imd-BH2O(CH2)4OC6H4Cl) (169a): Following GP7 with NaHMDS (1 M in THF, 0.2 
mL, 0.2 mmol) and 4-chlorophenol 167a (25 mg, 0.20 mmol) in THF (1.5 mL)–CH2Cl2 (1 mL), 
elution with hexane:EtOAc = 6:1 gave 169a as a light yellow solid (30.5 mg, 50%): mp 115–120 
°C; IR (thin film, cm–1) νmax 3073, 2963, 2929, 2869, 2359 (B–H), 2222 (B–H), 1695, 1596, 
1580, 1492, 1471, 1426, 1385, 1364, 1332, 1286, 1245, 1211, 1161, 1123, 1104, 1092, 1060, 
1005, 824, 823, 759; 
1
H NMR (300 MHz, CDCl3) δ 7.42 (t, J = 7.5 Hz, 2H), 7.26 (d, J = 7.5 Hz, 
4H), 7.20 (d, J = 9.0 Hz, 2H), 7.00 (s, 2H), 6.76 (d, J = 9.0 Hz, 2H), 3.66 (t, J = 6.9 Hz, 2H), 
2.84 (t, J = 6.5 Hz, 2H), 2.64 (septet, J = 6.9, 4H), 1.31 (d, J = 6.9 Hz, 12H), 1.30–1.20 (m, 2H), 
1.18 (d, J = 7.2 Hz, 12H), 1.06 (app quintet, J = 7.1 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 
157.9, 145.2, 134.2, 129.7, 129.1, 124.7, 123.6, 122.3, 115.7, 68.7, 68.6, 28.7, 28.3, 25.6, 24.8, 
22.9; 
11
B NMR (96.3 MHz, CDCl3) δ –9.3 (t, JB–H = 84 Hz); HRMS (ESI) calcd. for 
C37H50
11
B
35
ClN2NaO2 ([M + Na]
+
) 623.3552, found 623.3535.  
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (4-cyanophenoxy)borane (dipp-Imd-BH2- 
OC6H4CN) (168b) and 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(4-cyanophe-
noxy)butyloxy]borane (dipp-Imd-BH2O(CH2)4OC6H4CN) (169b): Following GP7 with 
NaHMDS (1 M in THF, 0.2 mL, 0.2 mmol) and 4-cyanophenol 167b (24 mg, 0.20 mmol) in 
THF (1.5 mL)–CH2Cl2 (1 mL), elution with hexane:EtOAc = 8:1 to 3:1 gave dipp-Imd-
BH2OC6H4CN 168b as a white solid (10.6 mg, 20%): mp 181–182 °C; IR (thin film, cm
–1
) νmax 
2966, 2929, 2871, 2306, 2212, 1600, 1511, 1471, 1385, 1366, 1325, 1174, 1155, 1125, 1101, 
1086, 1061, 937, 839, 762, 740; 
1
H NMR (300 MHz, CDCl3) δ 7.51 (t, J = 7.8 Hz, 2H), 7.30 (d, 
J = 7.5, 4H), 7.19 (d, J = 8.7 Hz, 2H), 7.11 (s, 2H), 6.17 (d, J = 9.0 Hz, 2H), 2.60 (septet, J = 6.9, 
4H), 1.21 (d, J = 6.9 Hz, 12H), 1.20 (d, J = 6.9 Hz, 12H); 
13
C NMR (75 MHz, CDCl3) δ 165.8, 
145.2, 133.7, 133.0, 130.2, 123.8, 122.8, 121.2, 117.1, 97.8, 28.8, 24.7, 23.0; 
11
B NMR (96.3 
MHz, CDCl3) δ –11.2 (br s); HRMS (ESI) calcd. for C34H42
11
BN3NaO ([M + Na]
+
) 542.3319, 
found 542.3342. 
Further elution gave dipp-Imd-BH2O(CH2)4OC6H4CN 169b as yellow oil (8.2 mg, 14%). 
The compound 169b was only about 70% pure and was not stable enough to be fully 
characterized: IR (thin film, cm
–1
) νmax 2965, 2929, 2871, 2224, 1698, 1651, 1605, 1508, 1470, 
1386, 1367, 1331, 1303, 1259, 1207, 1171, 1114, 1061; 
1
H NMR (300 MHz, CDCl3) δ 7.55 (t, J 
= 6.9 Hz, 2H), 7.40 (d, J = 7.2 Hz, 2H), 7.25 (d, J = 7.8 Hz, 4H), 7.08 (s, 2H), 6.87 (d, J = 9.0 
Hz, 2H), 3.74 (t, J = 6.9 Hz, 2H), 2.84 (t, J = 6.3 Hz, 2H), 2.65 (septet, J = 6.9, 4H), 1.30 (d, J = 
6.9 Hz, 12H), 1.30–1.20 (m, 2H), 1.17 (d, J = 6.9 Hz, 12H), 1.06 (app quintet, J = 6.9 Hz, 2H); 
11
B NMR (96.3 MHz, CDCl3) δ –9.3 (t, JB–H = 92 Hz); HRMS (ESI) calcd. for C38H50
11
BN3NaO2 
([M + Na]
+
) 614.3894, found 614.3888. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (4-nitrophenoxy)borane (dipp-Imd-BH2- 
OC6H4NO2) (168c): 
1) With NaHMDS: Following GP7 with NaHMDS (0.6 M in toluene, 0.35 mL, 0.2 mmol) 
and 4-nitrophenol 167c (28 mg, 0.20 mmol) in THF (2 mL)–toluene (0.4 mL), elution with 
hexane:EtOAc = 80:20 gave 168c as a light yellow solid (23.5 mg, 43%): mp 175–178 °C; IR 
(thin film, cm
–1
) νmax 2965, 2929, 2871, 2328 (B–H), 1594, 1500, 1471, 1429, 1386, 1365, 1313, 
1257, 1178, 1158, 1104, 1089, 952, 938, 849, 804, 758; 
1
H NMR (300 MHz, CDCl3) δ 7.87–7.83 
(m, 2H), 7.52 (t, J = 7.8 Hz, 2H), 7.31 (d, J = 7.8 Hz, 4H), 7.12 (s, 2H), 6.16–6.12 (m, 2H), 2.61 
(septet, J = 6.9, 4H), 1.22 (d, J = 6.9 Hz, 12H), 1.21 (d, J = 6.9 Hz, 12H); 
13
C NMR (100 MHz, 
CDCl3) δ 168.4, 145.2, 137.7, 133.7, 130.3, 125.5, 123.9, 122.9, 116.1, 28.9, 24.7, 23.0; 
11
B 
NMR (96.3 MHz, CDCl3) δ –10.9 (br s); HRMS (ESI) calcd. for C33H42
11
BN3NaO3 ([M + Na]
+
) 
562.3217, found 562.3209. 
2) With LiHMDS: Following GP7 with LiHMDS (1 M in toluene, 0.2 mL, 0.2 mmol) and 4-
nitrophenol 167c (28 mg, 0.20 mmol) in THF (2 mL)–toluene (0.4 mL), elution with 
hexane:EtOAc = 80:20 gave 168c as a light yellow solid (20.0 mg, 37%). Its NMR data were 
identical with those of the previously prepared sample. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(p-tolyloxy)butyloxy]borane (dipp- 
Imd-BH2O(CH2)4OC6H4Me) (169d): Following GP7 with KHMDS (0.5 M in toluene, 0.4 mL, 
0.2 mmol), p-cresol 167d (22 mg, 0.20 mmol), and THF (0.04 mL, 0.5 mmol) in CH2Cl2 (2 
mL)–toluene (0.5 mL), elution with hexane:EtOAc = 90:10 gave 169d as a white solid (20.5 mg, 
35%): mp 120–121 °C; IR (thin film, cm–1) νmax 3070, 3033, 2964, 2929, 2870, 2235 (B–H), 
1687, 1585, 1538, 1512, 1469, 1386, 1368, 1346, 1332, 1290, 1244, 1209, 1175, 1109, 1061, 
953, 937, 803, 755; 
1
H NMR (400 MHz, CDCl3) δ 7.42 (t, J = 7.8 Hz, 2H), 7.26 (d, J = 7.6 Hz, 
4H), 7.06 (d, J = 8.0 Hz, 2H), 6.99 (s, 2H), 6.75 (d, J = 8.8 Hz, 2H), 3.66 (t, J = 7.2 Hz, 2H), 
2.84 (t, J = 6.6 Hz, 2H), 2.64 (septet, J = 6.9 Hz, 4H), 2.29 (s, 3H), 1.32 (d, J = 6.8 Hz, 12H), 
1.29 (app quintet, J = 8.0 Hz, 2H), 1.17 (d, J = 6.8 Hz, 12H), 1.05 (app quintet, J = 7.1 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 157.2, 145.2, 134.2, 129.8, 129.7, 129.2, 123.7, 122.3, 114.4, 
68.9, 68.4, 28.8, 28.5, 25.9, 24.9, 23.0, 20.5; 
11
B NMR (128.4 MHz, CDCl3) δ –9.2 (t, JB–H = 92 
Hz); HRMS (ESI) calcd. for C38H53
11
BN2NaO2 ([M + Na]
+
) 603.4098, found 603.4098.  
 
 
 179 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(4-tert-butylphenoxy)butyloxy]borane 
(dipp-Imd-BH2O(CH2)4OC6H4-t-Bu) (169e): Following GP7 with KHMDS (0.5 M in toluene, 
0.4 mL, 0.2 mmol), 4-tert-butylphenol 167e (30 mg, 0.20 mmol), and THF (0.04 mL, 0.5 mmol) 
in CH2Cl2 (2 mL)–toluene (0.5 mL), elution with hexane:EtOAc = 90:10 gave 169e as a slowly 
crystallizing white solid (21.1 mg, 34%): mp 118–119 °C; IR (thin film, cm–1) νmax 3070, 2963, 
2928, 2869, 2357 (B–H), 1699, 1609, 1514, 1471, 1426, 1385, 1364, 1332, 1296, 1248, 1182, 
1123, 1060, 949, 937, 828, 802, 759; 
1
H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 
7.29 (d, J = 9.0 Hz, 2H), 7.27 (d, J = 9.5 Hz, 2H), 7.01 (s, 2H), 6.80 (d, J = 8.5 Hz, 2H), 3.69 (t, 
J = 7.0 Hz, 2H), 2.85 (t, J = 6.5 Hz, 2H), 2.66 (septet, J = 6.8 Hz, 4H), 1.33 (d, J = 6.5 Hz, 12H), 
1.32 (s, 9H), 1.28 (app quintet, J = 6.5 Hz, 2H), 1.19 (d, J = 7.0 Hz, 12H), 1.07 (app quintet, J = 
6.5 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 157.1, 145.2, 142.6, 134.2, 129.8, 126.0, 123.7, 
122.4, 113.9, 69.0, 68.3, 34.0, 31.6, 28.8, 28.5, 25.9, 24.9, 23.0; 
11
B NMR (128.4 MHz, CDCl3) δ 
–9.3 (t, JB–H = 88 Hz); HRMS (ESI) calcd. for C41H59
11
BN2NaO2 ([M + Na]
+
) 645.4567, found 
645.4571.  
 
DiCy-Imd-BH2OTf (170) + PhOLi in THF: Triflic acid (11 µL, 0.12 mmol) was added to a 
solution of diCy-Imd-BH3 75 (29.4 mg, 0.12 mmol) in CDCl3 (0.6 mL) at 0 °C under argon. 
After 5 min, the 
11
B NMR spectrum showed a complete disappearance of the signal of 75 (at –36 
ppm) and the formation of a new signal of 170 at –10 ppm (br s). A solution of PhOLi (1 M in 
THF, 0.24 mL, 0.24 mmol) was added and the resulting solution was stirred at rt for 20 h. The 
volatiles were removed and the residue was purified by column chromatography. Elution with 
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hexane:EtOAc = 6:1 gave an inseparable mixture of diCy-Imd-BH3 75 and PhOH (17.9 mg, 44% 
recovery of 75). 
 
Decomposition of Ph3P-BH2OTf (171) in THF: Triflic acid (26 µL, 0.30 mmol) was added to a 
solution of Ph3P-BH3 172 (55 mg, 0.20 mmol) in CH2Cl2 (1 mL) at rt under argon. After 5 min, 
the NMR spectra showed a complete conversion into Ph3P-BH2OTf 171: 
1
H NMR (400 MHz, 
CDCl3) δ 7.80–7.50 (m, 15H), 3.74 (br q, 2H); 
13
C NMR (100 MHz, CDCl3) δ 133.5 (d, JC–P = 
10 Hz), 132.7 (d, JC–P = 2 Hz), 129.5 (d, JC–P = 10 Hz), 123.6 (d, JC–P = 63 Hz); 
11
B NMR (128.4 
MHz, CDCl3) δ –8.2 (br s);  
31
P NMR (161.9 MHz, CDCl3): δ 2.2 (s). 
Compound 171 was stable in a CH2Cl2 solution for at least 1 day. Then a solution of PhOLi (1 M 
in THF, 0.4 mL, 0.4 mmol) was added and the resulting solution was stirred at rt for 20 h. The 
31
P NMR of the crude mixture showed a 2:1 mixture of Ph3P 173 (–5.5 ppm) and Ph3P-BH3 172 
(+20 ppm). Similar decomposition to 172 and 173 was observed when pure THF was added to a 
solution of 171 in CH2Cl2. 
 
Cy3P-BH2OTf (174) + PhOLi in THF: A solution of PhOLi (0.2 mmol; prepared from 
LiHMDS and PhOH) in THF (0.5 mL)–toluene (0.4 mL) was added to a solution of Cy3P-
BH2OTf 174 (0.1 mmol, prepared from Cy3P-BH3 and TfOH) in THF (1.5 mL). The colorless 
reaction mixture was stirred at rt for 20 h. The 
11
B NMR of the crude mixture did not show any 
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boron signal. The solvents were removed and the residue was purified by flash chromatography. 
Elution with hexane:EtOAc = 1:1 gave Ph(CH2)4OH as the only stable product. Its 
1
H NMR 
spectrum was in agreement with the literature data for this compound.
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene ethoxyborane (dipp-Imd-BH2OEt) (176): 
Lithium ethoxide was prepared by the addition of BuLi (1.6 M solution in hexanes, 0.13 mL, 
0.21 mmol) to a solution of ethanol (12 µL, 0.20 mmol) in THF (0.5 mL) at 0 °C. Then 
compound 176 was prepared according to GP5 (nucleophilic substitutions) from resulting EtOLi 
(0.20 mmol) and dipp-Imd-BH2OTf 119 (50 mg, 0.09 mmol) in a THF (1.5 mL)–CH2Cl2 (0.5 
mL) solution. Chromatographic separation (elution with hexane : EtOAc = 8 : 1 to 5 : 1) gave 
dipp-Imd-BH2OEt 176 as a light yellow solid (14.9 mg, 33%): 
1
H NMR (300 MHz, CDCl3) δ 
7.44 (t, J = 7.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 4H), 7.00 (s, 2H), 2.82 (q, J = 6.9 Hz, 2H), 2.65 
(septet, J = 6.8, 4H), 1.32 (d, J = 6.9 Hz, 12H), 1.17 (d, J = 6.9 Hz, 12H), 0.52 (t, J = 6.9 Hz, 
6H); 
11
B NMR (96.3 MHz, CDCl3) δ –9.5 (t, J = 96 Hz).  
The isolated sample of 176 was only 90% pure and the attempt to purify the product by 
recrystallization before further characterization resulted in its decomposition. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (ethylthio)borane (dipp-Imd-BH2SEt) 
(178) and 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene [4-(ethylthio)butyloxy]borane 
(dipp-Imd-BH2O(CH2)4SEt) (179): A solution of LiHMDS (1 M in toluene, 0.2 mL, 0.2 mmol) 
was added to a solution of EtSH (15 µL, 0.20 mmol) in THF (0.5 mL) at rt. After 5 min of 
stirring, the formation of EtSLi was assumed. In a separate flask, triflic acid (10 µL, 0.1 mmol) 
was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) in toluene (1 mL) at rt. After 
10 min of stirring, the formation of dipp-Imd-BH2OTf 119 was assumed. Toluene was removed 
by rotary evaporation and the white residue was dissolved in THF (1.5 mL). Then the solution of 
EtSLi was added to the resulting solution of dipp-Imd-BH2OTf 119. The cloudy reaction mixture 
was stirred at rt for 20 h. The volatiles were removed under vacuum and the residue was loaded 
onto silica gel. The product was purified by flash chromatography. Elution with hexane:EtOAc = 
95:5 to 90:10 gave dipp-Imd-BH2SEt 178 as a white solid (7.3 mg, 16%): mp 204–207 °C; IR 
(thin film, cm
–1
) νmax 3156, 3053, 2963, 2926, 2869, 2365 (B–H), 1565, 1471, 1429, 1383, 1364, 
1333, 1258, 1233, 1173, 1061, 1038, 937, 803, 763; 
1
H NMR (400 MHz, CDCl3) δ 7.46 (t, J = 
7.8 Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 7.04 (s, 2H), 2.62 (septet, J = 6.8 Hz, 4H), 1.53 (q, J = 7.3 
Hz, 2H), 1.34 (d, J = 6.8 Hz, 12H), 1.16 (d, J = 6.8 Hz, 12H), 0.85 (t, J = 7.2 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ 145.5, 133.9, 130.1, 123.8, 122.4, 28.8, 27.1, 25.3, 22.7, 17.3; 
11
B NMR 
(128.4 MHz, CDCl3) δ –24.0 (t, J = 99 Hz); HRMS (ESI) calcd. for C29H44
11
BN2S ([M + H]
+
) 
463.3318, found 463.3301. 
Further elution gave dipp-Imd-BH2O(CH2)4SEt 179 as a white solid (29.3 mg, 54%): mp 66–68 
°C; IR (thin film, cm–1) νmax 3075, 2963, 2928, 2869, 2708, 2218 (B–H), 1596, 1471, 1459, 
1426, 1384, 1364, 1332, 1259, 1211, 1173, 1121, 1107, 1060, 1037, 981, 949, 937, 802, 759; 
1
H 
NMR (400 MHz, CDCl3) δ 7.44 (t, J = 7.8 Hz, 2H), 7.26 (d, J = 8.0 Hz, 4H), 6.98 (s, 2H), 2.78 
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(t, J = 6.6, 2H), 2.63 (septet, J = 6.8 Hz, 4H), 2.45 (q, J = 7.5 Hz, 2H), 2.26 (t, J = 7.8 Hz, 2H), 
1.31 (d, J = 6.8 Hz, 12H), 1.20 (t, J = 7.4 Hz, 3H), 1.17 (d, J = 6.8 Hz, 12H), 1.12 (app. quintet, J 
= 8.0 Hz, 2H), 0.99 (app. quintet, J = 7.0 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 145.2, 134.2, 
129.7, 123.6, 122.3, 68.9, 31.8, 31.7, 28.7, 26.4, 25.7, 24.8, 22.9, 14.8; 
11
B NMR (128.4 MHz, 
CDCl3) δ –9.3 (t, J = 94 Hz); HRMS (ESI) calcd. for C33H50
11
BN2OS ([M – H]
+
) 533.3737, 
found 533.3749. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (4-hydroxybutyloxy)borane (dipp-Imd-
BH2O(CH2)4OH) (180): Compound 180 was prepared according to GP5 from TMSOK (26 mg, 
0.20 mmol) and dipp-Imd-BH2OTf 119 (55 mg, 0.10 mmol) in a THF (2 mL) solution. 
Chromatographic separation (elution with hexane : EtOAc = 2 : 1 to 1 : 1) gave dipp-Imd-
BH2O(CH2)4OH 180 as a white solid (18.3 mg, 37%): mp 106–108 °C; IR (thin film, cm
–1
) νmax 
3159, 3073, 2963, 2928, 2870, 2287, 2228 (B–H), 1683, 1595, 1471, 1460, 1426, 1385, 1364, 
1332, 1299, 1271, 1257, 1213, 1171, 1103, 1061, 1043, 949, 937, 871, 803, 759, 733; 
1
H NMR 
(400 MHz, CDCl3) δ 7.45 (t, J = 7.8 Hz, 2H), 7.28 (d, J = 7.6 Hz, 4H), 7.02 (s, 2H), 5.41 (t, J = 
6.2 Hz, 1H), 3.27 (q, J = 5.5 Hz, 2H), 2.66 (t, J = 5.2 Hz, 2H), 2.62 (septet, J = 6.9, 4H), 1.33 (d, 
J = 6.8 Hz, 12H), 1.35–1.25 (m, 2H), 1.16 (d, J = 6.8 Hz, 12H), 1.06 (app quintet, J = 7.3 Hz, 
2H); 
13
C NMR (100 MHz, CDCl3) δ 145.2, 133.9, 129.9, 123.7, 122.4, 70.0, 62.4, 32.2, 30.4, 
28.7, 25.0, 22.7; 
11
B NMR (128.4 MHz, CDCl3) δ –9.3 (t, J = 96 Hz); HRMS (ESI) calcd. for 
C31H48
11
BN2O2 ([M]
+
) 491.3809, found 491.3828. 
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 1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene acetoxyborane (190): A solution of BuLi 
(0.9 M in hexanes, 0.22 mL, 0.2 mmol) was added to a solution of PhOH (19 mg, 0.20 mmol) in 
EtOAc (0.5 mL) at rt. After 5 min of stirring, the formation of PhOLi was assumed. In a separate 
flask, triflic acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 
mmol) in PhH (0.5 mL) at rt. After 10 min of stirring, the formation of dipp-Imd-BH2OTf 119 
was assumed. The solvent was removed by rotary evaporation and the residue was dissolved in 
EtOAc (0.5 mL). Then the resulting solution of dipp-Imd-BH2OTf 119 was added to the solution 
of PhOLi. The reaction mixture was stirred at rt for 20 h. The volatiles were removed under 
vacuum and the residue was purified by column chromatography. Elution with hexane:EtOAc = 
9:1 to pure EtOAc gave dipp-Imd-BH2OAc 190 as a white solid (14.5 mg, 31%): mp 203–204 
˚C; IR (thin film, cm–1)  νmax 3153, 3114, 3082, 2962, 2926, 2872, 2359, 2340, 1682, 1470, 1428, 
1372, 1314, 1160, 1106, 802, 760; 
13
C
 
NMR (100 MHz, CDCl3) δ 172.8, 145.1, 133.6, 130.1, 
123.8, 122.7, 28.8, 24.8, 22.9, 22.2;  
11
B NMR (128.4 MHz, CDCl3) δ –12.4 (t, J = 89 Hz); 
HRMS (ESI) calcd. for C29H41
11
BN2NaO2 ([M + Na]
+
) 483.3159, found 483.3150. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (3-phenyloxypropoxy]borane (dipp-Imd-
BH2O(CH2)3OPh) (192): A solution of BuLi (1.5 M in hexanes, 0.13 mL, 0.2 mmol) was added 
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to a solution of PhOH (19 mg, 0.20 mmol) in PhH (0.5 mL) at rt. After 5 min of stirring, the 
formation of a precipitate of PhOLi was observed. In a separate flask, triflic acid (10 µL, 0.1 
mmol) was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) in CH2Cl2 (0.5 mL) at 
rt. After 10 min of stirring, the formation of dipp-Imd-BH2OTf 119 was assumed. Then the 
resulting solution of dipp-Imd-BH2OTf 119 was added to the suspension of PhOLi followed by 
oxetane (0.13 mL, 2.0 mmol). The reaction mixture was stirred at rt for 20 h. The volatiles were 
removed under vacuum and the residue was purified by column chromatography. Elution with 
hexane:EtOAc = 5:1 gave dipp-Imd-BH2O(CH2)3OPh 192 as yellow oil (24 mg, 43%). The 
product was about 90% pure: IR (thin film, cm
–1
) νmax 3071, 2963, 2929, 2869, 2224 (B–H), 
1691, 1600, 1586, 1497, 1471, 1426, 1384, 1364, 1332, 1300, 1247, 1212, 1172, 1123, 1061, 
1032, 950, 937, 803, 755; 
1
H NMR (300 MHz, CDCl3) δ 7.39 (t, J = 7.8 Hz, 2H), 7.30–7.20 (m, 
6H), 6.99 (s, 2H), 6.90 (t, J = 7.4 Hz, 1H), 6.79 (d, J = 8.4 Hz, 2H), 3.46 (t, J = 7.2 Hz, 2H), 3.00 
(t, J = 6.0 Hz, 2H), 2.64 (septet, J = 6.9, 4H), 1.44 (app. quintet, J = 6.8, 2H), 1.31 (d, J = 6.6 Hz, 
12H), 1.30–1.20 (m, 2H), 1.18 (d, J = 6.9 Hz, 12H); 13C NMR (100 MHz, CDCl3) δ 159.4, 
145.2, 134.1, 129.8, 129.0, 123.6, 122.3, 119.8, 114.7, 66.5, 65.7, 32.1, 28.8, 24.8, 24.6, 23.0; 
11
B NMR (96.3 MHz, CDCl3) δ –9.2 (t, J = 87 Hz); HRMS (ESI) calcd. for C36H49
11
BN2NaO2 
([M + Na]
+
) 575.3785, found 575.3755. 
 
Reaction of dipp-Imd-BH2OTf (119) with PhOK in dioxane: A solution of KHMDS (0.5 M in 
toluene, 0.4 mL, 0.2 mmol) was added to a solution of PhOH (19 mg, 0.20 mmol) in 1,4-dioxane 
(0.5 mL) at rt. The solution became cloudy and a precipitate of PhOK formed. In a separate 
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flask, triflic acid (10 µL, 0.1 mmol) was added to a solution of dipp-Imd-BH3 40 (40.5 mg, 0.10 
mmol) in CH2Cl2 (1 mL) at 0 °C. After 10 min of stirring, the formation of dipp-Imd-BH2OTf 
119 was assumed. The solvent was removed by rotary evaporation and the white residue was 
dissolved in 1,4-dioxane (1.5 mL). Then resulting solution of dipp-Imd-BH2OTf 119 was added 
to the suspension of PhOK. The light yellow reaction mixture was stirred at rt for 20 h. The 
volatiles were removed under vacuum and the residue was loaded onto silica gel. The product 
was purified by flash chromatography. Elution with hexane:EtOAc = 90:10 gave dipp-Imd-
BH2OPh 162 as a white solid (22.6 mg, 45%). The 
1
H NMR spectrum was identical to that of 
previously isolated sample of 162. 
 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (trimethylsilyloxy)borane (dipp-Imd-BH2-
OTMS) (181): A solution of LiHMDS (1 M in toluene, 0.2 mL, 0.2 mmol) was added to a 
solution of PhOH (19 mg, 0.20 mmol) in 1,4-dioxane (0.5 mL) at rt. After 5 min, a formation of 
PhOLi was assumed. In a separate flask, triflic acid (10 µL, 0.1 mmol) was added to a solution of 
dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) in CH2Cl2 (1 mL) at 0 °C. After 10 min of stirring, the 
formation of dipp-Imd-BH2OTf 119 was assumed. The solvent was removed by rotary 
evaporation and the white residue was dissolved in 1,4-dioxane (1.5 mL). Then resulting solution 
of dipp-Imd-BH2OTf 119 was added to the solution of PhOLi. The colorless reaction mixture 
was stirred at rt for 20 h. The volatiles were removed under vacuum and the residue was loaded 
onto silica gel. The product was purified by flash chromatography. Elution with hexane:EtOAc = 
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90:10 gave dipp-Imd-BH2OTMS 181 as a white solid (8.3 mg, 20%): mp 101–103 °C; IR (thin 
film, cm
–1
) νmax 3169, 3136, 2960, 2928, 2869, 2221 (B–H), 2182 (B–H), 1593, 1470, 1423, 
1384, 1364, 1331, 1250, 1240, 1210, 1170, 1161, 1109, 1088, 1075, 876, 830, 805, 761, 746; 
1
H 
NMR (400 MHz, CDCl3) δ 7.43 (t, J = 7.8 Hz, 2H), 7.24 (d, J = 7.6 Hz, 4H), 6.94 (s, 2H), 2.76 
(br q, J = 79 Hz, 2H), 2.64 (septet, J = 6.8 Hz, 4H), 1.29 (d, J = 6.8 Hz, 12H), 1.17 (d, J = 7.2 
Hz, 12H), –0.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 145.1, 134.3, 129.6, 123.5, 122.1, 28.7, 
24.6, 23.0, 0.4; 
11
B NMR (128.4 MHz, CDCl3) δ –12.3 (t, J = 98 Hz); HRMS (ESI) calcd. for 
C30H46
11
BN2OSi ([M – H]
+
) 489.3472, found 489.3434. Compound 181 was the only stable 
product isolated in this experiment. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene dihydroxyborenium triflate ([dipp-Imd-
B(OH)2]OTf) (196):  
1) From dipp-Imd-BH(OTf)2 130: 
Triflic acid (22 µL, 0.25 mmol, 5 equiv) was added to a solution of dipp-Imd-BH3 40 (20.3 mg, 
0.05 mmol) in CDCl3 (0.6 mL) at rt. The vigorous evolution of H2 gas was immediately 
observed. After 10 min, the 
11
B NMR spectroscopy showed the complete conversion into dipp-
Imd-BH(OTf)2 130: a broad signal at –2 ppm. After 1 day at rt, the conversion of 130 to 196 was 
about 40% according to the 
11
B NMR spectrum. The reaction was complete after 5 days. The 
solvent was allowed to slowly evaporate to approximately one-third of the initial volume. The 
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precipitated colorless crystals were filtered, washed with CH2Cl2 (0.5 mL), and dried in air. 
[dipp-Imd-B(OH)2]OTf 196 was obtained as a white solid (9.7 mg, 33%): mp 121–124 °C; IR 
(thin film, cm
–1
)  νmax 3291 (O–H), 2964, 2924, 2850, 1463, 1429, 1390, 1251, 1199, 1162, 1125, 
1029, 970, 905, 803, 760; 
1
H NMR (400 MHz, CDCl3) δ 8.23 (br s, 2H), 7.55 (t, J = 7.8 Hz, 2H), 
7.40 (s, 2H), 7.31 (d, J = 8.0 Hz, 4H), 2.33 (septet, J = 6.7, 4H), 1.22 (d, J = 6.8 Hz, 12H), 1.21 
(d, J = 6.8 Hz, 12H); 
13
C
 
NMR (100 MHz, CDCl3) δ 144.5, 131.6, 131.6, 125.9, 124.4, 29.1, 
24.6, 23.2; 
11
B NMR (128.4 MHz, CDCl3) δ +22.5 (br s); 
19
F NMR (376 MHz, CDCl3) δ –78.9 
(s). Crystals of 196 grown from CDCl3 was submitted for the X-ray analysis. 
2) From dipp-Imd-BH(OTf)Cl 132: 
A solution of hydrochloric acid in dioxane (4 M, 25 µL, 0.10 mmol, 2 equiv) was added to a 
solution of dipp-Imd-BH3 40 (20.3 mg, 0.05 mmol) in CDCl3 (0.6 mL) at rt. The vigorous 
evolution of H2 gas was immediately observed. After 30 min, the 
11
B NMR spectroscopy showed 
the complete conversion into dipp-Imd-BH2Cl 114: a broad signal at –18 ppm.
2
 Then triflic acid 
(22 µL, 0.25 mmol, 5 equiv) was added to the resulting solution of 114 at rt. After 10 min, the 
11
B NMR spectroscopy showed the complete conversion into dipp-Imd-BH(OTf)Cl 132: a broad 
signal at –3 ppm. After 1 day at rt, the conversion of 132 to 196 was about 60% according to the 
11
B NMR spectrum. The reaction was complete after 5 days. The spectral data of the product in 
solution were identical with those of 196 isolated in the previous experiment. 
7.5 COMPOUND DATA FOR SECTION 5 
Complexes 215–218, and 221 were synthesized and characterized by Dr. Julien Monot.140 
Complex 138 was prepared by Dr. Anne Boussonnière according to the known procedure.83 
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Compounds 241
75
 and 257
178
 were prepared according to the known procedures. NMR spectral 
data matched those reported in the literature. 
 
Lithium di-tert-butyl biphenylide (LDBB) + tetramethylethylenediamine (TMEDA) 
solution: Lithium wire (17 mg, 2.5 mmol,) was weighted in hexanes. The lithium was cut in 
about 9 pieces and each piece was flattened and scratched to expose a fresh surface. The pieces 
were added to a 4,4'-di-tert-butylbiphenylide (800 mg, 3 mmol) solution in THF (15 mL) under 
sonication at 0 °C. After the addition of about 5 pieces, the solution became dark green. The 
resulting suspension was sonicated for 3 h at 0 °C. Then, the freshly distilled TMEDA (0.375 
mL, 2.5 mmol) was added to the solution of LDBB under sonication at 0 °C. In this way, about 
15 mL of a solution of LDBB and TMEDA (0.17 M) in THF was obtained. 
 
 
11
B NMR observation of NHC-boryl anion (212): A solution of iodide 116 (20 mg, 0.038 
mmol) in dry THF (0.1 mL) was added to a solution of LDBB/TMEDA (0.17 M each in THF, 
0.45 mL, 0.076 mmol) in an NMR tube capped with a septum at –78 °C. After 5 min, the 
11
B{
1
H} NMR spectrum of the resulting dark solution was recorded at –70 °C. There were two 
singlets at −18.1 and −35.5 ppm. The former was assigned to [dipp-Imd-BH2]Li 212, the latter 
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signal corresponds to dipp-Imd-BH3 40. No signal of 116 was observed. Then, the mixture was 
allowed to warm to rt inside the NMR probe. The 
11
B NMR spectra (without decoupling from 
protons) were recorded at −40, −10, 0, 8, 10, and 25 °C (Figure 26). A gradual diminishing of a 
triplet at –18.9 ppm (1JB–H = 93 Hz at –40 °C; 104 Hz at 25 °C) and simultaneous growing of a 
quartet at –36.1 ppm (1JB–H = 83 Hz at all temperatures) were observed. The signal of [dipp-Imd-
BH2]Li 212 disappeared completely after 10 min at 25 °C. 
 
  
Figure 26. 
11
B NMR spectra of the NHC-boryl anion 212 and study of its stability from –40 °C to 25 °C. 
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General procedure 8: Reductive lithiation of dipp-Imd-BH2I (116) and trapping of [dipp-
Imd-BH2]Li (212) with electrophiles (GP8): A solution of LDBB/TMEDA (0.17 M each in 
THF, 1.78 mL, 4 equiv) was added to an oven-dried flask at –78 °C and was kept under argon. 
Then a solution of 116 (40 mg, 0.075 mmol) in dry THF (1 mL) was added to the 
LDBB/TMEDA solution at −78 °C. The color remained dark. After 5 min of stirring, an 
electrophile was added (0.9 mmol, 12 equiv) at −78 °C. A color change was observed depending 
on the nature of the electrophile. The reaction mixture was stirred for 30 min at −78 °C, then 
warmed to rt and became light yellow. The mixture was concentrated and the crude product was 
purified by flash chromatography. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene ethoxycarbonylborane (dipp-Imd-BH2- 
CO2Et) (213):
140
 Compound 213 was prepared following GP8 with 116 (0.075 mmol), 
LDBB/TMEDA (0.3 mmol), and  diethyl carbonate (0.11 mL, 0.9 mmol) as the electrophile. 
Elution with hexane:EtOAc = 9:1 gave 213 as a white solid (22.9 mg, 64%): mp 196−198 °C; IR 
(thin film, cm
–1) νmax 3114, 2965, 2927, 2868, 2366 (B–H), 2342, 1651, 1470, 1428, 1147, 1043, 
1020, 803, 758; 
1
H NMR (300 MHz, CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 7.28 (d, J = 7.8 Hz, 4H), 
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7.09 (s, 2H), 3.69 (q, J = 6.9 Hz, 2H), 2.70 (septet, J = 6.9 Hz, 4H), 1.29 (d, J = 6.9 Hz, 12H), 
1.15 (d, J = 6.9 Hz, 12H), 0.99 (t, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3): δ 145.7, 133.9, 
130.1, 124.0, 122.6, 55.8, 28.5, 25.5, 22.8, 14.7; 
11
B NMR (96.3 MHz, CDCl3): δ −29.6 (t, J = 
92 Hz); HRMS (ESI) calcd. for C30H43
11
BN2O2Na ([M + Na]
+
): 497.3315, found: 497.3307. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene acetylborane (214):
140
 Compound 214 was 
prepared following GP8 with 116 (0.075 mmol), LDBB/TMEDA (0.3 mmol), and ethyl acetate 
(0.09 mL, 0.91 mmol) as the electrophile. Elution with hexane:EtOAc = 9:1 gave 214 as a white 
solid (13.2 mg, 39%): mp 194−196 °C; IR (thin film, cm–1) νmax 2967, 2337 (B-H), 1622, 1472, 
1384, 1364, 1149, 1061, 803, 759; 
1
H NMR (300 MHz, CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 7.27 
(d, J = 7.8 Hz, 4H), 7.05 (s, 2H), 2.69 (septet, J = 6.9 Hz, 4H), 1.63 (s, 3H), 1.27 (d, J = 6.9 Hz, 
12H), 1.14 (d, J = 6.9 Hz, 12H); 
13
C NMR (75 MHz, CDCl3): δ 145.9, 134.0, 130.0, 123.8, 
122.3, 28.4, 25.5, 22.8; 
11
B NMR (96.3 MHz, CDCl3): δ −25.5 (t, J = 83 Hz); HRMS (ESI) 
calcd. for C29H41
11
BN2ONa ([M + Na]
+
): 467.3210, found: 467.3195. Crystals of 214 were 
grown by vapor phase diffusion from 1,2-dichloroethane to hexanes. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (4-methylbenzoyl)borane (dipp-Imd-BH2- 
C(O)C6H4Me) (219): Compound 219 was prepared following GP8 with 116 (0.075 mmol), 
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LDBB/TMEDA (0.3 mmol), and methyl p-toluate (136 mg, 0.91 mmol) as the electrophile. 
Elution with hexane:EtOAc = 10:1 gave 219 as a white solid (8.5 mg, 22%): mp 225–227 °C; IR 
(thin film, cm
–1
) νmax 3116, 2965, 2926, 2869, 2341 (B–H), 1613 (C=O), 1596, 1568, 1472, 
1459, 1427, 1385, 1364, 1332, 1215, 1158, 917, 804, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.60 
(d, J = 8.1 Hz, 2H), 7.40 (t, J = 7.7 Hz, 2H), 7.23 (d, J = 7.5 Hz, 4H), 7.10 (s, 2H), 6.98 (d, J = 
8.1 Hz, 2H), 3.54 (br q, 1H), 2.84 (septet, J = 6.6 Hz, 4H), 2.25 (s, 3H), 1.26 (d, J = 6.9 Hz, 
12H), 1.14 (d, J = 6.9 Hz, 12H); 
13
C NMR (75 MHz, CDCl3) δ 145.9, 142.2, 139.6, 134.1, 129.9, 
127.9, 127.1, 123.9, 122.5, 28.4, 25.5, 23.0, 21.3; 
11
B NMR (96.3 MHz, CDCl3) δ –26.1 (t, J = 
85 Hz); HRMS (ESI) calcd. for C35H45
11
BN2NaO ([M + Na]
+
) 543.3523, found 543.3511. 
 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene butylborane (220):
140
 Compound 220 was 
prepared following GP8 with 116 (0.075 mmol), LDBB/TMEDA (0.3 mmol), and 1-
chlorobutane (95 L, 0.91 mmol) as the electrophile. Elution with hexane:EtOAc = 98:2 gave 
220 as a white solid (15.8 mg, 46%): 
1
H NMR (300 MHz, CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 
7.28 (d, J = 7.8 Hz, 4H), 6.96 (s, 2H), 2.63 (septet, J = 6.9 Hz, 4H), 1.32 (d, J = 6.9 Hz, 12H), 
1.16 (d, J = 6.9 Hz, 12H), 1.05–0.85 (m, 4H), 0.64 (t, J = 7.2 Hz, 3H), −0.20 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ 145.6, 134.7, 129.9, 123.8, 122.0, 35.4, 28.8, 26.5, 25.3, 22.8, 14.2; 
11
B 
NMR (96.3 MHz, CDCl3): δ −26.0 (t, J = 82 Hz). These data are consistent with those reported 
for 220 in the literature.
70b
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene adamantylborane (222):
140
 Compound 222 
was prepared following GP8 with 116 (0.075 mmol), LDBB/TMEDA (0.3 mmol), and 1-
iodoadamantane (240 mg, 0.91 mmol) as the electrophile. Elution with hexane:Et2O = 98:2 gave 
222 as a white solid (20.2 mg, 50%): mp 191−193.5 °C; IR (thin film, cm–1) νmax 2964, 2900, 
2872, 2857, 2838, 2318 (B–H), 1456, 1410, 1382, 1206, 1161, 1066, 802, 760; 1H NMR (400 
MHz, CDCl3) δ 7.47 (t, J = 7.6 Hz, 2H), 7.29 (d, J = 7.6 Hz, 4H), 7.01 (s, 2H), 2.73 (septet, J = 
6.8 Hz, 4H), 1.56−1.43 (m, 9H), 1.38 (d, J = 6.8 Hz, 12H), 1.13−1.10 (m, 18H); 13C NMR (100 
MHz, CDCl3): δ 145.6, 135.4, 129.9, 123.8, 122.6, 45.7, 38.1, 29.4, 28.9, 26.2, 22.2; 
11
B NMR 
(128.4 MHz, CDCl3): δ −19.1 (t, J = 80 Hz); HRMS (ESI) calcd. for C37H53
11
BN2Na ([M + 
Na]
+
): 559.4200, found: 559.4199. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene allylborane (223):
140
 Compound 223 was 
prepared following GP8 with 116 (0.6 mmol), LDBB/TMEDA (2.4 mmol), and allyl bromide 
(0.62 mL, 7.2 mmol) as the electrophile. Elution with hexane:EtOAc = 99:1 gave 223 as a light 
yellow solid (96.3 mg, 36%): mp 162−165 °C; IR (thin film, cm–1) νmax 3163, 3129, 3105, 3062, 
2964, 2929, 2871, 2257 (B–H), 1624, 1472, 1421, 1386, 1201, 1149, 805; 1H NMR (300 MHz, 
CDCl3) δ 7.47 (t, J = 7.8 Hz, 2H), 7.29 (d, J = 7.8 Hz, 4H), 6.99 (s, 2H), 5.80−5.70 (m, 1H), 
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4.42−4.32 (m, 2H), 2.59 (septet, 4H, J = 7.2 Hz), 1.32 (d, 12H, J = 7.2 Hz), 1.13 (d, 12H, J = 
7.2 Hz), 0.75−0.6 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 148.2, 145.4, 134.3, 130.0, 123.8, 
122.0, 106.2, 28.7, 25.2, 22.8; 
11
B NMR (96.3 MHz, CDCl3): δ −26.9 (t, J = 85 Hz); HRMS 
(ESI) calcd. for C30H43
11
BN2 442.3519, found: 442.3497. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (perfluorobutyl)borane (dipp-Imd-BH2-
C4F9) (224): Compound 224 was prepared following GP8 with 116 (0.075 mmol), 
LDBB/TMEDA (0.3 mmol), and perfluorobutyl iodide (0.16 mL, 0.9 mmol) as the electrophile. 
Elution with hexane:Et2O = 10:1 gave 224 as a light yellow semisolid (3.2 mg, 7%): IR (thin 
film, cm
–1
) νmax 2966, 2928, 2871, 2425 (B–H), 1470, 1426, 1386, 1366, 1231, 1201, 1121, 856, 
804; 
1
H NMR (400 MHz, CDCl3) δ 7.49 (t, J = 7.8 Hz, 2H), 7.30 (d, J = 7.6 Hz, 4H), 7.12 (s, 
2H), 2.54 (septet, J = 6.7, 4H), 1.29 (d, J = 6.4 Hz, 12H), 1.14 (d, J = 6.4 Hz, 12H); 
13
C NMR 
(100 MHz, CDCl3) δ 145.5, 133.9, 130.3, 123.9, 123.3,  28.7, 25.8, 22.2; 
11
B NMR (128.4 MHz, 
CDCl3) δ –29.4 (br s); 
19
F NMR (376 MHz, CDCl3): δ −81.3 (septet, J = 4 Hz, 3F), −111.5 (s, 
2F), −123.4 (s, 2F), −125.7 (t, J = 11 Hz, 2F); HRMS (EI) calcd. for C31H38
11
BN2F9 ([M]
+
) 
620.298434, found 620.298400. 
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1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (perfluorophenyl)borane (225):
140
 
Compound 225 was prepared following GP8 with 116 (0.075 mmol), LDBB/TMEDA (0.3 
mmol), and hexafluorobenzene (0.10 mL, 0.91 mmol) as the electrophile. Elution with 
hexane:Et2O = 98:2 gave 225 as a white solid (11.8 mg, 27%): mp 189−191°C; IR (thin film, 
cm
–1) νmax 3128, 2965, 2929, 2873, 2353 (B–H), 1508, 1468, 1423, 1388, 1213, 1158, 1098, 
1086, 891, 802, 760; 
1
H NMR (300 MHz, CDCl3) δ 7.41 (t, J = 7.5 Hz, 2H), 7.20 (d, J = 7.5 Hz, 
4H), 7.06 (s, 2H), 2.60 (septet, J = 6.9 Hz, 4H), 1.27 (d, J = 6.9 Hz, 12H), 1.12 (d, J = 6.9 Hz, 
12H); 
13
C NMR (75 MHz, CDCl3): δ 145.5, 133.5, 130.2, 123.8, 122.6, 28.7, 25.9, 22.1;  
11
B 
NMR (96.3 MHz, CDCl3): δ −31.5 (t, J = 89 Hz); 
19
F NMR (282 MHz, CDCl3): δ −129.4 (d, J = 
23.1 Hz, 2F), −162.9 (t, J = 20.3 Hz, 1F), −166.5 (m, 2F); HRMS (ESI) calcd. for 
C33H38
11
BN2F5Na ([M + Na]
+
): 591.2946, found: 591.2949. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene [3',6-dioxobi(cyclohexan)-2-yl]borane 
(226): Compound 226 was prepared following GP8 with 116 (0.075 mmol), LDBB/TMEDA 
(0.3 mmol), and 2-cyclohexen-1-one (88 µL, 0.91 mmol) as the electrophile. Elution with 
hexane:EtOAc = 5:1 gave 226 as a white solid (6.3 mg, 14%). It was isolated as an inseparable 
mixture of diastereomers: IR (thin film, cm
–1
) νmax 2964, 2929, 2867, 2349 (B–H), 1695 (C=O), 
1469, 1418, 1385, 1364, 1329, 1256, 1163, 1061, 916, 803, 760, 733; 
1
H NMR (400 MHz, 
CDCl3) δ 7.50 (t, J = 7.6 Hz, 2H), 7.35 (dd, J = 7.6, 1.2 Hz, 2H), 7.29 (dd, J = 8.0, 1.6 Hz, 2H), 
7.03 (s, 2H), 2.60 (septet, J = 7.0 Hz, 2H), 2.58 (septet, J = 7.0 Hz, 2H), 2.34 (d, J = 13.6 Hz, 
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1H), 2.20–1.92 (m, 5H), 1.92–1.80 (m, 2H), 1.80–1.72 (m, 1H), 1.56 –1.37 (m, 3H), 1.34 (d, J = 
6.8 Hz, 6H), 1.32 (d, J = 6.8 Hz, 6H), 1.30–1.25 (m, 2H), 1.22 (d, J = 6.4 Hz, 2H), 1.15 (d, J = 
6.8 Hz, 6H), 1.12 (d, J = 6.8 Hz, 6H), 0.61 (br d, J = 8.0 Hz, 1H); 
13
C NMR (100 MHz, CDCl3) δ 
217.5, 213.3, 145.6, 145.2, 134.1, 130.3, 124.4, 123.7, 122.4, 60.6, 43.4, 43.3, 41.7, 37.9, 34.2, 
29.2, 28.8, 28.3, 26.1, 25.9, 25.5, 25.4, 22.4, 22.3; 
11
B NMR (96.3 MHz, CDCl3) δ –23.9 (br t, 
J = 54 Hz); HRMS (ESI) calcd. for C39H55
11
BN2NaO2 ([M + Na]
+
) 617.4254, found 617.4244. 
 
1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene (2-hydroxybutyl)borane (227) and 1,3-
bis(2,6-diisopropylphenyl)-4-(2-hydroxybutyl)imidazol-2-ylidene (2-hydroxybutyl)borane 
(228):
140
 GP8 was followed with 116 (0.075 mmol), LDBB/TMEDA (0.3 mmol), and 1,2-
epoxybutane (79 L, 0.91 mmol) as the electrophile. Elution with hexane:EtOAc = 95:5 gave 
227 as a white solid (12.3 mg, 34%): mp 133−135 °C; IR (thin film, cm–1) νmax 3534, 3077, 
2963, 2928, 2871, 2284 (B–H), 1471, 1423, 1363, 1331, 1060, 1023, 803, 759; 1H NMR (300 
MHz, CDCl3) δ 7.46 (t, J = 7.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 4H), 6.99 (s, 2H), 3.10−3.04 (m, 
1H), 2.62−2.52 (m, 4H), 2.21 (br s, 1H), 1.30 (d, J = 6 Hz, 12H), 1.15 (d, J = 6 Hz, 12H), 
0.92−0.73 (m, 2H), 0.63 (t, J = 7.2 Hz), 0.16−0.09 (m, 1H), −0.08 to −0.14 (m, 1H); 13C NMR 
(75 MHz, CDCl3): δ 145.4, 134.2, 130.1, 123.8, 122.1, 75.3, 32.0, 28.7, 25.2, 22.7, 10.2; 
11
B 
NMR (96.3 MHz, CDCl3): δ −28.6 (t, J = 80 Hz); HRMS (ESI) calcd. for C31H47
11
BN2ONa ([M 
+ Na]
+
): 497.3679, found: 497.3657. 
Further elution with hexane:EtOAc = 90:10 gave 228 as a white solid (12.5 mg, 30%). It was 
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isolated as an inseparable mixture of diastereomers: mp 159−161°C; IR (thin film, cm–1) νmax 
3391, 2964, 2928, 2871, 2357, 1470, 1415, 1386, 116, 804; 
1
H NMR (300 MHz, CDCl3) δ 
7.50−7.41 (m,  2H), 7.29−7.23 (m, 4H), 7.01 (s, 1H), 3.8−3.68 (m, 1H), 3.1−3.0 (m, 1H), 
2.65−2.50 (m, 2H), 2.49−2.38 (m, 2H), 2.33−2.30 (m, 2H), 1.50−1.35 (m, 2H), 1.28−1.24 (m, 
12H), 1.17−1.13 (m, 12H), 0.89 (t, J = 7.5 Hz, 3H), 0.6 (t, J = 7.5 Hz, 3H), 0.15−0.0 (m, 1H), 
−0.1 to −0.3 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 145.8, 145.5, 134.4, 132.2, 131.3, 130.1, 
130.0, 124.1, 124.0, 123.7, 120.5, 75.6, 71.3, 32.0, 30.6, 28.7, 25.6, 24.1, 23.8, 22.5, 10.2, 9.8; 
11
B NMR (96.3 MHz, CDCl3): δ −28.0 (br t); HRMS (ESI) calcd. for C35H55
11
BN2O2Na ([M + 
Na]
+
): 569.4254, found: 569.4237. 
 
General Procedure 9: Functionalization of the NHC ring (GP9): A solution of butyllithium 
(1.3 M in hexanes, 0.08 mL, 0.10 mmol) was added to a solution of NHC-borane (0.10 mmol) in 
THF (1 mL) at rt under argon. The resulting colorless or light yellow solution was stirred for 5 
min, and then the electrophile (0.11 mmol) was added either as neat for liquid or as a solution in 
THF (0.5 mL) for solids. The reaction mixture was stirred at rt for 18 h. In cases when a 
precipitate of lithium alkoxide formed, the mixture was quenched with methanol (0.2 mL). 
Solvents and volatiles were removed under vacuum and the residue was loaded onto silica gel. 
The product was purified by flash chromatography (elution with hexane:EtOAc or hexane:Et2O). 
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1,3-bis(2,6-diisopropylphenyl)-4-(trimethylsilyl)imidazol-2-ylidene borane (4-TMS-dipp-
Imd-BH3) (243a):
163
 Compound 243a was prepared according to GP9 from dipp-Imd-BH3 40 
(40.3 mg, 0.10 mmol) and chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with 
hexane:EtOAc = 95:5 gave a 10:1 mixture of 4-TMS-diiPr-Imd-BH3 243a and dipp-Imd-BH3 40 
as a white solid (42.3 mg, 89%). An analytically pure sample of 4-TMS-diiPr-Imd-BH3 243a 
was obtained in first two fractions: mp 200–201 °C; IR (thin film, cm–1)  νmax 3109, 2961, 2929, 
2903, 2869, 2364 (B–H), 2349 (B–H), 2336 (B–H), 1533, 1469, 1396, 1363, 1254, 1125, 1111, 
1060, 1003, 980, 844, 800, 755; 
1
H NMR (400 MHz, CDCl3) δ 7.45 (t, J = 7.6 Hz, 1H), 7.44 (t, J 
= 7.6 Hz, 1H), 7.27 (d, J = 7.6 Hz, 2H), 7.26 (d, J = 7.6 Hz, 2H), 7.05 (s, 1H), 2.59–2.47 (m, 
4H), 1.30 (d, J = 7.2 Hz, 6H), 1.28 (d, J = 6.8 Hz, 6H), 1.25 (d, J = 7.2 Hz, 6H), 1.15 (d, J = 6.8 
Hz, 6H), 0.58 (q, J = 83 Hz, 3H), 0.01 (s, 9H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.3, 135.8, 
134.3, 133.2, 129.9, 129.8, 123.9, 123.7, 28.6, 24.8, 24.0, 23.4, 22.8, –0.4; 11B NMR (128.4 
MHz, CDCl3) δ –35.7 (q, J = 89 Hz); HRMS (ESI) calcd. for C30H47
11
BN2NaSi ([M + Na]
+
)
 
497.3499, found 497.3502. 
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1,3-dimethyl-4-(trimethylsilyl)imidazol-2-ylidene borane (4-TMS-diMe-Imd-BH3) (243b):
163
 
Compound 243b was prepared according to GP9 from diMe-Imd-BH3 41 (11.0 mg, 0.10 mmol) 
and chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with hexane:EtOAc = 75:25 gave  4-
TMS-diMe-Imd-BH3 243b as colorless oil (15.5 mg, 85%): IR (thin film, cm
–1
)  νmax 3137, 2956, 
2853, 2341 (B–H), 2302 (B–H), 2275 (B–H), 1557, 1450, 1392, 1254, 1203, 1121, 1081, 882, 
843, 759; 
1
H NMR (400 MHz, CDCl3) δ 6.76 (s, 1H), 3.77 (s, 3H), 3.71 (s, 3H), 1.02 (q, JB–H = 
86 Hz, 3H), 0.31 (s, 9H); 
13
C
 
NMR (100 MHz, CDCl3) δ 131.1, 123.9, 36.0, 35.7, –1.3; 
11
B 
NMR (128.4 MHz, CDCl3) δ –37.3 (q, J = 87 Hz); HRMS (ESI) calcd. for C8H19
11
BN2NaSi ([M 
+ Na]
+
)
 
205.1308, found 205.1291. 
 
1,3-diisopropyl-4-(trimethylsilyl)imidazol-2-ylidene borane (4-TMS-diiPr-Imd-BH3) 
(243c):
163
 Compound 243c was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 mg, 
0.10 mmol) and chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with hexane:EtOAc = 85:15 
gave  4-TMS-diiPr-Imd-BH3 243c as a white solid (22.1 mg, 93%): mp 65–66 °C; IR (thin film, 
cm
–1
)  νmax 3138, 2971, 2936, 2370 (B–H), 2301 (B–H), 2224 (B–H), 1549, 1448, 1380, 1338, 
1255, 1200, 1123, 1072, 902, 842, 757; 
1
H NMR (400 MHz, CDCl3) δ 6.80 (s, 1H), 5.14 (septet, 
J = 6.7 Hz, 1H), 4.58 (br s, 1H), 1.65 (d, J = 6.8 Hz, 6H), 1.37 (d, J = 6.8 Hz, 6H), 1.18 (q, JB–H 
= 86 Hz, 3H), 0.33 (s, 9H); 
13
C
 
NMR (100 MHz, CDCl3) δ 131.1, 122.5, 53.8, 48.4, 22.6, 21.5, –
0.5; 
11
B NMR (128.4 MHz, CDCl3) δ –35.6 (q, J = 87 Hz); HRMS (ESI) calcd. for 
C12H27
11
BN2NaSi ([M + Na]
+
)
 
261.1934, found 261.1959. 
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1,3-dicyclohexyl-4-(trimethylsilyl)imidazol-2-ylidene borane (4-TMS-diCy-Imd-BH3) 
(243d):
163
 Compound 243d was prepared according to GP9 from diCy-Imd-BH3 75 (24.6 mg, 
0.10 mmol) and chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with hexane:EtOAc = 90:10 
gave  4-TMS-diCy-Imd-BH3 243d as a white solid (29.9 mg, 92%): mp 145–147 °C; IR (thin 
film, cm
–1
)  νmax 3136, 2931, 2853, 2375 (B–H), 2279 (B–H), 2223 (B–H), 1549, 1451, 1383, 
1364, 1256, 1184, 1120, 1065, 997, 911, 887, 844, 764; 
1
H NMR (500 MHz, CDCl3) δ 6.79 (s, 
1H), 4.72 (tt, J = 8.6, 6.4 Hz, 1H), 4.09 (br s, 1H), 2.66 (br s, 2H), 2.05 (d, J = 11.0 Hz, 2H), 1.91 
(d, J = 12.0 Hz, 2H), 1.84 (d, J = 12.5 Hz, 2H), 1.78 (d, J = 12.5 Hz, 2H), 1.74 (d, J = 14.5 Hz, 
1H), 1.66 (s, 1H), 1.50–1.38 (m, 4H), 1.38–1.15 (m, 4H), 1.18 (q, JB–H = 82 Hz, 3H), 0.31 (s, 
9H); 
13
C
 
NMR (125 MHz, CDCl3) δ 131.1, 123.1, 62.2, 55.9, 33.2, 30.9, 26.2, 25.4, 25.4, 24.7, –
0.5; 
11
B NMR (128.4 MHz, CDCl3) δ –35.4 (q, J = 88 Hz); HRMS (ESI) calcd. for 
C18H35
11
BN2NaSi ([M + Na]
+
)
 
341.2558, found 341.2560. 
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1,3-bis(2,4,6-trimethylphenyl)-4-(trimethylsilyl)imidazol-2-ylidene borane (4-TMS-diMes-
Imd-BH3) (243e):
163
 Compound 243e was prepared according to GP9 from diMes-Imd-BH3 241 
(31.8 mg, 0.10 mmol) and chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with 
hexane:EtOAc = 90:10 gave 4-TMS-diMes-Imd-BH3 243e as colorless oil that slowly 
crystallized (20.4 mg, 52%): mp 180–181 °C; IR (thin film, cm–1)  νmax 2954, 2920, 2859, 2357 
(B–H), 2343 (B–H), 1610, 1538, 1487, 1397, 1251, 1216, 1113, 1002, 983, 843, 760; 1H NMR 
(400 MHz, CDCl3) δ 6.99 (s, 2H), 6.98 (s, 2H), 6.95 (s, 1H), 2.35 (s, 3H), 2.34 (s, 3H), 2.06 (s, 
6H), 2.03 (s, 6H), 0.51 (q, J = 91 Hz, 3H), 0.05 (s, 9H); 
13
C
 
NMR (125 MHz, CDCl3) δ 138.9, 
138.8, 135.2, 135.0, 134.8, 134.6, 132.1, 129.0, 128.3, 21.2, 21.1, 17.8, 17.6, –1.3; 11B NMR 
(128.4 MHz, CDCl3) δ –37.4 (q, J = 88 Hz); HRMS (ESI) calcd. for C24H35
11
BN2NaSi ([M + 
Na]
+
)
 
413.2560, found 413.2575. 
 
1,3-bis(2,6-diisopropylphenyl)-4-(hydroxy(phenyl)methyl)imidazol-2-ylidene borane (4-
PhCH(OH)-dipp-Imd-BH3) (244a):
163
 Compound 244a was prepared according to GP9 from 
dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and benzaldehyde (12 µL, 0.12 mmol). Elution with 
hexane:EtOAc = 80:20 gave 4-PhCH(OH)-dipp-Imd-BH3 244a as a white solid (42.2 mg, 82%): 
mp 208–209 °C; IR (thin film, cm–1)  νmax 3429 (O–H), 3030, 2962, 2928, 2869, 2359 (B–H), 
1595, 1471, 1416, 1385, 1364, 1329, 1182, 1148, 1114, 1060, 803, 762; 
1
H NMR (400 MHz, 
CDCl3) δ 7.52 (t, J = 7.6 Hz, 1H), 7.41 (t, J = 7.8 Hz, 1H), 7.37 (dd, J = 7.6, 1.2 Hz, 1H), 7.37–
7.32 (m, 5H), 7.30 (dd, J = 7.6, 1.2 Hz, 1H), 7.25 (dd, J = 7.6, 1.2 Hz, 1H), 7.22 (dd, J = 7.6, 1.2 
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Hz, 1H), 6.50 (s, 1H), 5.45 (d, J = 4.0 Hz, 1H), 2.67 (septet, J = 6.8 Hz, 1H), 2.64 (septet, J = 
6.8 Hz, 1H), 2.43 (septet, J = 6.8 Hz, 1H), 2.43 (septet, J = 6.8 Hz, 1H),  2.05 (d, J = 4.4 Hz, 
1H), 1.35 (app t, J = 6.8 Hz, 6H), 1.30 (app t, J = 7.2 Hz, 6H), 1.28 (d, J = 6.8 Hz, 3H), 1.16 (app 
t, J = 7.2 Hz, 6H), 1.03 (d, J = 6.8 Hz, 3H), 0.58 (br q, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 
146.6, 145.4, 145.2, 145.2, 140.0, 136.2, 134.0, 131.9, 130.3, 129.8, 128.7, 128.5, 126.0, 124.4, 
123.9, 123.9, 123.8, 121.4, 66.7, 29.2, 29.1, 28.6, 28.6, 24.8, 24.7, 24.2, 24.2, 23.6, 23.4, 22.9, 
22.7; 
11
B NMR (128.4 MHz, CDCl3) δ –35.7 (q, J = 83 Hz); HRMS (ESI) calcd. for 
C34H45
11
BN2NaO ([M + Na]
+
)
 
531.3523, found 531.3561. 
 
4-(hydroxy(phenyl)methyl)-1,3-diisopropylimidazol-2-ylidene borane (4-PhCH(OH)-diiPr-
Imd-BH3) (244c):
163
 Compound 244c was prepared according to GP9 from diiPr-Imd-BH3 45 
(16.6 mg, 0.10 mmol) and benzaldehyde (12 µL, 0.12 mmol). Elution with hexane:EtOAc = 
80:20 gave 4-PhCH(OH)-diiPr-Imd-BH3 244c as a white solid (23.9 mg, 88%): mp 152–153 °C; 
IR (thin film, cm
–1
)  νmax 3445 (O–H), 3139, 3029, 2977, 2935, 2878, 2336 (B–H), 2283 (B–H), 
2207 (B–H), 1602, 1494, 1436, 1422, 1370, 1333, 1178, 1125, 1096, 1036, 1022, 914, 737, 703; 
1
H NMR (400 MHz, CDCl3) δ 7.44–7.36 (m, 5H), 6.52 (s, 1H), 5.94 (d, J = 3.6 Hz, 1H), 5.12 
(septet, J = 6.7 Hz, 1H), 4.96 (br s, 1H), 2.45 (d, J = 4.4 Hz, 1H), 1.56 (d, J = 7.2 Hz, 3H), 1.50 
(d, J = 7.2 Hz, 3H), 1.32 (d, J = 6.8 Hz, 3H), 1.30 (d, J = 6.8 Hz, 3H), 1.13 (q, JB–H = 81 Hz, 
3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 140.5, 134.2, 128.8, 128.6, 126.5, 114.9, 67.9, 50.8, 48.9, 
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22.5, 22.5, 21.3, 21.1; 
11
B NMR (128.4 MHz, CDCl3) δ –36.0 (q, J = 88 Hz); HRMS (ESI) calcd. 
for C16H25
11
BN2NaO ([M + Na]
+
)
 
295.1958, found 295.1975. 
 
1,3-Bis(2,6-diisopropylphenyl)-4-(2-hydroxybutyl)-imidazol-2-ylidene borane  
(4-EtCH(OH)CH2-dipp-Imd-BH3) (245a):
163
 Compound 245a was prepared according to GP9 
from dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and 2-ethyloxirane (10 µL, 0.11 mmol). Elution 
with hexane:EtOAc = 80:20 gave 4-EtCH(OH)CH2-dipp-Imd-BH3 245a as a white solid (29.6 
mg, 62%): mp 176–177 °C; IR (thin film, cm–1)  νmax 3485 (O–H), 3148, 2960, 2927, 2868, 2350 
(B–H), 2343 (B–H), 2288 (B–H), 1470, 1409, 1362, 1267, 1184, 1092, 1019, 976, 805, 758, 737; 
1
H NMR (400 MHz, CDCl3) δ 7.48 (t, J = 7.8 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.35–7.20 (m, 
4H), 7.03 (s, 1H), 3.78 (d, J = 3.2 Hz, 1H), 2.59 (app septet, J = 6.7 Hz, 2H), 2.51–2.39 (m, 2H), 
2.39–2.30 (m, 2H), 1.58 (d, J = 2.4 Hz, 1H), 1.55–1.40 (m, 2H), 1.29 (app d, J = 6.4 Hz, 12H), 
1.25–1.10 (m, 12H), 0.91 (t, J = 7.4 Hz, 3H), 0.56 (br q, 3H); 13C NMR (100 MHz, CDCl3) δ 
145.8, 145.6, 145.3, 145.3, 134.4, 132.1, 131.1, 130.0, 129.7, 124.1, 124.0, 123.8, 123.7, 119.3, 
71.2, 31.9, 30.5, 28.7, 28.7, 28.6, 28.6, 24.7, 24.7, 23.8, 23.7, 23.7, 22.9, 22.9, 9.8; 
11
B NMR 
(128.4 MHz, CDCl3) δ –35.9 (q, J = 88 Hz); HRMS (ESI) calcd. for C31H47
11
BN2NaO ([M + 
Na]
+
)
 
497.3679, found 497.3690. 
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4-(2-hydroxybutyl)-1,3-diisopropylimidazol-2-ylidene borane (4-EtCH(OH)CH2-diiPr-Imd-
BH3) (245c):
163
 Compound 245c was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 
mg, 0.10 mmol) and 2-ethyloxirane (10 µL, 0.11 mmol). Elution with hexane:EtOAc = 80:20 
gave 4-EtCH(OH)CH2-diiPr-Imd-BH3 245c as colorless oil (9.6 mg, 40%): IR (thin film, cm
–1
)  
νmax 3471 (O–H), 3128, 2969, 2934, 2877, 2279 (B–H), 1610, 1463, 1420, 1370, 1333, 1190, 
1120, 1060, 1022, 980, 920, 766; 
1
H NMR (500 MHz, CDCl3) δ 6.83 (s, 1H), 5.25 (br s, 1H), 
5.13 (septet, J = 6.7 Hz, 1H), 3.79 (t, J = 3.8 Hz, 1H), 2.84 (dd, J = 15.8, 2.8 Hz, 1H), 2.72 (dd, J 
= 15.8, 8.8 Hz, 1H), 1.71 (br s, 1H), 1.70–1.55 (m, 2H), 1.53–1.50 (m, 6H), 1.37 (d, J = 7.0 Hz, 
3H), 1.37 (d, J = 6.5 Hz, 3H), 1.03 (t, J = 7.5 Hz, 3H), 1.02 (q, JB–H = 87 Hz, 3H); 
13
C
 
NMR (125 
MHz, CDCl3) δ 129.1, 113.5, 71.6, 49.7, 49.0, 33.0, 30.4, 22.6, 21.6, 21.5, 9.9; 
11
B NMR (128.4 
MHz, CDCl3) δ –36.5 (q, J = 87 Hz); HRMS (ESI) calcd. for C13H27
11
BN2NaO ([M + Na]
+
)
 
261.2114, found 261.2128. 
 
4-(6-azidohexyl)-1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene borane  
(4-N3(CH2)6-dipp-Imd-BH3) (246a):
163
 Compound 246a was prepared according to GP9 from 
dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and 1-azido-6-bromohexane
179
 (104 mg, 0.50 mmol). 
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Elution with hexane:Et2O = 90:10 gave 4-N3(CH2)6-dipp-Imd-BH3 246a as a white solid (32.6 
mg, 61%): mp 126–127 °C; IR (thin film, cm–1)  νmax 2963, 2928, 2868, 2355 (B–H), 2095 (N3), 
1471, 1409, 1384, 1364, 1257, 1149, 1118, 1060, 1014, 805, 756; 
1
H NMR (500 MHz, CDCl3) δ 
7.48 (t, J = 7.8 Hz, 1H), 7.44 (t, J = 7.8 Hz, 1H), 7.31 (d, J = 7.5 Hz, 2H), 7.27 (d, J = 8.0 Hz, 
2H), 6.74 (s, 1H), 3.24 (t, J = 6.8 Hz, 2H), 2.58 (septet, J = 6.9 Hz, 2H), 2.46 (septet, J = 6.9 Hz, 
2H), 2.22 (t, J = 7.5 Hz, 2H), 1.65 (app quintet, J = 6.9 Hz, 2H), 1.56 (app quintet, J = 6.3 Hz, 
2H), 1.40–1.33 (m, 4H), 1.29 (app d, J = 7.0 Hz, 12H), 1.21 (d, J = 7.0 Hz, 6H), 1.19 (d, J = 7.0 
Hz, 2H), 0.55 (br q, 3H); 
13
C
 
NMR (125 MHz, CDCl3) δ 145.6, 145.3, 134.4, 133.9, 132.1, 
130.0, 129.7, 124.0, 123.8, 117.7, 51.2, 28.7, 28.7, 28.6, 26.8, 26.5, 24.7, 24.5, 23.8, 23.7, 23.0; 
11
B NMR (128.4 MHz, CDCl3) δ –36.2 (q, J = 89 Hz); HRMS (ESI) calcd. for C33H50
11
BN5Na 
([M + Na]
+
)
 
550.4057, found 550.4066. 
 
4-(6-azidohexyl)-1,3-diisopropylimidazol-2-ylidene borane (4-N3(CH2)6-diiPr-Imd-BH3) 
(246c):
163
 Compound 246c was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 mg, 
0.10 mmol) and 1-azido-6-bromohexane
179
 (103 mg, 0.50 mmol). Elution with hexane:EtOAc = 
80:20 gave 4-N3(CH2)6-diiPr-Imd-BH3 246c as colorless semi-solid (2.5 mg, 9%): IR (thin film, 
cm
–1
)  νmax 2926, 2855, 2276 (B–H), 2095 (N3), 1615, 1408, 1348, 1330, 1176, 1151, 1135; 
1
H 
NMR (500 MHz, CDCl3) δ 6.71 (s, 1H), 5.37 (septet, J = 6.9 Hz, 1H), 5.14 (septet, J = 6.8 Hz, 
1H), 3.96 (t, J = 5.5 Hz, 2H), 3.74 (t, J = 6.0 Hz, 2H), 1.95–1.87 (m, 2H), 1.85–1.79 (m, 2H), 
1.70–1.60 (m, 4H), 1.54 (d, J = 6.5 Hz, 6H), 1.39 (d, J = 7.0 Hz, 6H), 1.10 (q, JB–H = 87 Hz, 3H); 
 207 
13
C
 
NMR (100 MHz, CDCl3) δ 143.3, 98.7, 54.4, 50.0, 49.2, 49.0, 29.9, 28.8, 28.2, 24.9, 22.7, 
21.3; 
11
B NMR (128.4 MHz, CDCl3) δ –37.1 (q, J = 86 Hz); HRMS (ESI) calcd. for 
C15H30
11
BN5Na ([M + Na]
+
)
 
314.2492, found 314.2505. 
 
1,3-bis(2,6-diisopropylphenyl)-4-(pent-4-en-1-yl)imidazol-2-ylidene borane  
(4-CH2=CH(CH2)3-dipp-Imd-BH3) (247a):
163
 Compound 247a was prepared according to GP9 
from dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and 5-bromopent-1-ene (14 µL, 0.12 mmol). 
Elution with hexane:Et2O = 90:10 gave an inseparable mixture of 4-CH2=CH(CH2)3-dipp-Imd-
BH3 247a and dipp-Imd-BH3 40 as white solid (29.9 mg). By 
1
H NMR spectroscopy, the ratio of 
247a and 40 was 1 : 0.8.  The yield of 247a was estimated to be 37%. 
 
1,3-diisopropyl-4-(pent-4-en-1-yl)imidazol-2-ylidene borane (4-CH2=CH(CH2)3-diiPr-Imd-
BH3) (247c):
163
 Compound 247c was prepared according to GP9 from diiPr-Imd-BH3 45 (33.2 
mg, 0.20 mmol), BuLi (1.3 M in hexanes, 0.15 mL, 0.20 mmol), and 5-bromopent-1-ene (28 µL, 
0.24 mmol). Elution with hexane:EtOAc = 85:15 gave 4-CH2=CH(CH2)3-diiPr-Imd-BH3 247c as 
colorless oil (32.5 mg, 69%): IR (thin film, cm
–1
)  νmax 3123, 3076, 2977, 2935, 2357 (B–H), 
2336 (B–H), 2277 (B–H), 1641, 1609, 1446, 1421, 1370, 1189, 1135, 1093, 994, 914; 1H NMR 
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(400 MHz, CDCl3) δ 6.59 (s, 1H), 5.86–5.76 (m, 1H), 5.21 (br s, 1H), 5.12 (septet, J = 7.1 Hz, 
1H), 5.07–5.00 (m, 2H), 2.62 (t, J = 7.8 Hz, 2H), 2.17 (app q, J = 7.1 Hz, 2H), 1.73 (app quintet, 
J = 7.5 Hz, 2H), 1.49 (d, J = 7.2 Hz, 6H), 1.35 (d, J = 6.8 Hz, 6H), 1.08 (q, JB–H = 86 Hz, 3H); 
13
C
 
NMR (125 MHz, CDCl3) δ 137.5, 132.1, 115.7, 112.0, 49.7, 48.9, 33.2, 27.2, 24.9, 22.6, 
21.3; 
11
B NMR (128.4 MHz, CDCl3) δ –36.6 (q, J = 87 Hz); HRMS (ESI) calcd. for 
C14H27
11
BN2Na ([M + Na]
+
)
 
257.2165, found 257.2178. 
 
1,3-bis(2,6-diisopropylphenyl)-4-(diphenylphosphoryl)imidazol-2-ylidene borane  
(4-Ph2P(O)-dipp-Imd-BH3) (248a):
163
 Compound 248a was prepared according to GP9 from 
dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol) and diphenylphosphinyl chloride (21 µL, 0.11 mmol). 
Elution with hexane:EtOAc = 60:40 gave 4-Ph2P(O)-dipp-Imd-BH3 248a as a white solid (45.2 
mg, 75%): mp 245–247 °C; IR (thin film, cm–1)  νmax 3062, 2962, 2928, 2870, 2378 (B–H), 2328 
(B–H), 2236 (B–H), 1547, 1469, 1438, 1398, 1385, 1364, 1327, 1216, 1199, 1139, 1118, 1060, 
913, 803, 727; 
1
H NMR (400 MHz, CDCl3) δ 7.68–7.55 (m, 6H), 7.55–7.40 (m, 6H), 7.28 (d, J = 
7.6 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 6.83 (s, 1H), 2.55 (septet, J = 6.8 Hz, 2H), 2.36 (septet, J = 
6.7 Hz, 2H), 1.33 (d, J = 6.8 Hz, 6H), 1.22 (d, J = 6.8 Hz, 6H), 1.14 (d, J = 6.8 Hz, 6H), 0.89 (d, 
J = 6.8 Hz, 6H), 0.88 (br q, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.3, 145.0, 133.4, 132.8, 
132.7, 132.7, 132.1, 131.9, 131.7, 131.7, 131.6, 130.6, 130.3, 130.3, 128.9, 128.7, 126.9, 125.8, 
124.1, 123.6, 29.5, 28.8, 24.8, 24.1, 22.6, 22.5; 
11
B NMR (128.4 MHz, CDCl3) δ –35.6 (q, J = 89 
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Hz); 
31
P NMR (161.9 MHz, CDCl3) δ +14.6 (quintet, J = 12 Hz); HRMS (ESI) calcd. for 
C39H49
11
BN2NaOP ([M + Na]
+
)
 
603.3676, found 603.3701. 
 
4-(diphenylphosphoryl)-1,3-diisopropylimidazol-2-ylidene borane (4-Ph2P(O)-diiPr-Imd-
BH3) (248c):
163
 Compound 248c was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 
mg, 0.10 mmol) and diphenylphosphinyl chloride (21 µL, 0.11 mmol). Elution with 
hexane:EtOAc = 55:45 gave 4-Ph2P(O)-diiPr-Imd-BH3 248c as a white solid (12.2 mg, 33%): 
mp 162–164 °C; IR (thin film, cm–1)  νmax 2977, 2936, 2392 (B–H), 2288 (B–H), 1591, 1557, 
1438, 1389, 1190, 1161, 1120, 1072, 754, 726; 
1
H NMR (500 MHz, CDCl3) δ 7.75–7.62 (m, 
6H), 7.58–7.50 (m, 4H), 6.50 (d, J = 2.0 Hz, 1H), 5.19 (septet, J = 6.7 Hz, 1H), 4.98 (br s, 1H), 
1.49 (d, J = 7.0 Hz, 6H), 1.30 (d, J = 6.5 Hz, 6H), 1.18 (q, JB–H = 85 Hz, 3H); 
13
C
 
NMR (100 
MHz, CDCl3) δ 132.9, 132.9, 131.8, 131.7, 130.4, 129.6, 129.4, 190.0, 128.9, 125.6, 54.0, 49.4, 
22.5, 20.9; 
11
B NMR (128.4 MHz, CDCl3) δ –35.5 (q, J = 86 Hz); 
31
P NMR (161.9 MHz, 
CDCl3) δ +16.2 (s); HRMS (ESI) calcd. for C21H28
11
BN2NaOP ([M + Na]
+
)
 
389.1930, found 
389.1898. 
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4-Iodo-1,3-diisopropylimidazol-2-ylidene borane (249c):
163
 Compound  249c was prepared 
according to GP9 from diiPr-Imd-BH3 45 (16.6 mg, 0.10 mmol) and iodine (28 mg, 0.11 mmol). 
Elution with hexane:EtOAc = 90:10 gave  4-I-diiPr-Imd-BH3 249c (5.3 mg, 18%) as white 
solids:
163
 mp 138–141 °C; IR (thin film, cm–1)  νmax 3135, 3067, 2969, 2931, 2357 (B–H), 2342 
(B–H), 2262 (B–H), 1595, 1545, 1456, 1435, 1399, 1370, 1348, 1301, 1265, 1190, 1137, 1086, 
1022, 896, 800; 
1
H NMR (400 MHz, CDCl3) δ 7.01 (s, 1H), 5.49 (br s, 1H), 5.19 (septet, J = 6.6 
Hz, 1H), 1.62 (d, J = 7.2 Hz, 6H), 1.39 (d, J = 6.4 Hz, 6H), 1.14 (q, JB–H = 85 Hz, 3H); 
13
C
 
NMR 
(100 MHz, CDCl3) δ 123.5, 52.4, 50.0, 22.6, 21.0; 
11
B NMR (128.4 MHz, CDCl3) δ –36.4 (q, J = 
89 Hz); HRMS (ESI) calcd. for C7H16
11
BN2NaI ([M + Na – 2H]
+
)
 
289.0349, found 289.0302. 
 
1,3-bis(2,6-diisopropylphenyl)-4-(trimethylsilyl)imidazol-2-ylidene trifluoroborane  
(4-TMS-dipp-Imd-BF3) (250):
163
 Compound 250 was prepared according to GP9 from dipp-
Imd-BF3 138 (38.2 mg, 0.084 mmol), BuLi (1.3 M in hexanes, 0.08 mL, 0.10 mmol) and 
chlorotrimethylsilane (15 µL, 0.12 mmol). Elution with hexane:EtOAc = 90:10 gave 4-TMS-
dipp-Imd-BF3 250 as a white solid (37.5 mg, 85%): mp 340–342 °C (decomp.); IR (thin film, 
cm
–1
)  νmax 2963, 2928, 2873, 1608, 1535, 1469, 1404, 1362, 1329, 1256, 1195, 1149, 1086, 
1015, 982, 936, 916, 847, 805, 763; 
1
H NMR (400 MHz, CDCl3) δ 7.48 (t, J = 7.8 Hz, 1H), 7.48 
(t, J = 7.8 Hz, 1H), 7.29 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 6.4 Hz, 2H), 7.09 (s, 1H), 2.58–2.43 (m, 
4H), 1.33 (d, J = 6.4 Hz, 6H), 1.29 (d, J = 6.8 Hz, 6H), 1.27 (d, J = 6.8 Hz, 6H), 1.14 (d, J = 7.2 
Hz, 6H), 0.03 (s, 9H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.5, 144.9, 135.4, 134.6, 133.0, 131.6, 
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130.4, 130.4, 123.8, 123.7, 28.9, 28.7, 25.5, 24.1, 23.7, 22.3, –0.5; 11B NMR (128.4 MHz, 
CDCl3) δ –0.8 (q, J = 35 Hz); 
19
F NMR (376 MHz, CDCl3) δ –139.20 (q, J = 34 Hz); HRMS 
(ESI) calcd. for C30H44
11
BF3N2NaSi ([M + Na]
+
)
 
551.3217, found 551.3197. 
 
1,3-bis(2,6-diisopropylphenyl)-4-(2-hydroxybutyl)-imidazol-2-ylidene trifluoroborane  
(4-EtCH(OH)CH2-dipp-Imd-BF3) (251):
163
 Compound 251 was prepared according to GP9 
from dipp-Imd-BF3 138 (45.6 mg, 0.10 mmol) and 2-ethyloxirane (10 µL, 0.11 mmol). Elution 
with hexane:EtOAc = 85:15 gave 4-EtCH(OH)CH2-dipp-Imd-BF3 251 as a white solid (34.6 mg, 
66%): mp 183–184 °C; IR (thin film, cm–1)  νmax 3550 (O–H), 3154, 3075, 2964, 2931, 2872, 
1598, 1468, 1456, 1416, 1386, 1364, 1327, 1304, 1256, 1186, 1141, 1101, 1061, 1016, 998, 918, 
805, 759, 741; 
1
H NMR (400 MHz, CDCl3) δ 7.49 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.0 Hz, 1H), 
7.32–7.22 (m, 4H), 7.16 (s, 1H), 3.77 (br s, 1H), 2.54 (app septet, J = 6.5 Hz, 2H), 2.47–2.20 (m, 
4H), 1.72 (d, J = 3.6 Hz, 1H), 1.47 (app quintet, J = 7.0 Hz, 2H), 1.35–1.25 (m, 12H), 1.25–1.10 
(m, 12H), 0.88 (t, J = 7.4 Hz, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.5, 145.4, 145.3, 145.3, 
133.3, 132.8, 130.8, 130.5, 130.2, 124.1, 124.0, 123.6, 123.6, 121.7, 71.1, 31.1, 30.7, 28.8, 28.8, 
28.7, 25.4, 25.4, 24.1, 24.0, 23.6, 22.5, 9.7; 
11
B NMR (128.4 MHz, CDCl3) δ –0.8 (q, J = 35 Hz); 
19
F NMR (376 MHz, CDCl3) δ –139.16 (q, J = 34 Hz); HRMS (ESI) calcd. for 
C31H44
11
BF3N2NaO ([M + Na]
+
) 551.3396, found 551.3405. 
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4-(hydroxy(phenyl)methyl)-1,3-diisopropyl-5-(pent-4-en-1-yl)imidazol-2-ylidene borane (4-
PhCH(OH)-5-CH2=CH(CH2)3-diiPr-Imd-BH3) (252):
163
 Compound 252 was prepared 
according to GP9 from 4-CH2=CH(CH2)3-diiPr-Imd-BH3 247c (32.5 mg, 0.14 mmol), BuLi (1.3 
M in hexanes, 0.12 mL, 0.16 mmol), and benzaldehyde (17 µL, 0.17 mmol). Elution with 
hexane:EtOAc = 90:10 gave 4-PhCH(OH)-5-CH2=CH(CH2)3-diiPr-Imd-BH3 252 as a white 
solid (28.9 mg, 61%): mp 162–163 °C; IR (thin film, cm–1)  νmax 3427 (O–H), 3063, 3027, 2972, 
2936, 2873, 2391 (B–H), 2276 (B–H), 2225 (B–H), 1641, 1602, 1493, 1449, 1401, 1367, 1331, 
1195, 1174, 1121, 1092, 1034, 918, 734. The signals in the 
1
H NMR spectrum at rt were very 
broad due to the restricted rotation. 
1
H NMR (400 MHz, toluene-d8, 373K) δ 7.24 (d, J = 7.6 Hz, 
2H), 7.12 (t, J = 7.4 Hz, 2H), 7.04 (d, J = 7.2 Hz, 1H), 5.87 (s, 1H), 5.65–5.50 (m, 1H), 5.20 (br 
s, 1H), 4.99 (br s, 1H), 4.95–4.85 (m, 2H), 2.50–2.40 (m, 1H), 2.32 (br s, 1H), 2.24 (br s, 1H), 
1.91 (br s, 1H), 1.90–1.75 (m, 2H), 1.68 (br s, 1H), 1.51 (d, J = 5.6 Hz, 3H), 1.43 (d, J = 6.4 Hz, 
6H), 1.27 (br q, 3H), 1.26 (d, J = 7.2 Hz, 3H); 
13
C
 
NMR (100 MHz, CDCl3, 323K) δ 170.2 
(Ccarbene), 140.4, 137.1, 129.6, 128.9, 128.4, 127.5, 125.3, 115.9, 65.4, 50.7, 49.2, 33.6, 30.7, 
23.5, 21.5, 21.5, 21.1, 19.8; 
11
B NMR (128.4 MHz, CDCl3, 293K) δ –34.8 (br q, J = 78 Hz); 
HRMS (ESI) calcd. for C21H33
11
BN2NaO ([M + Na]
+
)
 
363.2584, found 363.2595. 
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1,3-diisopropyl-4,5-bis(pent-4-en-1-yl)imidazol-2-ylidene borane (4,5-[CH2=CH(CH2)3]2-
diiPr-Imd-BH3) (253):
163
 Compound 253 was prepared according to GP9 from 4-
CH2=CH(CH2)3-diiPr-Imd-BH3 247c (26.9 mg, 0.11 mmol), BuLi (1.3 M in hexanes, 0.11 mL, 
0.14 mmol), and 5-bromo-1-pentene (16 µL, 0.14 mmol). Elution with hexane:EtOAc = 90:10 
gave 4,5-[CH2=CH(CH2)3]2-diiPr-Imd-BH3 253 as colorless oil (3.3 mg, 10%): IR (thin film, 
cm
–1
)  νmax 3075, 2973, 2934, 2872, 2360 (B–H), 2331 (B–H), 2275 (B–H), 1641, 1616, 1464, 
1399, 1369, 1329, 1192, 1122, 992, 914. 
1
H NMR (400 MHz, CDCl3) δ 5.90–5.75 (m, 2H), 
5.15–4.95 (m, 6H), 2.53 (t, J = 8.0 Hz, 4H), 2.15 (app q, J = 7.1 Hz, 4H), 1.70–1.50 (m, 16H); 
13
C
 
NMR (100 MHz, CDCl3) δ 137.3, 127.7, 115.8, 49.3, 33.6, 29.5, 23.5, 21.6; 
11
B NMR (128.4 
MHz, CDCl3) δ –34.8 (q, J = 86 Hz); HRMS (ESI) calcd. for C21H33
11
BN2NaO ([M + Na]
+
)
 
325.2791, found 325.2806. 
 
4,5-dichloro-1,3-diisopropylimidazol-2-ylidene borane (4,5-Cl2-diiPr-Imd-BH3) (254):
163
 
Compound 254 was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 mg, 0.10 mmol) 
and p-toluenesulfonyl chloride (229 mg, 0.12 mmol). Elution with hexane:EtOAc = 90:10 gave 
4-Cl2-diiPr-Imd-BH3 254 as a white solid (10.6 mg, 45%): mp 71–72 °C; IR (thin film, cm
–1
)  
νmax 3005, 2976, 2940, 2887, 2286 (B–H), 1580, 1465, 1430, 1383, 1310, 1187, 1147, 917, 735; 
1
H NMR (500 MHz, CDCl3) δ 5.53 (br s, 2H), 1.56 (d, J = 7.0 Hz, 12H), 1.10 (q, JB–H = 87 Hz, 
3H); 
13
C
 
NMR (125 MHz, CDCl3) δ 115.5, 52.4, 20.5; 
11
B NMR (128.4 MHz, CDCl3) δ –36.2 
(q, J = 88 Hz); HRMS (ESI) calcd. for C9H16
11
B
35
Cl2N2 ([M – H]
+
)
 
233.0784, found 233.0787. 
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1,3-bis(2,6-diisopropylphenyl)-12b-hydroxy-8-oxo-5,6-
dihydroimidazo[4',5':3,4]azepino[2,1-a]isoindol-2-ylidene borane (256):
163
 Compound 256 
was prepared according to GP9 from dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol), BuLi (1.3 M in 
hexanes, 0.23 mL, 0.30 mmol), and N-(3-bromopropyl)phthalimide 255 (81 mg, 0.30 mmol). 
Elution with hexane:EtOAc = 75:25 gave 256 as a yellow solid (39.6 mg, 67%): mp 238–240 °C; 
IR (thin film, cm
–1
)  νmax 3411 (O–H), 3106, 2963, 2929, 2869, 2381 (B–H), 2328 (B–H), 1715 
(C=O), 1595, 1469, 1389, 1365, 1326, 1282, 1181, 1147, 1060, 1038, 1022, 994, 937, 914, 803, 
764, 733; 
1
H NMR (400 MHz, CDCl3) δ 7.71–7.65 (m, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.48–7.43 
(m, 2H), 7.40 (t, J = 7.8 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.20 (dd, J = 7.6, 1.2 Hz, 1H), 7.04 
(dd, J = 7.6, 1.2 Hz, 1H), 6.78–6.72 (m, 1H), 4.36 (dd, J = 13.6, 5.2 Hz, 1H), 4.36 (dt, J = 2.4, 
11.6 Hz, 1H), 3.97–3.88 (m, 1H), 3.18 (dt, J = 4.0, 12.8 Hz, 1H), 2.63 (septet, J = 6.8 Hz, 1H), 
2.54 (septet, J = 6.8 Hz, 1H), 2.23 (septet, J = 6.7 Hz, 1H), 2.02 (septet, J = 6.7 Hz, 1H),  1.81–
1.67 (m, 2H), 1.58 (dd, J = 13.2, 2.0 Hz, 1H), 1.34 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 6.4 Hz, 3H), 
1.30 (d, J = 6.8 Hz, 3H), 1.26 (d, J = 6.4 Hz, 3H), 1.22 (d, J = 6.8 Hz, 3H), 1.11 (d, J = 6.8 Hz, 
3H), 1.01 (d, J = 6.8 Hz, 3H), 0.69 (d, J = 6.8 Hz, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 167.8, 
146.2, 145.5, 145.1, 145.0, 133.6, 132.9, 132.8, 130.5, 130.3, 130.3, 130.2, 129.4, 124.9, 124.1, 
124.1, 124.1, 123.6, 122.9, 87.3, 62.6, 37.6, 29.,3, 29.3, 28.7, 28.6, 25.3, 25.2, 25.0, 24.7, 24.4, 
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23.2, 22.7, 22.7, 22.7; 
11
B NMR (128.4 MHz, CDCl3) δ –34.4 (q, J = 85 Hz); HRMS (ESI) calcd. 
for C38H48
11
BN3NaO2 ([M + Na]
+
)
 
612.3737, found 612.3747. 
 
1,3-Bis(2,6-diisopropylphenyl)-13b-hydroxy-9-oxo-4,5,6,7-
tetrahydroimidazo[4',5':3,4]azocino[2,1-a]isoindol-2-ylidene borane (258):
163
 Compound 258 
was prepared according to GP9 from dipp-Imd-BH3 40 (40.5 mg, 0.10 mmol), BuLi (1.3 M in 
hexanes, 0.12 mL, 0.16 mmol), and N-(4-bromobutyl)phthalimide 257 (85 mg, 0.30 mmol). 
Elution with hexane:EtOAc = 75:25 gave 258 as a white solid (4.8 mg, 8%): mp 238–239 °C 
(decomp.); IR (thin film, cm
–1
)  νmax 2962, 2928, 2869, 2385 (B–H), 2322 (B–H), 1713 (C=O), 
1468, 1444, 1367, 1351, 1147, 1080, 1063, 1021, 973, 803, 765, 745; 
1
H NMR (400 MHz, 
CDCl3) δ 7.57–7.38 (m, 4H), 7.32–7.27 (m, 3H), 7.18 (app t, J = 6.8 Hz, 2H), 6.91 (br d, J = 6.8 
Hz, 1H), 4.10 (br d, J = 14.0 Hz, 1H), 3.49 (br d, J = 12.8 Hz, 1H), 2.95–2.86 (m, 1H), 2.63–2.53 
(m, 2H), 2.47 (septet, J = 6.9 Hz, 1H), 2.32 (septet, J = 6.6 Hz, 1H), 2.27 (septet, J = 6.6 Hz, 
1H), 1.75–1.45 (m, 5H), 1.32 (d, J = 6.8 Hz, 3H), 1.32 (d, J = 6.8 Hz, 3H), 1.27 (d, J = 6.4 Hz, 
3H), 1.24 (d, J = 6.4 Hz, 3H), 1.23 (d, J = 6.8 Hz, 3H), 1.18 (d, J = 6.8 Hz, 3H), 1.17 (d, J = 6.8 
Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.53 (br q, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 168.0, 146.0, 
145.4, 145.2, 145.2, 143.3, 133.8, 133.1, 133.0, 132.4, 131.2, 130.1, 130.0, 124.3, 124.1, 123.7, 
123.4, 123.3, 123.2, 91.4, 63.3, 39.9, 29.5, 29.1, 28.7, 25.4, 25.3, 25.3, 25.1, 24.9, 23.4, 23.3, 
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22.7, 22.6; 
11
B NMR (128.4 MHz, CDCl3) δ –34.0 (br q, J = 94 Hz); HRMS (ESI) calcd. for 
C39H50
11
BN3NaO2 ([M + Na]
+
)
 
626.3894, found 626.3902. 
 
4,5-(PhS)2-diiPr-Imd-BH2SPh (259), 4-PhS-diiPr-Imd-BH2SPh (260), diiPr-Imd-BH2SPh 
(261):
163
 Compounds 259–261 was prepared according to GP9 from diiPr-Imd-BH3 45 (16.6 mg, 
0.10 mmol) and diphenyl disulfide (20 mg, 0.11 mmol). Elution with hexane:EtOAc = 95:5 gave  
4,5-(PhS)2-diiPr-Imd-BH2SPh 259 (7.0 mg, 14%) as colorless oil.  Elution with hexane:EtOAc = 
90:10 gave  4-PhS-diiPr-Imd-BH2SPh 260 (5.1 mg, 13%) as a white solid. Elution with 
hexane:EtOAc = 80:20 gave  diiPr-Imd-BH2SPh 261 (8.8 mg, 32%) as a white solid. 
1,3-diisopropyl-4,5-bis(phenylthio)imidazol-2-ylidene (phenylthio)borane (259): mp 138–
141 °C; IR (thin film, cm–1)  νmax 3060, 2973, 2933, 2360 (B–H), 2340 (B–H), 1581, 1476, 1440, 
1369, 1289, 1181, 1139, 1070, 1023, 737; 
1
H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 8.0 Hz, 
2H), 7.26–7.20 (m, 4H), 7.20–7.12 (m, 4H), 7.05–6.97 (m, 2H), 6.97–6.89 (m, 3H), 5.59 (br s, 
2H), 2.82 (br q, 2H) 1.53 (d, J = 6.5 Hz, 12H); 
13
C
 
NMR (125 MHz, CDCl3) δ 130.0, 129.4, 
129.3, 128.0, 126.8, 123.2, 53.2, 21.8; 
11
B NMR (128.4 MHz, CDCl3) δ –23.4 (br s); HRMS 
(ESI) calcd. for C27H30
11
BN2S3 ([M – H]
+
)
 
489.1664, found 489.1651. 
1,3-diisopropyl-4-(phenylthio)imidazol-2-ylidene (phenylthio)borane (260): mp 85–86 °C; IR 
(thin film, cm
–1
)  νmax 3146, 3066, 2973, 2930, 2399 (B–H), 2326 (B–H), 1581, 1476, 1440, 
1394, 1371, 1303, 1260, 1189, 1137, 1104, 1023, 738; 
1
H NMR (400 MHz, CDCl3) δ 7.44 (d, J 
= 7.8 Hz, 2H), 7.31 (t, J = 7.6 Hz, 2H), 7.23 (t, J = 7.2 Hz, 2H), 7.14 (t, J = 7.8 Hz, 2H), 7.05–
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6.96 (m, 3H), 5.39 (br s, 1H), 5.24 (septet, J = 6.6 Hz, 1H), 2.72 (br q, J = 120 Hz, 2H), 1.47 (d, 
J = 6.8 Hz, 6H), 1.40 (d, J = 6.8 Hz, 6H); 
13
C
 
NMR (100 MHz, CDCl3) δ 142.6, 130.7, 129.5, 
128.0, 126.8, 126.4, 123.2, 52.0, 50.5, 23.2, 21.8; 
11
B NMR (128.4 MHz, CDCl3) δ –24.0 (t, J = 
105 Hz); HRMS (ESI) calcd. for C21H26
11
BN2S2 ([M – H]
+
)
 
381.1630, found 381.1624. 
1,3-diisopropylimidazol-2-ylidene (phenylthio)borane (261): mp 96–98 °C; IR (thin film, cm–
1
)  νmax 3157, 3121, 3103, 3053, 2981, 2966, 2930, 2872, 2415 (B–H), 2344 (B–H), 1578, 1568, 
1475, 1441, 1398, 1371, 1211, 1180, 1137, 1063, 1036, 746, 714; 
1
H NMR (400 MHz, CDCl3) δ 
7.43 (dd, J = 8.0, 1.2 Hz, 2H), 7.12 (t, J = 6.8 Hz, 2H), 6.99 (s, 2H), 6.97 (t, J = 7.2 Hz, 1H), 
5.19 (septet, J = 6.7 Hz, 2H), 2.68 (q, JB–H = 114 Hz, 2H), 1.38 (d, J = 6.8 Hz, 12H),; 
13
C
 
NMR 
(125 MHz, CDCl3) δ 142.9, 130.5, 127.9, 123.0, 116.1, 49.7, 23.2; 
11
B NMR (128.4 MHz, 
CDCl3) δ –24.5 (t, J = 103 Hz); HRMS (ESI) calcd. for C15H22
11
BN2S ([M – H]
+
)
 
273.1597, 
found 273.1612. 
 
4-(6-Bromohexyl)-1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene borane (4-Br(CH2)6-
dipp-Imd-BH3) (262):
163
 Compound 262 was prepared according to GP9 from dipp-Imd-BH3 40 
(40.5 mg, 0.10 mmol) and 1,6-dibromohexane
179
 (77 µL, 0.50 mmol). Elution with hexane:Et2O 
= 90:10 gave 4-Br(CH2)6-dipp-Imd-BH3 262 as a white solid (36.6 mg, 64%): mp 129–131 °C; 
IR (thin film, cm
–1
)  νmax 3128, 3070, 2963, 2931, 2868, 2353 (B–H), 1594, 1471, 1418, 1384, 
1363, 1329, 1303, 1256, 1180, 1146, 1121, 1060, 937, 804, 756, 736; 
1
H NMR (400 MHz, 
CDCl3) δ 7.48 (t, J = 8.0 Hz, 1H), 7.44 (t, J = 8.2 Hz, 1H), 7.31 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 
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7.6 Hz, 2H), 6.74 (s, 1H), 3.38 (t, J = 6.8 Hz, 2H),  2.58 (septet, J = 6.8 Hz, 2H),  2.47 (septet, J 
= 6.7 Hz, 2H), 2.23 (t, J = 7.6 Hz, 2H), 1.82 (quintet, J = 6.9 Hz, 2H), 1.65 (quintet, J = 7.5 Hz, 
2H), 1.50–1.35 (m, 4H), 1.29 (d, J = 6.8 Hz, 12H), 1.21 (d, J = 8.0 Hz, 6H), 1.19 (d, J = 7.6 Hz, 
6H), 0.54 (br q, J = 81 Hz, 3H); 
13
C
 
NMR (125 MHz, CDCl3) δ 145.6, 145.3, 134.4, 134.0, 
132.2, 130.0, 129.7, 124.1, 123.8, 117.7, 33.5, 32.5, 28.8, 28.6, 28.3, 27.9, 26.8, 24.7, 24.5, 23.8, 
23.8, 23.0; 
11
B NMR (128.4 MHz, CDCl3) δ –36.0 (q, J = 89 Hz); HRMS (ESI) calcd. for 
C33H50
11
B
79
BrN2 ([M]
+
)
 
564.3250, found 564.3237. 
 
4-(6-Bromohexyl)-1,3-bis(2,6-diisopropylphenyl)imidazolium triflate (4-Br(CH2)6-dipp- 
Imd-HOTf) (263):
163
 Triflic acid (2 µL, 0.023 mmol) was added to a solution of 4-Br(CH2)6-
dipp-Imd-BH3 262 (13 mg, 0.023 mmol) in CDCl3 (1 mL) in an NMR tube at rt. The evolution of 
hydrogen gas was observed. The NMR spectroscopy of the crude mixture showed the complete 
transformation into boryl triflate 4-Br(CH2)6-dipp-Imd-BH2OTf (
11B NMR δ = –8.6, br s). 
Methanol (0.09 mL, 2.2 mmol) was added to the resulting solution at rt. After 40 min, the single 
peak in the 
11
B
 
NMR spectrum of the crude mixture was that of B(OMe)3 at +18.7 ppm. The 
volatiles were removed and 4-Br(CH2)6-dipp-Imd-HOTf 263 was obtained as colorless 
hygroscopic oil (18.6 mg, 115%). The compound was pure by 
13
C and 
19
F NMR spectroscopy 
and there were no signals in the 
11
B NMR spectrum. We assumed that the broad signal in the 
1
H 
NMR spectrum is water that is also responsible for the exceeding mass of the product: IR (thin 
film, cm
–1
)  νmax 2966, 2931, 2872, 1645, 1538, 1467, 1389, 1368, 1331, 1260, 1225, 1182, 1156, 
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1031, 913, 804, 755, 732; 
1
H NMR (500 MHz, CDCl3) δ 9.28 (s, 1H), 7.63 (t, J = 7.5 Hz, 1H), 
7.57 (t, J = 7.8 Hz, 1H), 7.46 (s, 1H), 7.39 (d, J = 7.5 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 3.37 (t, J 
= 6.3 Hz, 2H),  2.50–2.35 (m, 4H),  2.27 (septet, J = 6.8 Hz, 2H), 1.81 (quintet, J = 6.8 Hz, 2H), 
1.69 (quintet, J = 7.3 Hz, 2H), 1.50–1.35 (m, 4H), 1.30 (d, J = 7.0 Hz, 6H), 1.28 (d, J = 7.0 Hz, 
6H), 1.22 (d, J = 7.0 Hz, 6H), 1.20 (d, J = 7.0 Hz, 6H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.2, 
144.8, 138.0, 137.8, 132.5, 132.1, 129.8, 127.2, 125.1, 124.7, 122.8, 33.7, 32.2, 29.2, 29.1, 28.0, 
27.4, 26.8, 25.0, 24.3, 23.9, 23.6, 22.9; 
19
F
 
NMR (376 MHz, CDCl3) δ –78.75 (s); HRMS (ESI) 
calcd. for C33H48
79
BrN2 ([M – OTf]
+
)
 
551.3001, found 551.3034. 
 
4-(6-Azidohexyl)-1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene iodoborane (4-N3(CH2)6-
dipp-Imd-BH2I) (283):
163
 A solution of iodine (7.6 mg, 0.03 mmol) in C6D6 (0.5 mL) was added 
to a solution of 4-N3(CH2)6-dipp-Imd-BH3 246a (26 mg, 0.049 mmol) in C6D6 (0.5 mL) in an 
NMR tube at rt. The dark brown mixture was shaken for 10 min while the evolution of gas was 
observed. NMR spectroscopy of the crude mixture showed the complete formation of iodoborane 
283: 
1
H NMR (400 MHz, C6D6) δ 7.26 (t, J = 7.6 Hz, 1H), 7.20 (t, J = 7.6 Hz, 1H), the doublet 
(2H) is overlapped with the solvent peak at 7.15 ppm, 7.07 (d, J = 7.8 Hz, 2H), 6.53 (s, 1H), 2.93 
(septet, J = 6.8 Hz, 2H), 2.68 (septet, J = 6.8 Hz, 2H), 2.60 (t, J = 6.8 Hz, 2H), 1.97 (t, J = 7.8 
Hz, 2H), 1.48 (d, J = 6.8 Hz, 6H), 1.45 (d, J = 6.8 Hz, 6H), 1.17 (app quintet, J = 7.7 Hz, 2H), 
1.05 (d, J = 6.8 Hz, 6H), 1.04 (d, J = 6.8 Hz, 6H), 0.86 (app quintet, J = 6.8 Hz, 2H); 0.76 (app 
quintet, J = 7.2 Hz, 2H); 
11
B NMR (128.4 MHz, C6D6) δ –31.9 (br s). 
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4-(6-Aminohexyl)-1,3-bis(2,6-diisopropylphenyl)imidazolium iodide (4-H2N(CH2)6-dipp- 
Imd-HI) (264):
163
 Methanol (0.2 mL, 4.9 mmol) was added to a solution of 4-N3(CH2)6-dipp-
Imd-BH2I 283 (0.049 mmol) in C6D6 (1 mL) at rt. The resulting light brown transparent solution 
was shaken for 5 min until the evolution of gas stopped. 
11
B
 
NMR spectroscopy of the crude 
mixture showed the single peak of B(OMe)3 at +18.7 ppm. The volatiles were removed and the 
brown oily residue was dissolved in CH2Cl2 and purified by column chromatography on silica 
gel. Elution with CH2Cl2:MeOH = 90:10 gave 4-H2N(CH2)6-dipp-Imd-HI 264 as a light yellow 
semi-solid (24.6 mg, 81%): IR (thin film, cm
–1
)  νmax 2962, 2927, 2869, 1728, 1642, 1537, 1464, 
1388, 1367, 1330, 1276, 1258, 1182, 1116, 1061, 1031, 806, 756; 
1
H NMR (400 MHz, CDCl3) δ 
8.74 (d, J = 1.6 Hz, 1H) (this signal H-2 disappears in CD3OD due to H/D exchange), 8.20 (s, 
1H), 7.66 (t, J = 7.8 Hz, 1H), 7.59 (t, J = 7.8 Hz, 1H), 7.42 (d, J = 7.8 Hz, 2H), 7.37 (d, J = 8.0 
Hz, 2H), 3.10 (t, J = 7.4 Hz, 2H), 2.55–2.40 (m, 4H), 2.33 (septet, J = 6.8 Hz, 2H), 2.00 (app 
quintet, J = 7.3 Hz, 2H), 1.82 (app quintet, J = 7.6 Hz, 2H), 1.51 (app quintet, J = 6.1 Hz, 2H), 
1.42 (app quintet, J = 6.8 Hz, 2H), 1.36 (d, J = 6.8 Hz, 6H), 1.34 (d, J = 6.8 Hz, 6H), 1.22 (d, J = 
7.4 Hz, 6H), 1.20 (d, J = 7.4 Hz, 6H); 
13
C
 
NMR (100 MHz, CDCl3) δ 145.4, 145.0, 138.7, 135.2, 
132.7, 132.3, 129.5, 127.1, 125.3, 124.9, 123.6, 39.8, 29.7, 29.1, 27.5, 26.4, 25.6, 25.4, 24.8, 
24.4, 23.8, 23.2; HRMS (ESI) calcd. for C33H50N3 ([M – I]
+
)
 
488.4005, found 488.3968. 
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4-(6-(4-(4-Bromophenyl)-1,2,3-triazol-1-yl)hexyl)-1,3-bis(2,6-diisopropylphenyl)imidazol-2-
ylidene borane (4-Triazol-(CH2)6-dipp-Imd-BH3) (265):
163
 Copper sulfate pentahydrate (12.5 
mg, 0.050 mmol) was added to a suspension of 4-N3(CH2)6-dipp-Imd-BH3 246a (26.4 mg, 0.050 
mmol), 1-bromo-4-ethynylbenzene (18 mg, 0.10 mmol), and sodium ascorbate (99 mg, 0.50 
mmol) in tert-butanol (0.5 mL) and H2O (0.5 mL) at rt. The yellow heterogeneous mixture was 
stirred for 18 h. Then it was diluted with H2O (5 mL) and filtered. The yellow solid was washed 
with H2O (2 × 5 mL) and dried under vacuum. Then it was dissolved in CH2Cl2 (10 mL) and 
insoluble particles were filtered off. The filtrate was concentrated to give 4-Triazol-(CH2)6-dipp-
Imd-BH3 265 as a light yellow solid (33.2 mg, 94%): mp 71–73 °C; IR (thin film, cm
–1
)  νmax 
3118, 3070, 3032, 2962, 2929, 2868, 2350 (B–H), 2234 (B–H), 1594, 1548, 1471, 1459, 1412, 
1384, 1364, 1329, 1257, 1226, 1181, 1151, 1069, 1045, 1011, 972, 938, 911, 826, 805, 759, 734; 
1
H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 7.69 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 8.0 Hz, 2H), 
7.47 (t, J = 7.6 Hz, 1H), 7.43 (t, J = 7.6 Hz, 1H), 7.28 (d, J = 9.6 Hz, 2H), 7.26 (d, J = 8.8 Hz, 
2H), 6.72 (s, 1H), 4.35 (t, J = 6.2 Hz, 2H),  2.56 (br septet, J = 6.6 Hz, 2H),  2.44 (br septet, J = 
6.6 Hz, 2H), 2.20 (br t, J = 7.0 Hz, 2H), 1.90 (br quintet, 2H), 1.63 (br quintet, 2H), 1.45–1.25 
(m, 4H), 1.26 (d, J = 6.0 Hz, 12H), 1.18 (br d, 12H), 0.55 (br q, 3H); 
1
H NMR (500 MHz, 
acetone-d6) δ 8.35 (s, 1H), 7.81 (d, J = 6.8 Hz, 2H), 7.60 (d, J = 7.0 Hz, 2H), 7.49 (t, J = 7.8 Hz, 
1H), 7.44 (t, J = 7.8 Hz, 1H), 7.35 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 7.5 Hz, 2H), 4.41 (t, J = 7.3 
Hz, 2H), 2.64 (septet, J = 6.9 Hz, 2H),  2.53 (septet, J = 6.8 Hz, 2H), 2.25 (t, J = 7.3 Hz, 2H), 
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1.92 (quintet, J = 7.3 Hz, 2H), 1.72 (quintet, J = 7.6 Hz, 2H), 1.44 (quintet, J = 7.5 Hz, 2H), 1.35 
(quintet, J = 7.5 Hz, 2H),  1.25 (d, J = 7.0 Hz, 12H), 1.20 (d, J = 7.0 Hz, 6H), 1.15 (d, J = 6.5 Hz, 
6H), 0.62 (br q, J = 88 Hz, 3H); 
13
C
 
NMR (100 MHz, CDCl3) δ 146.7, 145.6, 145.3, 134.3, 
133.9, 132.1, 132.0, 130.0, 129.7, 129.5, 127.1, 124.1, 123.8, 122.0, 119.5, 117.7, 50.2, 30.2, 
28.7, 28.7, 28.6, 26.8, 26.3, 24.7, 24.5, 23.8, 23.7, 23.0; 
11
B NMR (128.4 MHz, CDCl3) δ –36.0 
(br q, J = 89 Hz); HRMS (ESI) calcd. for C41H55
11
B
79
BrN5 ([M]
+
)
 
708.3812, found 708.3752. 
 
4-(6-(4-(4-Bromophenyl)-1,2,3-triazol-1-yl)hexyl)-1,3-bis(2,6-
diisopropylphenyl)imidazolium triflate (4-Triazol-(CH2)6-dipp-Imd-HOTf) (266):
163
  Triflic 
acid (3.7 µL, 0.042 mmol) was added to a solution of 4-Triazol-(CH2)6-dipp-Imd-BH3 265 (30 
mg, 0.042 mmol) in CDCl3 (1 mL) in an NMR tube at rt. The evolution of hydrogen gas was 
observed. The NMR spectroscopy of the crude mixture showed the complete transformation into 
boryl triflate 4-Triazol-(CH2)6-dipp-Imd-BH2OTf (
11
B NMR δ = –8.8, br s). Methanol (0.17 mL, 
4.2 mmol) was added to the resulting solution at rt. After 40 min, the single peak in the 
11
B
 
NMR 
spectrum of the crude mixture was that of B(OMe)3 at +18.5 ppm. The volatiles were removed 
and the yellow oily residue was washed with diethyl ether (2 × 3 mL). The insoluble solid was 
dried under vacuum to give 4-Triazol-(CH2)6-dipp-Imd-HOTf 266 as a light yellow solid (32.8 
mg, 92%): mp 98–102 °C; IR (thin film, cm–1)  νmax 3099, 3027, 2966, 2931, 2872, 1699, 1622, 
1597, 1538, 1467, 1389, 1368, 1353, 1331, 1279, 1259, 1225, 1159, 1071, 1060, 1031, 1011, 
973, 829, 807, 756; 
1
H NMR (400 MHz, acetone-d6) δ 9.72 (s, 1H), 8.94 (s, 1H), 8.25 (s, 1H), 
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7.91 (d, J = 8.0 Hz, 2H), 7.77–7.63 (m, 4H), 7.58 (d, J = 7.6 Hz, 2H), 7.52 (d, J = 8.0 Hz, 2H), 
4.64 (t, J = 6.6 Hz, 2H), 2.65–2.54 (m, 4H), 2.50 (br septet, J = 6.6 Hz, 2H), 2.05 (br s, 2H), 1.82 
(br quintet, J = 6.8 Hz, 2H), 1.60–1.40 (m, 4H), 1.34 (d, J = 6.4 Hz, 6H), 1.29 (d, J = 6.4 Hz, 
6H), 1.24 (d, J = 6.8 Hz, 6H), 1.22 (d, J = 6.8 Hz, 6H); 
13
C
 
NMR (100 MHz, acetone-d6) δ 146.5, 
146.1, 139.2, 138.4, 133.4, 133.2, 132.9, 131.2, 129.0, 128.6, 127.1, 126.1, 125.5, 124.2, 123.9, 
52.7, 28.8, 27.2, 26.4, 25.5, 24.7, 24.4, 23.9, 23.0; 
19
F
 
NMR (376 MHz, CDCl3, 323K) δ –78.43 
(s); HRMS (ESI) calcd. for C41H53
79
BrN5 ([M – OTf]
+
)
 
694.3484, found 694.3437. 
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APPENDIX A 
STEREOVIEWS OF X-RAY CRYSTAL STRUCTURES 
1. Dipp-Imd-BH2SC(=O)SMe 84 (see also Figure 7, Section 2.3) 
 
Figure 27. Stereoview of dipp-Imd-BH2SC(=O)SMe. 
2. Dipp-Imd-BH2OTs 117 (see also Figure 10, Section 3.2) 
 
Figure 28. Stereoview of dipp-Imd-BH2OTs. 
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3. Dipp-Imd-BH2SO2PT 156 (see also Figure 12, Section 4.1) 
 
Figure 29. Stereoview of dipp-Imd-BH2SO2PT. 
4. Dipp-Imd-BH2NCS 148 (see also Figure 13, Section 4.1) 
 
Figure 30. Stereoview of dipp-Imd-BH2NCS. 
5. Dipp-Imd-BH2NCO 149 (see also Figure 13, Section 4.1) 
 
Figure 31. Stereoview of dipp-Imd-BH2NCO. 
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6. Dipp-Imd-BH2N3 150 (see also Figure 14, Section 4.1) 
 
Figure 32. Stereoview of dipp-Imd-BH2N3. 
7. Dipp-Imd-BH2ONO 151 (see also Figure 15, Section 4.1) 
 
Figure 33. Stereoview of dipp-Imd-BH2ONO. 
 
8. Dipp-Imd-BH2NO2 152 (see also Figure 15, Section 4.1) 
 
Figure 34. Stereoview of dipp-Imd-BH2NO2. 
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9. [Dipp-Imd-B(OH)2]OTf 196 (see also Figure 18, Section 4.3) 
 
Figure 35. Stereoview of [dipp-Imd-B(OH)2]OTf. 
 
10. Dipp-Imd-BH2Ac 214 (see also Figure 22, Section 5.1) 
 
Figure 36. Stereoview of dipp-Imd-BH2Ac. 
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APPENDIX B 
CONTENT OF THE SUPPORTING DVD 
1. An electronic copy of this dissertation. 
2. Seven papers with the Supporting Information where results of this dissertation work 
were published: 
a) Ueng, S.-H.; Solovyev, A.; Yuan, X.; Geib, S. J.; Fensterbank, L.; Lacôte, E.; 
Malacria, M.; Newcomb, M.; Walton, J. C.; Curran, D. P. J. Am. Chem. Soc. 2009, 
131, 11256-11262. 
b) Chu, Q.; Makhlouf Brahmi, M.; Solovyev, A.; Ueng, S.-H.; Curran, D.; Malacria, M.; 
Fensterbank, L.; Lacôte, E. Chem. Eur. J. 2009, 15, 12937-12940. 
c) Walton, J. C.; Makhlouf Brahmi, M.; Fensterbank, L.; Lacôte, E.; Malacria, M.; Chu, 
Q.; Ueng, S.-H.; Solovyev, A.; Curran, D. P. J. Am. Chem. Soc. 2010, 132, 2350-
2358. 
d) Solovyev, A.; Ueng, S.-H.; Monot, J.; Fensterbank, L.; Malacria, M.; Lacôte, E.; 
Curran, D. P. Org. Lett. 2010, 12, 2998-3001. 
e) Solovyev, A.; Chu, Q.; Geib, S. J.; Fensterbank, L.; Malacria, M.; Lacôte, E.; Curran, 
D. P. J. Am. Chem. Soc. 2010, 132, 15072-15080. 
f) Monot, J.; Solovyev, A.; Bonin-Dubarle, H.; Derat, É.; Curran, D. P.; Robert, M.; 
Fensterbank, L.; Malacria, M.; Lacôte, E. Angew. Chem. Int. Ed. 2010, 49, 9166-
9169. 
g) Solovyev, A.; Lacôte, E.; Curran, D. P. Org. Lett. 2011, 13, 6042–6045. 
3. Copies of all unpublished NMR spectra. 
4. Cif files with X-ray crystal structures. 
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